,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,5,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
1,7,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
2,9,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
3,11,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
4,15,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
5,17,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
6,19,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
7,21,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
8,23,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
9,25,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
10,27,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
11,29,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
12,31,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
13,33,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
14,35,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
15,37,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
16,39,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
17,45,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
18,47,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
19,49,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
20,51,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
21,53,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
22,55,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
23,57,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
24,59,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
25,61,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
26,63,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
27,67,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
28,69,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
29,71,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
30,73,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
31,75,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
32,77,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
33,79,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
34,81,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
35,99,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
36,101,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
37,103,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
38,105,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
39,107,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
40,109,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
41,115,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
42,119,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
43,121,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
44,123,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
45,125,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
46,129,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
47,131,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
48,133,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
49,135,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
50,137,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
51,139,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
52,141,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
53,143,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
54,145,1,1,,74741,5280343,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
55,155,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
56,157,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
57,161,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
58,165,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
59,167,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
60,175,1,1,,74741,5280343,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
61,179,1,1,,74741,5280343,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
62,192,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
63,200,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
64,210,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
65,220,1,1,,74741,5280343,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
66,222,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in C57BL/6 mice,Other,,
67,248,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
68,256,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
69,270,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
70,272,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
71,328,1,1,,74741,5280343,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
72,330,1,1,,74741,5280343,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
73,351,1,4,,7636346,5280343,Inactive,,,,,Tubulin destabilizers,Other,,
74,357,2,1,,11111704,5280343,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
75,365,1,3,,8137945,5280343,Inactive,67472286.0,,,,E. coli RNase H Inhibition,Screening,,
76,366,1,3,,8137945,5280343,Active,21359816.0,246243.0,,,human RNase H Inhibition,Screening,,
77,367,1,3,,8137945,5280343,Active,24987805.0,,,,HIV-2 RNase H Inhibition,Screening,,
78,382,1,4,,10318962,5280343,Active,206729857.0,1195.0,,,"Compound Screen Assay, Human CLK1",Other,,
79,382,1,4,,10318963,5280343,Active,206729857.0,1195.0,,,"Compound Screen Assay, Human CLK1",Other,,
80,383,1,3,,10318962,5280343,Active,153791372.0,1198.0,,,"Compound Screen Assay, Human CLK3",Other,,
81,383,1,3,,10318963,5280343,Active,153791372.0,1198.0,,,"Compound Screen Assay, Human CLK3",Other,,
82,384,1,3,,10318962,5280343,Active,153791733.0,1455.0,,,"Compound Screen Assay, Human CSNK1G2",Screening,,
83,386,1,3,,10318962,5280343,Active,21553323.0,148252.0,,,"Compound Screen Assay, Human DIRAS",Screening,,
84,393,1,2,,10318962,5280343,Active,4505811.0,5292.0,,,"Compound Screen Assay, Human PIM1",Other,,
85,395,1,3,,10318962,5280343,Active,57165436.0,8576.0,,,"Compound Screen Assay, Human STK16",Screening,,
86,395,1,3,,10318963,5280343,Active,57165436.0,8576.0,,,"Compound Screen Assay, Human STK16",Screening,,
87,396,1,2,,10318962,5280343,Active,4507949.0,7529.0,,,"Compound Screen Assay, Human YWHAB",Screening,,
88,410,1,5,,11111704,5280343,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
89,410,1,5,,11111705,5280343,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
90,410,1,5,,11111706,5280343,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
91,410,1,5,,11113933,5280343,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
92,411,2,1,,11111704,5280343,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
93,411,2,1,,11111705,5280343,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
94,411,2,1,,11111706,5280343,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
95,411,2,1,,11113933,5280343,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
96,422,1,5,,17405557,5280343,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
97,429,1,5,,17405557,5280343,Active,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
98,429,1,5,,17405557,5280343,Active,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
99,436,2,1,,17405557,5280343,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
100,444,1,1,,11111704,5280343,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
101,445,3,1,,11111704,5280343,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
102,445,3,1,,11111705,5280343,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
103,445,3,1,,11111706,5280343,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
104,445,3,1,,11113933,5280343,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
105,446,1,1,,11111704,5280343,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
106,447,1,1,,11111704,5280343,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
107,447,1,1,,11111705,5280343,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
108,447,1,1,,11111706,5280343,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
109,447,1,1,,11113933,5280343,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
110,448,1,2,,11111704,5280343,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
111,448,1,2,,11111705,5280343,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
112,448,1,2,,11111706,5280343,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
113,448,1,2,,11113933,5280343,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
114,450,1,2,,11111704,5280343,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
115,450,1,2,,11111705,5280343,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
116,450,1,2,,11111706,5280343,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
117,450,1,2,,11113933,5280343,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
118,451,1,2,,11111704,5280343,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
119,451,1,2,,11111705,5280343,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
120,451,1,2,,11111706,5280343,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
121,451,1,2,,11113933,5280343,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
122,505,1,2,,10318962,5280343,Active,42821112.0,11040.0,,,"Compound Screen Assay, Human PIM2",Screening,,
123,505,1,2,,10318963,5280343,Active,42821112.0,11040.0,,,"Compound Screen Assay, Human PIM2",Screening,,
124,506,1,2,,10318962,5280343,Active,4505373.0,4751.0,,,"Compound Screen Assay, Human NEK2",Screening,,
125,513,1,2,,10318962,5280343,Active,98986450.0,53944.0,,,"Compound Screen Assay, Human CSNK1G1",Screening,,
126,514,1,2,,10318962,5280343,Active,41281453.0,9748.0,,,"Compound Screen Assay, Human SLK",Screening,,
127,515,1,2,,10318962,5280343,Active,5174547.0,4217.0,,,"Compound Screen Assay, Human MAP3K5",Screening,,
128,526,1,1,,11111704,5280343,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
129,526,1,1,,11111705,5280343,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
130,526,1,1,,11111706,5280343,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
131,526,1,1,,11113933,5280343,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
132,530,1,1,,11111704,5280343,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
133,530,1,1,,11111705,5280343,Active,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
134,530,1,1,,11111706,5280343,Active,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
135,530,1,1,,11113933,5280343,Active,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
136,547,1,4,,17405557,5280343,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
137,584,1,3,,11111704,5280343,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
138,584,1,3,,11111705,5280343,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
139,584,1,3,,11111706,5280343,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
140,584,1,3,,11113933,5280343,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
141,585,1,4,,11111704,5280343,Active,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
142,585,1,4,,11111705,5280343,Active,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
143,585,1,4,,11111706,5280343,Active,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
144,585,1,4,,11113933,5280343,Active,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
145,587,1,5,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
146,587,1,5,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
147,587,1,5,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
148,588,1,4,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
149,588,1,4,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
150,588,1,4,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
151,589,1,3,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
152,589,1,3,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
153,589,1,3,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
154,590,1,3,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
155,590,1,3,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
156,590,1,3,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
157,591,1,4,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
158,591,1,4,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
159,591,1,4,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
160,592,1,6,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
161,592,1,6,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
162,592,1,6,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
163,593,1,4,,11111704,5280343,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
164,593,1,4,,11111705,5280343,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
165,593,1,4,,11111706,5280343,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
166,594,1,4,,11111704,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
167,594,1,4,,11111705,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
168,594,1,4,,11111706,5280343,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
169,595,1,3,,11111704,5280343,Active,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
170,595,1,3,,11111705,5280343,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
171,595,1,3,,11111706,5280343,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
172,595,1,3,,11113933,5280343,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
173,596,1,2,,11111704,5280343,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
174,596,1,2,,11111705,5280343,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
175,596,1,2,,11111706,5280343,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
176,596,1,2,,11113933,5280343,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
177,597,1,3,,11111704,5280343,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
178,597,1,3,,11111705,5280343,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
179,597,1,3,,11111706,5280343,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
180,597,1,3,,11113933,5280343,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
181,603,1,2,,11111704,5280343,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
182,603,1,2,,11111705,5280343,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
183,603,1,2,,11111706,5280343,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
184,603,1,2,,11113933,5280343,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
185,605,1,2,,11111704,5280343,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
186,605,1,2,,11111705,5280343,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
187,605,1,2,,11111706,5280343,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
188,605,1,2,,11113933,5280343,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
189,607,1,3,,11111704,5280343,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
190,607,1,3,,11111705,5280343,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
191,607,1,3,,11111706,5280343,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
192,607,1,3,,11113933,5280343,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
193,662,1,1,,11111704,5280343,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
194,662,1,1,,11111705,5280343,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
195,662,1,1,,11111706,5280343,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
196,662,1,1,,11113933,5280343,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
197,694,1,1,,17405557,5280343,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
198,732,1,2,,17405557,5280343,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
199,747,1,1,,24715041,5280343,Unspecified,4885617.0,6783.0,,,Basic StarGazer Assay on Human SULT1E1,Other,,
200,875,1,2,,11113933,5280343,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
201,879,1,2,,11113933,5280343,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
202,879,1,2,,11113933,5280343,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
203,880,2,1,,11113933,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
204,880,2,1,,11113933,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
205,880,2,1,,26747157,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
206,880,2,1,,26747157,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
207,880,2,1,,26752084,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
208,880,2,1,,26752084,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
209,880,2,1,,26752085,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
210,880,2,1,,26752085,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
211,880,2,1,,26752086,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
212,880,2,1,,26752086,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
213,880,2,1,,50104737,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
214,880,2,1,,50104737,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
215,880,2,1,,50104738,5280343,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
216,880,2,1,,50104738,5280343,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
217,881,2,2,,11113933,5280343,Active,317373425.0,247.0,15.8489,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
218,881,2,2,,26752084,5280343,Active,317373425.0,247.0,12.5893,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
219,883,1,3,,11111704,5280343,Inconclusive,13699818.0,1559.0,19.9526,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
220,883,1,3,,11111705,5280343,Active,13699818.0,1559.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
221,883,1,3,,11111706,5280343,Active,13699818.0,1559.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
222,883,1,3,,11113933,5280343,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
223,884,1,2,,11113933,5280343,Active,13435386.0,1576.0,6.3096,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
224,885,1,2,,11113933,5280343,Inactive,13435386.0,1576.0,6.3096,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
225,886,1,2,,11111704,5280343,Active,122921310.0,,1.0,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
226,886,1,2,,11111704,5280343,Active,122921311.0,,1.0,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
227,886,1,2,,11111705,5280343,Active,122921310.0,,0.1259,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
228,886,1,2,,11111705,5280343,Active,122921311.0,,0.1259,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
229,886,1,2,,11111706,5280343,Active,122921310.0,,0.1585,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
230,886,1,2,,11111706,5280343,Active,122921311.0,,0.1585,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
231,886,1,2,,11113933,5280343,Active,122921310.0,,0.2512,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
232,886,1,2,,11113933,5280343,Active,122921311.0,,0.2512,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
233,887,1,2,,11113933,5280343,Active,1832253.0,246.0,0.7943,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
234,889,1,3,,11113933,5280343,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
235,891,1,2,,11111704,5280343,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
236,891,1,2,,11111705,5280343,Inconclusive,40805836.0,1565.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
237,891,1,2,,11111706,5280343,Inconclusive,40805836.0,1565.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
238,891,1,2,,11113933,5280343,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
239,892,1,2,,11113933,5280343,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
240,893,1,2,,11113933,5280343,Inconclusive,122921310.0,,7.9433,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
241,893,1,2,,11113933,5280343,Inconclusive,122921311.0,,7.9433,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
242,894,2,1,,11113933,5280343,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
243,894,2,1,,26747157,5280343,Active,31542939.0,3248.0,8.9125,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
244,894,2,1,,26752084,5280343,Active,31542939.0,3248.0,19.9526,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
245,894,2,1,,50104737,5280343,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
246,894,2,1,,50104738,5280343,Inconclusive,31542939.0,3248.0,22.3872,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
247,895,1,2,,11113933,5280343,Active,21620132.0,4790.0,5.6234,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
248,899,1,2,,11111704,5280343,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
249,899,1,2,,11111705,5280343,Active,4503219.0,1557.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
250,899,1,2,,11111706,5280343,Active,4503219.0,1557.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
251,899,1,2,,11113933,5280343,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
252,900,1,3,,11113933,5280343,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
253,901,1,2,,11113933,5280343,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
254,902,1,2,,11113933,5280343,Inactive,120407068.0,7157.0,1.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
255,910,1,2,,11113933,5280343,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
256,912,1,2,,11111704,5280343,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
257,912,1,2,,11111705,5280343,Inconclusive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
258,912,1,2,,11111706,5280343,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
259,912,1,2,,11113933,5280343,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
260,914,1,3,,11111704,5280343,Inconclusive,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
261,915,1,3,,11111704,5280343,Active,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
262,917,1,3,,11113933,5280343,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
263,918,1,3,,11113933,5280343,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
264,922,1,2,,11111706,5280343,Inconclusive,15724400.0,6778.0,2.5119,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Antagonists of Stat Signaling Pathway,Confirmatory,,
265,923,1,2,,11113933,5280343,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
266,924,1,2,,11113933,5280343,Inactive,120407068.0,7157.0,2.5119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
267,925,1,2,,11111704,5280343,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
268,926,1,2,,11111704,5280343,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
269,926,1,2,,11111705,5280343,Inconclusive,38016895.0,7253.0,10.0,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
270,926,1,2,,11111706,5280343,Inactive,38016895.0,7253.0,39.8107,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
271,926,1,2,,11113933,5280343,Inconclusive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
272,927,1,3,,11113933,5280343,Inconclusive,188528692.0,9099.0,31.6228,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
273,928,1,2,,11113933,5280343,Inconclusive,21620132.0,4790.0,5.6234,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
274,930,1,2,,11113933,5280343,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
275,934,1,2,,11111706,5280343,Inactive,15724400.0,6778.0,,Potency,Parental Cell Counter Screen for Stat Signaling Pathway Assay,Confirmatory,,
276,935,1,3,,11111706,5280343,Inconclusive,15724400.0,6778.0,2.5119,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Agonists of Stat Signaling Pathway,Confirmatory,,
277,938,1,2,,11111704,5280343,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
278,938,1,2,,11111705,5280343,Inactive,38016895.0,7253.0,10.0,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
279,938,1,2,,11111706,5280343,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
280,938,1,2,,11113933,5280343,Inactive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
281,940,1,2,,17405557,5280343,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
282,940,1,2,,26612015,5280343,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
283,943,1,2,,11113933,5280343,Inactive,18249941.0,25229.0,3.1623,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
284,944,1,2,,11113933,5280343,Inconclusive,18249941.0,25229.0,19.9526,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
285,945,1,4,,11113933,5280343,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
286,954,1,2,,11113933,5280343,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
287,957,1,2,,11113933,5280343,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
288,958,1,2,,11113933,5280343,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
289,959,1,4,,11113933,5280343,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
290,992,1,3,,11113933,5280343,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
291,995,1,2,,11113933,5280343,Inconclusive,66932916.0,5594.0,39.8107,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
292,997,1,2,,11113933,5280343,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
293,998,1,2,,11113933,5280343,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
294,999,1,1,,46487918,5280343,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor Using a Diverse Compound Set,Screening,,
295,1004,1,1,,46487918,5280343,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression Using a Diverse Compound Set,Screening,,
296,1030,2,1,,11113933,5280343,Inconclusive,30582681.0,216.0,35.4813,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
297,1030,2,1,,26747157,5280343,Active,30582681.0,216.0,12.5893,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
298,1030,2,1,,26752084,5280343,Inconclusive,30582681.0,216.0,25.1189,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
299,1030,2,1,,26752085,5280343,Inconclusive,30582681.0,216.0,35.4813,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
300,1030,2,1,,26752086,5280343,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
301,1030,2,1,,50104737,5280343,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
302,1030,2,1,,50104738,5280343,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
303,1189,1,5,,48414403,5280343,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
304,1194,1,3,,48414403,5280343,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
305,1199,1,3,,48414403,5280343,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
306,1204,1,2,,48421822,5280343,Inactive,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
307,1205,1,4,,48414403,5280343,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
308,1208,1,3,,48414403,5280343,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
309,1332,1,1,,49698528,5280343,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
310,1379,1,2,,11113933,5280343,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
311,1379,1,2,,26747157,5280343,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
312,1379,1,2,,26752084,5280343,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
313,1379,1,2,,50104737,5280343,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
314,1379,1,2,,50104738,5280343,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
315,1422,1,1,,17405557,5280343,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
316,1422,1,1,,26612015,5280343,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
317,1452,1,1,,11113933,5280343,Inconclusive,154426292.0,239.0,1.122,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
318,1452,1,1,,26752084,5280343,Inconclusive,154426292.0,239.0,1.0,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
319,1454,1,1,,11113933,5280343,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
320,1454,1,1,,26747157,5280343,Inconclusive,66932916.0,5594.0,31.6228,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
321,1454,1,1,,50104737,5280343,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
322,1454,1,1,,50104738,5280343,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
323,1457,1,1,,11113933,5280343,Inactive,44888968.0,83523.0,12.5893,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
324,1457,1,1,,26747157,5280343,Inactive,44888968.0,83523.0,10.0,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
325,1457,1,1,,26752084,5280343,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
326,1457,1,1,,26752085,5280343,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
327,1457,1,1,,26752086,5280343,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
328,1457,1,1,,50104737,5280343,Inactive,44888968.0,83523.0,11.2202,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
329,1457,1,1,,50104738,5280343,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
330,1458,1,1,,26747157,5280343,Inactive,10937869.0,6607.0,35.4813,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
331,1458,1,1,,26752085,5280343,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
332,1458,1,1,,26752086,5280343,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
333,1458,1,1,,50104737,5280343,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
334,1459,1,1,,50104737,5280343,Inconclusive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
335,1460,1,3,,11113933,5280343,Active,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
336,1460,1,3,,26747157,5280343,Active,92096784.0,4137.0,2.5119,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
337,1460,1,3,,26752084,5280343,Active,92096784.0,4137.0,8.9125,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
338,1460,1,3,,26752085,5280343,Active,92096784.0,4137.0,3.1623,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
339,1460,1,3,,26752086,5280343,Active,92096784.0,4137.0,7.0795,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
340,1460,1,3,,50104737,5280343,Active,92096784.0,4137.0,7.0795,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
341,1460,1,3,,50104738,5280343,Active,92096784.0,4137.0,12.5893,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
342,1461,1,2,,50104737,5280343,Inconclusive,46395496.0,387129.0,0.1585,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
343,1463,1,1,,11113933,5280343,Active,,,17.7828,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
344,1463,1,1,,26747157,5280343,Active,,,5.0119,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
345,1463,1,1,,26752084,5280343,Active,,,17.7828,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
346,1463,1,1,,26752085,5280343,Active,,,11.2202,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
347,1463,1,1,,26752086,5280343,Active,,,11.2202,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
348,1463,1,1,,50104737,5280343,Active,,,10.0,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
349,1463,1,1,,50104738,5280343,Inconclusive,,,19.9526,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
350,1467,1,3,,11113933,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
351,1467,1,3,,26747157,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
352,1467,1,3,,26752084,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
353,1467,1,3,,50104737,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
354,1467,1,3,,50104738,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
355,1468,1,1,,11113933,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
356,1468,1,1,,26747157,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
357,1468,1,1,,26752084,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
358,1468,1,1,,26752085,5280343,Inconclusive,92096784.0,4137.0,15.8489,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
359,1468,1,1,,26752086,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
360,1468,1,1,,50104737,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
361,1468,1,1,,50104738,5280343,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
362,1469,1,1,,11113933,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
363,1469,1,1,,26747157,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
364,1469,1,1,,26752084,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
365,1469,1,1,,26752085,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
366,1469,1,1,,26752086,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
367,1469,1,1,,50104737,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
368,1469,1,1,,50104738,5280343,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
369,1471,2,1,,11111704,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
370,1471,2,1,,11111705,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
371,1471,2,1,,11111706,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
372,1471,2,1,,11113933,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
373,1471,2,1,,26752084,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
374,1471,2,1,,26752085,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
375,1471,2,1,,26752086,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
376,1471,2,1,,50104738,5280343,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
377,1476,2,1,,11113933,5280343,Inconclusive,281307097.0,,15.8489,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
378,1476,2,1,,26747157,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
379,1476,2,1,,26752084,5280343,Active,281307097.0,,19.9526,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
380,1476,2,1,,50104737,5280343,Active,281307097.0,,19.9526,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
381,1476,2,1,,50104738,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
382,1477,1,1,,11113933,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
383,1477,1,1,,26752084,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
384,1477,1,1,,26752085,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
385,1477,1,1,,26752086,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
386,1477,1,1,,50104737,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
387,1477,1,1,,50104738,5280343,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
388,1478,2,1,,11113933,5280343,Inconclusive,281307097.0,,28.1838,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
389,1478,2,1,,26747157,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
390,1478,2,1,,26752084,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
391,1478,2,1,,50104737,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
392,1478,2,1,,50104738,5280343,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
393,1479,1,2,,11113933,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
394,1479,1,2,,26747157,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
395,1479,1,2,,26752084,5280343,Inconclusive,189491771.0,7068.0,44.6684,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
396,1479,1,2,,26752085,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
397,1479,1,2,,26752086,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
398,1479,1,2,,50104737,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
399,1479,1,2,,50104738,5280343,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
400,1487,1,1,,26747157,5280343,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
401,1487,1,1,,50104737,5280343,Inconclusive,27436948.0,4000.0,14.1254,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
402,1490,2,1,,11113933,5280343,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
403,1490,2,1,,26747157,5280343,Active,10954339.0,,89.1251,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
404,1490,2,1,,26752084,5280343,Inconclusive,10954339.0,,56.2341,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
405,1490,2,1,,26752085,5280343,Inconclusive,10954339.0,,39.8107,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
406,1490,2,1,,26752086,5280343,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
407,1490,2,1,,50104738,5280343,Active,10954339.0,,56.2341,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
408,1519,1,3,,11113933,5280343,Active,,,39.8107,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
409,1519,1,3,,26747157,5280343,Inconclusive,,,25.1189,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
410,1519,1,3,,50104737,5280343,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
411,1519,1,3,,50104738,5280343,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
412,1580,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
413,1581,1,1,,8149624,5280343,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
414,1582,1,1,,8149624,5280343,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
415,1583,1,1,,8149624,5280343,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
416,1584,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
417,1585,1,1,,8149624,5280343,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
418,1586,1,1,,8149624,5280343,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
419,1587,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
420,1588,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
421,1589,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
422,1590,1,1,,8149624,5280343,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
423,1593,1,1,,8149624,5280343,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
424,1594,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
425,1595,1,1,,8149624,5280343,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
426,1596,1,1,,8149624,5280343,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
427,1597,1,1,,8149624,5280343,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
428,1598,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
429,1599,1,1,,8149624,5280343,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
430,1600,1,1,,8149624,5280343,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
431,1601,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
432,1602,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
433,1603,1,1,,8149624,5280343,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
434,1604,1,1,,8149624,5280343,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
435,1605,1,1,,8149624,5280343,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
436,1606,1,1,,8149624,5280343,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
437,1607,1,1,,8149624,5280343,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
438,1608,1,1,,8149624,5280343,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
439,1609,1,1,,8149624,5280343,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
440,1610,1,1,,8149624,5280343,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
441,1612,1,1,,8149624,5280343,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
442,1613,1,1,,8149624,5280343,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
443,1614,1,1,,8149624,5280343,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
444,1616,1,1,,8149624,5280343,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
445,1705,1,2,,50104737,5280343,Inconclusive,6980812.0,,19.9526,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
446,1707,1,3,,50104737,5280343,Active,,,2.5119,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
447,1708,1,3,,50104737,5280343,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
448,1766,1,1,,11113933,5280343,Inconclusive,18860839.0,4221.0,35.4813,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
449,1766,1,1,,11113933,5280343,Inconclusive,56550039.0,4297.0,35.4813,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
450,1766,1,1,,26747157,5280343,Inconclusive,18860839.0,4221.0,10.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
451,1766,1,1,,26747157,5280343,Inconclusive,56550039.0,4297.0,10.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
452,1766,1,1,,26752084,5280343,Inconclusive,18860839.0,4221.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
453,1766,1,1,,26752084,5280343,Inconclusive,56550039.0,4297.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
454,1766,1,1,,50104737,5280343,Inconclusive,18860839.0,4221.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
455,1766,1,1,,50104737,5280343,Inconclusive,56550039.0,4297.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
456,1766,1,1,,50104738,5280343,Inconclusive,18860839.0,4221.0,22.3872,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
457,1766,1,1,,50104738,5280343,Inconclusive,56550039.0,4297.0,22.3872,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
458,1768,1,1,,11113933,5280343,Inconclusive,18860839.0,4221.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
459,1768,1,1,,11113933,5280343,Inconclusive,56550039.0,4297.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
460,1768,1,1,,26747157,5280343,Inconclusive,18860839.0,4221.0,15.8489,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
461,1768,1,1,,26747157,5280343,Inconclusive,56550039.0,4297.0,15.8489,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
462,1768,1,1,,26752084,5280343,Inconclusive,18860839.0,4221.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
463,1768,1,1,,26752084,5280343,Inconclusive,56550039.0,4297.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
464,1768,1,1,,50104737,5280343,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
465,1768,1,1,,50104737,5280343,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
466,1768,1,1,,50104738,5280343,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
467,1768,1,1,,50104738,5280343,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
468,1815,1,1,,50104737,5280343,Active,,,3.5481,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
469,1816,1,1,,50104737,5280343,Active,,,2.5119,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
470,1828,2,1,,50104737,5280343,Active,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
471,1851,1,2,,11113933,5280343,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
472,1851,1,2,1.0,11113933,5280343,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
473,1851,1,2,2.0,11113933,5280343,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
474,1851,1,2,3.0,11113933,5280343,Active,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
475,1851,1,2,4.0,11113933,5280343,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
476,1851,1,2,5.0,11113933,5280343,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
477,1865,1,1,,11113933,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
478,1865,1,1,,26747157,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
479,1865,1,1,,26752084,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
480,1865,1,1,,26752085,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
481,1865,1,1,,26752086,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
482,1865,1,1,,50104737,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
483,1865,1,1,,50104738,5280343,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
484,1876,1,1,,50104737,5280343,Active,,,3.5481,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
485,1877,1,1,,50104737,5280343,Active,,,7.0795,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
486,1882,1,1,,50104737,5280343,Active,,,8.9125,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
487,1883,1,1,,50104737,5280343,Active,,,4.4668,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
488,1886,1,1,,50104737,5280343,Active,,,2.8184,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
489,1948,1,1,,11113933,5280343,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
490,1948,1,1,,26747157,5280343,Inconclusive,,,0.2512,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
491,1948,1,1,,26752084,5280343,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
492,1948,1,1,,50104737,5280343,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
493,1948,1,1,,50104738,5280343,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
494,1967,1,1,,85231204,5280343,Inconclusive,4505907.0,5376.0,47.7548,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
495,2015,1,1,,11113933,5280343,Active,4503895.0,2584.0,42.1285,Potency,Confirmation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
496,2017,1,1,,11113933,5280343,Inactive,15225820.0,817234.0,,Potency,Confirmatory Assay for Inhibitors of Human Galactokinase (GALK): CDP-Me assay counterscreen,Confirmatory,,
497,2035,1,1,,11113933,5280343,Inactive,,,,Potency,Confirmatory Assay for Inhibitors of Human Galactokinase (GALK): Phenol-HRP redox assay counterscreen,Confirmatory,,
498,2101,1,1,,11113933,5280343,Inconclusive,496369.0,2629.0,31.6228,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
499,2101,1,1,,26747157,5280343,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
500,2101,1,1,,26752084,5280343,Inconclusive,496369.0,2629.0,17.7828,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
501,2101,1,1,,26752085,5280343,Inconclusive,496369.0,2629.0,28.1838,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
502,2101,1,1,,26752086,5280343,Inconclusive,496369.0,2629.0,14.1254,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
503,2101,1,1,,50104737,5280343,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
504,2101,1,1,,50104738,5280343,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
505,2107,1,1,,11113933,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
506,2107,1,1,,26747157,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
507,2107,1,1,,26752084,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
508,2107,1,1,,26752085,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
509,2107,1,1,,26752086,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
510,2107,1,1,,50104737,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
511,2107,1,1,,50104738,5280343,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
512,2112,1,1,,11113933,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
513,2112,1,1,,26747157,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
514,2112,1,1,,26752084,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
515,2112,1,1,,26752085,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
516,2112,1,1,,26752086,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
517,2112,1,1,,50104737,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
518,2112,1,1,,50104738,5280343,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
519,2147,1,1,,11113933,5280343,Active,221046486.0,,10.0,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
520,2147,1,1,,26747157,5280343,Inconclusive,221046486.0,,8.9125,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
521,2147,1,1,,50104737,5280343,Active,221046486.0,,8.9125,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
522,2147,1,1,,50104738,5280343,Active,221046486.0,,14.1254,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
523,2230,2,1,,99460891,5280343,Active,70832125.0,3663016.0,22.378,IC50_Mean,Confirmation assay for inhibitors of Trypanosoma brucei hexokinase 1-Analogue-first series,Confirmatory,,
524,2240,1,1,,85787280,5280343,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
525,2240,1,1,,85787911,5280343,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
526,2241,1,1,,85787280,5280343,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
527,2241,1,1,,85787911,5280343,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
528,2275,1,1,,85787280,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
529,2275,1,1,,85787911,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
530,2313,1,1,,85787280,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
531,2313,1,1,,85787911,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
532,2316,1,1,,85787280,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
533,2316,1,1,,85787911,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
534,2322,1,1,,85787280,5280343,Active,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
535,2322,1,1,,85787911,5280343,Active,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
536,2323,1,1,,50104737,5280343,Inactive,254220970.0,,,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
537,2326,1,1,,50104737,5280343,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
538,2330,1,1,,85787280,5280343,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
539,2330,1,1,,85787911,5280343,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
540,2353,1,3,,50104737,5280343,Inconclusive,282403581.0,,0.631,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
541,2364,1,2,,50104737,5280343,Active,4557365.0,641.0,28.1838,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
542,2451,1,2,,11113933,5280343,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
543,2451,1,2,,26747157,5280343,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
544,2451,1,2,,26752084,5280343,Inconclusive,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
545,2451,1,2,,50104737,5280343,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
546,2451,1,2,,50104738,5280343,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
547,2472,1,2,,11113933,5280343,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
548,2472,1,2,,26747157,5280343,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
549,2472,1,2,,26752084,5280343,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
550,2472,1,2,,50104738,5280343,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
551,2517,2,1,,11113933,5280343,Inconclusive,6980812.0,,0.8913,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
552,2517,2,1,,26747157,5280343,Inactive,6980812.0,,1.0,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
553,2517,2,1,,26752084,5280343,Active,6980812.0,,1.4125,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
554,2517,2,1,,26752085,5280343,Inconclusive,6980812.0,,0.7079,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
555,2517,2,1,,26752086,5280343,Active,6980812.0,,0.8913,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
556,2517,2,1,,50104737,5280343,Active,6980812.0,,1.2589,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
557,2517,2,1,,50104738,5280343,Inconclusive,6980812.0,,1.0,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
558,2528,1,2,,11113933,5280343,Inconclusive,4557365.0,641.0,35.4813,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
559,2528,1,2,,26747157,5280343,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
560,2528,1,2,,26752084,5280343,Inconclusive,4557365.0,641.0,28.1838,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
561,2528,1,2,,50104737,5280343,Active,4557365.0,641.0,28.1838,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
562,2528,1,2,,50104738,5280343,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
563,2546,1,1,,11113933,5280343,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
564,2546,1,1,,26747157,5280343,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
565,2546,1,1,,26752084,5280343,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
566,2546,1,1,,50104738,5280343,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
567,2547,1,2,,11113933,5280343,Inconclusive,,,14.0685,Potency,Secondary Assay for Inhibitors of Human Galactokinase (GALK): HEK-293 Cell Viability Assay,Confirmatory,,
568,2549,1,1,,11113933,5280343,Inconclusive,282403581.0,,3.1623,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
569,2549,1,1,,26747157,5280343,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
570,2549,1,1,,26752084,5280343,Inconclusive,282403581.0,,1.0,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
571,2549,1,1,,26752085,5280343,Inconclusive,282403581.0,,1.122,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
572,2549,1,1,,26752086,5280343,Active,282403581.0,,2.5119,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
573,2549,1,1,,50104737,5280343,Active,282403581.0,,1.7783,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
574,2549,1,1,,50104738,5280343,Inconclusive,282403581.0,,1.122,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
575,2551,1,1,,11113933,5280343,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
576,2551,1,1,,26747157,5280343,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
577,2551,1,1,,26752084,5280343,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
578,2551,1,1,,50104738,5280343,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
579,2565,1,1,,50104737,5280343,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
580,2572,1,1,,50104737,5280343,Inactive,6980812.0,,,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
581,2579,2,1,,99460891,5280343,Inactive,149631.0,,25.0,IC50_Mean,G6DPH counterscreen for TbHK1 inhibitors - Analogues series,Confirmatory,,
582,2660,1,1,,90341524,5280343,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
583,2662,2,1,,85231204,5280343,Inconclusive,56550039.0,4297.0,22.3872,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
584,2666,1,1,,90341524,5280343,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
585,2667,1,1,,90341524,5280343,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
586,2668,1,1,,90341524,5280343,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
587,2675,1,1,,50104737,5280343,Inconclusive,41281591.0,4154.0,28.1838,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
588,2732,1,1,,17405557,5280343,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
589,2774,1,3,,92303342,5280343,Inactive,,,,,LOPAC Circadian Assay,Screening,,
590,3342,6,3,,103167027,5280343,Active,,,39.5,IC50,Cytotoxic effect on 3T3 cells,Confirmatory,8201603.0,
591,6809,9,1,,103167027,5280343,Active,,,0.3,IC50,In vitro inhibitory activity against RBL-1 5-LO,Confirmatory,3820229.0,
592,6820,11,1,,103167027,5280343,Active,,,0.2,IC50,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,Confirmatory,8254620.0,
593,6855,9,1,,103167027,5280343,Active,,,0.5,IC50,In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay),Confirmatory,2213827.0,
594,7079,9,1,,103167027,5280343,Active,,,0.4,IC50,"Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation)",Confirmatory,2213827.0,
595,7096,9,1,,103167027,5280343,Active,,,0.3,IC50,In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells,Confirmatory,2066989.0,
596,17283,6,2,,103167027,5280343,Active,,,1.98,Ki,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Confirmatory,9406602.0,
597,30342,8,1,,103167027,5280343,Unspecified,,,,,Ability to displace [3H]N6-phenylisopropyladenosine binding from adenosine A1 receptor.,Other,9438021.0,
598,31746,6,2,,103167027,5280343,Active,,,32.5,IC50,Cytotoxic effect on v-abl transformed murine ANN-1 cells,Confirmatory,8201603.0,
599,32357,9,2,,103167027,5280343,Active,,,2.47,Ki,Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes.,Confirmatory,8576921.0,
600,33150,8,1,,103167027,5280343,Unspecified,,,,,Ability to displace [3H]-CGS- 21680 binding from adenosine A2A receptor.,Other,9438021.0,
601,33196,6,2,,103167027,5280343,Inconclusive,,,,,Ability to displace [125I]AB-MECA binding from adenosine A3 receptor.,Other,9438021.0,
602,33221,3,9,,103167027,5280343,Unspecified,39932720.0,26760.0,,,The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 10 mins,Other,12182864.0,
603,33222,3,9,,103167027,5280343,Unspecified,39932720.0,26760.0,,,The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 20 mins,Other,12182864.0,
604,33223,3,9,,103167027,5280343,Unspecified,39932720.0,26760.0,,,The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 30 mins,Other,12182864.0,
605,33936,9,1,,103167027,5280343,Active,,,6.99,Ki,Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement.,Confirmatory,8576921.0,
606,34198,9,2,,103167027,5280343,Active,,,2.32,IC50,In vitro inhibitory activity against aldehyde reductase 1 (ALR1) from rat kidney.,Confirmatory,12672241.0,
607,34200,9,5,,103167027,5280343,Active,113594.0,317748.0,10.3,IC50,Inhibition of Aldehyde reductase 2,Confirmatory,8893834.0,
608,34337,9,3,,103167027,5280343,Active,,,10.34,IC50,The compound was tested for Inhibitory effect against ALR1 in bovine kidneys,Confirmatory,10354396.0,
609,34338,9,5,,103167027,5280343,Active,113594.0,317748.0,32.87,IC50,Inhibition of ALR2 (aldose reductase) of bovine lens,Confirmatory,10354396.0,
610,34658,3,7,,103167027,5280343,Unspecified,,,,,In vitro inhibitory activity against recombinant human aldose reductase (ALR2) was determined,Other,14613323.0,
611,34784,3,10,,103167027,5280343,Unspecified,1703235.0,100009122.0,,,Antiallergic agent with Aldose reductase Inhibitory Activity at 10E-5 M concentration,Other,6779009.0,
612,34785,3,10,,103167027,5280343,Unspecified,1703235.0,100009122.0,,,Antiallergic agent with Aldose reductase Inhibitory Activity at 10E-6 M concentration,Other,6779009.0,
613,34804,9,2,,103167027,5280343,Active,,,8.32,IC50,In vitro inhibitory activity against aldose reductase (ALR2) from rat lens extraction.,Confirmatory,12672241.0,
614,34885,9,5,,103167027,5280343,Active,803374855.0,140.0,30.0,Ki,Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells,Confirmatory,8576921.0,
615,34969,9,2,,103167027,5280343,Active,,,7.81,IC50,Inhibitory concentration to aldose reductase (ALR-2) obtained from rat lens,Confirmatory,11728182.0,
616,34976,9,5,,103167027,5280343,Active,1168407.0,24192.0,7.7,IC50,In vitro inhibitory activity against Aldose reductase from rat lens,Confirmatory,1956041.0,
617,35134,9,2,,103167027,5280343,Active,,,39.9,IC50,Evaluated for inhibition of Aldose reductase 2,Confirmatory,8893834.0,
618,38383,3,8,,103167027,5280343,Unspecified,,,,,Inhibition of cell surface aminopeptidase N (APN/CD13) at 0.3*10e-3 M compound concentration,Other,12930151.0,
619,43124,10,2,,103167027,5280343,Active,,,4.0,IC50,Inhibitory activity against Amp C beta-Lactamase,Confirmatory,13678405.0,
620,43125,10,2,,103167027,5280343,Active,,,4.0,IC50,Inhibitory activity against Beta-lactamase from DMSO stock was determined,Confirmatory,13678405.0,
621,43253,3,6,,103167027,5280343,Unspecified,,,,,Percentage inhibition against beta-Lactamase in the absence of detergent Triton X-100 was determined at a concentration of 25 uM,Other,13678405.0,
622,43262,3,6,,103167027,5280343,Unspecified,,,,,Percentage inhibition against beta-Lactamase in the presence of detergent 0.01% Triton X-100 was determined at a concentration of 25 uM,Other,13678405.0,
623,43268,3,6,,103167027,5280343,Unspecified,,,,,Percentage inhibition of Beta-lactamase at KPi (Potassium Phosphate) stock concentration of 5.9 uM,Other,13678405.0,
624,52462,9,3,,103167027,5280343,Unspecified,,,100.0,IC50,Inhibitory activity against Chymotrypsinogen from Thermus flavus,Confirmatory,12672248.0,
625,52780,9,2,,103167027,5280343,Unspecified,,,100.0,IC50,Inhibitory activity against chymotrypsinogen,Confirmatory,11931626.0,
626,53359,9,2,,103167027,5280343,Active,,,20.0,IC50,Inhibition of Cyclin-dependent kinase 1-cyclin B1,Confirmatory,10843211.0,
627,54030,9,2,,103167027,5280343,Unspecified,,,61.0,IC50,Inhibitory activity against cyclin-dependent kinase 4-cyclin D1,Confirmatory,10843211.0,
628,54410,6,5,,103167027,5280343,Active,,,27.0,Ki,Binding affinity towards cytochrome P450 2C9,Confirmatory,14761192.0,
629,69720,7,6,,103167027,5280343,Unspecified,2811086.0,1956.0,190.0,IC50,Cytotoxic effect on EGF-receptor overexpressing HN5 squamous carcinoma cells,Confirmatory,8201603.0,
630,69727,3,8,,103167027,5280343,Unspecified,,,,,Inhibition of epidermal growth factor (EGF) receptor from A431 cell membranes at 150 uM,Other,8201603.0,
631,69729,3,8,,103167027,5280343,Unspecified,,,,,Inhibition of epidermal growth factor (EGF) receptor from A431 cell membranes at 150 uM,Other,8201603.0,
632,69799,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
633,69800,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
634,69801,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
635,69802,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
636,71640,6,2,,103167027,5280343,Active,,,28.0,IC50,Inhibition of EGF-induced mitogenesis in human foreskin fibroblasts,Confirmatory,8201603.0,
637,71641,6,2,,103167027,5280343,Active,,,46.0,IC50,Inhibition of EGF-induced mitogenesis in human foreskin fibroblasts,Confirmatory,8201603.0,
638,74123,4,1,,103167027,5280343,Unspecified,,,66069300000.0,Ki,Inhibition constant of compound against binding of Yeast Glyoxalase I,Confirmatory,3290487.0,
639,74513,6,2,,103167027,5280343,Active,,,22.8,Ki,Inhibitory activity against glucose transporter isoform 2 (GLUT2),Confirmatory,12672248.0,
640,75433,6,4,,103167027,5280343,Unspecified,,,218.0,IC50,Inhibition of Glutathione reductase,Confirmatory,8893834.0,
641,75438,10,5,,103167027,5280343,Active,1708060.0,856014.0,48.8,IC50,In vitro inhibitory activity against glutathione reductase (GR) from bakers yeast,Confirmatory,12672241.0,
642,78545,6,5,,103167027,5280343,Unspecified,,,,,Concentration facilitating 50% of the maximum of the cleavable complex,Other,,
643,78696,6,6,,103167027,5280343,Unspecified,,,,,In vitro antibacterial activity was determined as inhibitory concentration causing 50% DNA-gyrase supercoiling inhibition (SCI),Other,,
644,78777,5,3,,103167027,5280343,Unspecified,,,,,Inhibitory activity against HIV-1 IIIB replication in H9 cell line,Other,,
645,78941,5,3,,103167027,5280343,Unspecified,,,,,Inhibitory activity against H9 cells uninfected with HIV-1,Other,,
646,91308,6,2,,103167027,5280343,Unspecified,,,100.0,IC50,Inhibition of PDGF-induced mitogenesis in human foreskin fibroblasts,Confirmatory,8201603.0,
647,93507,9,2,,103167027,5280343,Active,,,23.6,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,Confirmatory,7699704.0,
648,93508,9,2,,103167027,5280343,Active,,,13.6,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,Confirmatory,7699704.0,
649,95258,9,5,,103167027,5280343,Active,1168407.0,24192.0,1.0,IC50,In vitro inhibitory activity against L-Hexonate Dehydrogenase from rat kidney,Confirmatory,1956041.0,
650,101295,6,2,,103167027,5280343,Unspecified,,,,,Ex vivo inhibition of LTB4 production was measured in dog blood,Other,1848292.0,
651,103902,6,2,,103167027,5280343,Active,,,24.0,IC50,Cytotoxic effect on MCF-7 human breast carcinoma cells,Confirmatory,8201603.0,
652,106657,9,5,,103167027,5280343,Active,126917.0,,6.0,IC50,Inhibitory activity against malate dehydrogenase (MDH) from Thermus flavus,Confirmatory,12672248.0,
653,112434,4,2,,103167027,5280343,Unspecified,,,,,"Inhibition of TPA-induced inflammatory ear edema in mice(compound was applied 30 min before TPA (1 mg),Ear thickness was determined 6 hr after TPA treatment)",Other,7473540.0,
654,125798,6,2,,103167027,5280343,Active,,,0.95,IC50,Evaluated for the antioxidant property by measuring the inhibition of microsomal lipid peroxidation,Confirmatory,11206462.0,
655,132112,6,2,,103167027,5280343,Unspecified,,,,,In vivo inhibition of ear oedema in mice following p.o. administration.,Other,2213827.0,
656,132224,4,2,,103167027,5280343,Unspecified,,,,,In vivo inhibition of AA induced ear oedema in mice following topical administration.,Other,2213827.0,
657,144650,7,2,,103167027,5280343,Unspecified,,,60.0,GI50,In vitro cytotoxic potency against NCI-60 human tumor cell line,Confirmatory,9632366.0,
658,147515,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of neutral endopeptidase (NEP/CD13) at 0.3*10e-3 M compound concentration,Other,12930151.0,
659,155518,8,2,,103167027,5280343,Active,,,3.8,IC50,Inhibition of phosphatidylinositol 3-kinase,Confirmatory,12672248.0,
660,161024,9,1,,103167027,5280343,Unspecified,,,50.0,IC50,"In vitro for prostaglandin G/H synthase inhibitory activity against rat basophil leukemia type 1 cell homogenates, by measuring the radioactivity of [14C]-PGD2",Confirmatory,2213827.0,
661,161176,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of Prostaglandin G/H synthase activity in sheep seminal vesicle was determined 10E-4 uM,Other,8254620.0,
662,164264,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
663,164265,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
664,165000,9,2,,103167027,5280343,Active,,,23.3,IC50,The inhibitory activity tested against human Protein-tyrosine phosphatase 1B enzyme,Confirmatory,12419367.0,
665,179757,6,8,,103167027,5280343,Active,729945.0,25290.0,10.0,IC50,In vitro inhibition of LTB4 production was measured in rat blood,Confirmatory,1848292.0,
666,179759,6,8,,103167027,5280343,Unspecified,548484.0,29527.0,50.0,IC50,In vitro inhibition of PGE-2 production was measured in rat blood,Confirmatory,1848292.0,
667,179759,6,8,,103167027,5280343,Unspecified,3914292.0,24693.0,50.0,IC50,In vitro inhibition of PGE-2 production was measured in rat blood,Confirmatory,1848292.0,
668,191752,4,2,,103167027,5280343,Unspecified,,,,,Compound was evaluated for the mutagenicity by calculating number of revertants using Salmonella Typhimurium strain TA 98 (0.25 mg/plate) with S9 mix from rat liver; Toxic concentration,Other,1847431.0,
669,191754,4,2,,103167027,5280343,Unspecified,,,,,Compound was evaluated for the mutagenicity by calculating number of revertants using Salmonella Typhimurium strain TA 98 (2.5 mg/plate) with S9 mix from rat liver; Toxic concentration,Other,1847431.0,
670,191891,4,2,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (0.25 mg/plate) with S9 mix from rat liver; Toxic concentration,Other,1847431.0,
671,191892,3,4,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (0.25 mg/plate) without S9 mix from rat liver according to the plate incorporation assay.,Other,1847431.0,
672,191894,4,2,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (2.5 mg/plate) with S9 mix from rat liver; Toxic concentration,Other,1847431.0,
673,191896,4,2,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (2.5 mg/plate) without S9 mix from rat liver; Toxic concentration,Other,1847431.0,
674,191897,3,4,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 98 (0.25 mg/plate) without S9 mix from rat liver,Other,1847431.0,
675,191899,4,2,,103167027,5280343,Unspecified,,,,,Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 98 (2.5 mg/plate) without S9 mix from rat liver according to the plate incorporation assay; Toxic concentration,Other,1847431.0,
676,195229,3,3,,103167027,5280343,Unspecified,,,,,Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 10 mins,Other,12182864.0,
677,195230,3,3,,103167027,5280343,Unspecified,,,,,Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 20 mins,Other,12182864.0,
678,195231,3,3,,103167027,5280343,Unspecified,,,,,Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 30 mins,Other,12182864.0,
679,195232,3,3,,103167027,5280343,Unspecified,,,,,Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 5 mins,Other,12182864.0,
680,195382,3,3,,103167027,5280343,Unspecified,,,,,Effect of compound on AFB1-induced micronuclei formation in rat bone marrow cells (Activity: Micronucleated cells/1000 cells),Other,12182864.0,
681,195383,3,3,,103167027,5280343,Unspecified,,,,,Effect of compound on AFB1-induced micronuclei formation in rat bone marrow cells in the presence of AFB1 (Activity: Micronucleated cells/1000 cells),Other,12182864.0,
682,200878,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
683,200879,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
684,201080,3,3,,103167027,5280343,Inactive,,,,,"Minimum inhibitory concentration, that inhibits growth of Staphylococcus aureus in the presence of subinhibitory (30 ug/mL) Berberine; Inactive",Other,11170636.0,
685,203728,6,3,,103167027,5280343,Unspecified,,,177.0,IC50,Inhibition of sorbitol dehydrogenase from sheep liver (40 U/mg of protein),Confirmatory,8893834.0,
686,203731,9,1,,103167027,5280343,Active,,,35.6,IC50,In vitro inhibitory activity against sorbitol dehydrogenase (SD) from sheep liver,Confirmatory,12672241.0,
687,205908,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus epidermidis strain OC2603,Other,,
688,206159,6,3,,103167027,5280343,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus aureus strain OC6538,Other,,
689,213385,3,8,,103167027,5280343,Unspecified,,,,,Percent inhibition of mushroom tyrosinase at concentration of 18 ug/ml,Other,,
690,213386,3,8,,103167027,5280343,Unspecified,,,,,Percent inhibition of mushroom tyrosinase at concentration of 45 ug/ml,Other,,
691,213412,9,2,,103167027,5280343,Active,,,13.0,IC50,Ability to inhibit protein-tyrosine kinase activity of p56lck (isolated from bovine thymus) in vitro.,Confirmatory,1995903.0,
692,214874,10,5,,103167027,5280343,Active,205371855.0,780933.0,7.1,IC50,Inhibitory concentration of the compounds against Bovine trypsin enzyme.,Confirmatory,9406602.0,
693,215969,5,1,,103167027,5280343,Unspecified,,,,,Dose required for inhibitory activity against oxidation of L-DOPA by mushroom tyrosinase,Other,,
694,216252,6,2,,103167027,5280343,Active,,,,,In vitro inhibitory activity against the growth of WISH cell derived from human cervical carcinoma was determined; slight effect,Other,14684314.0,
695,216458,6,2,,103167027,5280343,Active,,,40.2,IC50,Cytotoxic effect on WiDr human colon cells,Confirmatory,8201603.0,
696,218564,3,7,,103167027,5280343,Unspecified,,,,,Decrease in inhibition of beta-lactamase due to 10-fold increase in enzyme concentration,Other,12672248.0,
697,218565,3,7,,103167027,5280343,Unspecified,,,,,Increase in inhibition of beta-lactamase due to the effect of incubation,Other,12672248.0,
698,218566,3,8,,103167027,5280343,Unspecified,,,,,"Preincubated with beta-lactamase, inhibitory activity expressed as fold decrease in IC50(ie. improved activity)",Other,11931626.0,
699,218575,9,2,,103167027,5280343,Active,,,4.0,IC50,Inhibitory activity against beta-lactamase,Confirmatory,11931626.0,
700,218679,8,2,,103167027,5280343,Active,,,4.0,IC50,Inhibition of beta-lactamase from Escherichia coli,Confirmatory,12672248.0,
701,218683,6,4,,103167027,5280343,Unspecified,,,220.0,IC50,inhibitory activity against Beta-lactamase,Confirmatory,11931626.0,
702,218689,3,8,,103167027,5280343,Unspecified,,,,,The effect of 10-fold increase in enzyme concentration on beta-lactamase inhibition.,Other,11931626.0,
703,219998,8,2,,103167027,5280343,Active,,,20.0,IC50,Inhibition of rat brain cytosolic cAMP phosphodiesterase,Confirmatory,6292419.0,
704,220001,8,2,,103167027,5280343,Unspecified,,,87.0,IC50,Inhibition of rat brain cytosolic cAMP phosphodiesterase,Confirmatory,6292419.0,
705,220005,3,5,,103167027,5280343,Unspecified,,,,,Relative inhibition of cAMP and cGMP hydrolysis by cytosolic phosphodiesterase,Other,6292419.0,
706,220006,3,5,,103167027,5280343,Unspecified,,,,,Relative inhibition of cAMP and cGMP hydrolysis by particulate phosphodiesterase,Other,6292419.0,
707,220159,9,5,,103167027,5280343,Unspecified,231819.0,29691.0,275.0,IC50,Inhibition of rat brain cytosolic cGMP phosphodiesterase,Confirmatory,6292419.0,
708,220159,9,5,,103167027,5280343,Unspecified,2499447.0,81742.0,275.0,IC50,Inhibition of rat brain cytosolic cGMP phosphodiesterase,Confirmatory,6292419.0,
709,220159,9,5,,103167027,5280343,Unspecified,81872474.0,,275.0,IC50,Inhibition of rat brain cytosolic cGMP phosphodiesterase,Confirmatory,6292419.0,
710,220162,10,5,,103167027,5280343,Unspecified,1705944.0,81743.0,81.3,IC50,Inhibition of rat brain particulate cGMP phosphodiesterase,Confirmatory,6292419.0,
711,230227,3,3,,103167027,5280343,Unspecified,,,,,Inhibitory ratio at 1.0 mg/ear,Other,7473540.0,
712,231882,3,3,,103167027,5280343,Unspecified,,,,,Compound was tested for Ratio of IC50(ALR1)/(ALR2),Other,10354396.0,
713,232928,3,10,,103167027,5280343,Unspecified,1168407.0,24192.0,,,Selectivity as ratio of IC50 for rat lens and kidney aldose reductase,Other,1956041.0,
714,235017,3,4,,103167027,5280343,Unspecified,,,,,Ratio of IC50 to EC50 was expressed as therapeutic index,Other,,
715,240981,9,2,,103167027,5280343,Active,,,2.1,IC50,Inhibition of glycogen synthase kinase 3,Confirmatory,15689157.0,
716,241206,9,2,,103167027,5280343,Unspecified,,,75.0,IC50,Inhibition of cyclin-dependent kinase 1/cyclinB,Confirmatory,15689157.0,
717,241232,9,3,,103167027,5280343,Active,,,23.0,IC50,Inhibition of Cyclin-dependent kinase 5-p25nck5a,Confirmatory,15689157.0,
718,242481,10,5,,103167027,5280343,Active,266423.0,1021.0,25.0,IC50,Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin),Confirmatory,15689157.0,
719,250527,3,5,,103167027,5280343,Unspecified,,,,,Antiproliferative effect against human colonic cell line (HT-29) after 6 hr at a concentration of 50 uM,Other,15828817.0,
720,250567,3,5,,103167027,5280343,Unspecified,,,,,Antiproliferative effect against human colonic cell line (HT-29) after 24 hr at a concentration of 50 uM,Other,15828817.0,
721,252875,3,4,,103167027,5280343,Unspecified,,,,,Caspase 3/7 activity is expressed as ratio of caspase activation in treated human colonic cell line (HT-29) to that of untreated control cells after 5 hr,Other,15828817.0,
722,253005,3,4,,103167027,5280343,Unspecified,,,,,Tested for vasorelaxant activity in rat thoracic aorta rings against PE-induced contractions,Other,15225704.0,
723,257079,3,9,,103167027,5280343,Unspecified,83305339.0,5292.0,,,Inhibitory activity against PIM1 at 1 uM,Other,16302800.0,
724,257080,3,9,,103167027,5280343,Unspecified,83305339.0,5292.0,,,Inhibitory activity against PIM1 at 10 uM,Other,16302800.0,
725,257081,8,5,,103167027,5280343,Active,83305339.0,5292.0,0.043,IC50,Inhibitory activity against PIM1,Confirmatory,16302800.0,
726,257082,12,1,,103167027,5280343,Unspecified,83305339.0,5292.0,,Kd,Binding affinity to non phosphorylated PIM1,Confirmatory,16302800.0,
727,257315,3,5,,103167027,5280343,Inactive,,,,,Inhibitory activity against baker's yeast alpha glucosidase at 200 uM,Other,16202584.0,
728,257316,3,9,,103167027,5280343,Inactive,113813.0,,,,Inhibitory activity against Bacillus licheniformis alpha amylase at 200 uM,Other,16202584.0,
729,257317,3,9,,103167027,5280343,Inactive,113786.0,100301984.0,,,Inhibitory activity against barley beta amylase at 200 uM,Other,16202584.0,
730,257903,7,1,,103167027,5280343,Active,,,,,Antioxidant potency assessed chemically,Other,16392814.0,
731,257904,6,2,,103167027,5280343,Active,,,5.0,IC50,Activity against hydrogen peroxide induced DNA damage in Jurkat T cells,Confirmatory,16392814.0,
732,257905,6,2,,103167027,5280343,Active,,,2.98,EC50,Inhibition of glutamate-induced oxytosis of mouse hippocampal HT22 cells,Confirmatory,16392814.0,
733,265758,8,7,,103167027,5280343,Active,74844869.0,,1.5,IC50,Inhibition of FabZ,Confirmatory,16722653.0,
734,265759,8,7,,103167027,5280343,Active,74844868.0,,1.5,IC50,Inhibition of FabI,Confirmatory,16722653.0,
735,265760,10,2,,103167027,5280343,Active,75020671.0,,5.4,IC50,Inhibition of FabG,Confirmatory,16722653.0,
736,265761,6,2,,103167027,5280343,Active,,,10.0,IC50,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54,Confirmatory,16722653.0,
737,265762,6,2,,103167027,5280343,Active,,,8.9,IC50,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1,Confirmatory,16722653.0,
738,277106,6,2,,103167027,5280343,Active,,,5.5,IC50,Inhibition of PMA-induced ROS production in human PMN,Confirmatory,17046255.0,
739,277107,6,2,,103167027,5280343,Active,,,2.5,IC50,Inhibition of fMLP-induced ROS production in human PMN,Confirmatory,17046255.0,
740,277108,6,3,,103167027,5280343,Active,,,3.1,IC50,Inhibition of PMA-induced ROS production in human mononuclear leukocytes,Confirmatory,17046255.0,
741,277109,6,3,,103167027,5280343,Active,,,4.0,IC50,Inhibition of fMLP-induced ROS production in human mononuclear leukocytes,Confirmatory,17046255.0,
742,277583,9,5,,103167027,5280343,Active,74844868.0,,2.5,IC50,Inhibition of Plasmodium falciparum ENR,Confirmatory,17263522.0,
743,277584,9,2,,103167027,5280343,Active,,,20.0,IC50,Inhibition of Escherichia coli ENR,Confirmatory,17263522.0,
744,277585,9,5,,103167027,5280343,Active,74844868.0,,1.09,Ki,Inhibition of Plasmodium falciparum ENR using NADH substrate,Confirmatory,17263522.0,
745,277586,9,5,,103167027,5280343,Active,74844868.0,,0.473,Ki,Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate,Confirmatory,17263522.0,
746,277587,8,5,,103167027,5280343,Active,74844868.0,,0.022000000000000002,Ki,Inhibition of Plasmodium falciparum ENR in presence of triclosan,Confirmatory,17263522.0,
747,286228,9,5,,103167027,5280343,Active,126407.0,240.0,0.79,IC50,Inhibition of 5LOX in human PBMC by EIA assay,Confirmatory,17378609.0,
748,286229,9,5,,103167027,5280343,Active,126397.0,100009114.0,0.43,IC50,Inhibition of 15LOX in rabbit reticulocytes by EIA assay,Confirmatory,17378609.0,
749,286230,9,5,,103167027,5280343,Active,3915797.0,5743.0,28.6,IC50,Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay,Confirmatory,17378609.0,
750,287076,4,2,,103167027,5280343,Unspecified,,,,,Inhibition of TPA-induced inflammation in mouse assessed per ear by edema assay,Other,17480098.0,
751,287077,3,4,,103167027,5280343,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
752,287078,3,4,,103167027,5280343,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 500 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
753,287079,3,4,,103167027,5280343,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 100 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
754,287080,3,4,,103167027,5280343,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 10 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
755,287081,3,4,,103167027,5280343,Unspecified,,,,,Cell viability of Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
756,288326,6,3,,103167027,5280343,Active,,,3.0,IC50,Inhibition of 5-LO activity in ionophore A23187 and arachidonic-stimulated human intact PMNL,Confirmatory,17461565.0,
757,289317,6,2,,103167027,5280343,Active,,,47.3,IC50,Superoxide radical scavenging activity by NBT reduction assay,Confirmatory,17624791.0,
758,289320,6,2,,103167027,5280343,Unspecified,,,785.0,IC50,Hydrogen peroxide scavenging activity by assessed as inhibition of lucigenin oxidation,Confirmatory,17624791.0,
759,289322,6,2,,103167027,5280343,Active,,,1.1,IC50,Hypochlorous acid scavenging activity assessed as inhibition of DHR oxidation,Confirmatory,17624791.0,
760,289327,6,2,,103167027,5280343,Active,,,5.3,IC50,Singlet oxygen scavenging activity by assessed as inhibition of DHR oxidation,Confirmatory,17624791.0,
761,289333,6,2,,103167027,5280343,Active,,,1.95,IC50,Nitric oxide scavenging activity assessed as inhibition of DAF2 oxidation,Confirmatory,17624791.0,
762,289337,6,2,,103167027,5280343,Active,,,0.26,IC50,Peroxynitrite scavenging activity assessed as inhibition of DHR oxidation,Confirmatory,17624791.0,
763,289341,6,2,,103167027,5280343,Active,,,0.44,IC50,Peroxynitrite scavenging activity assessed as inhibition of DHR oxidation in presence of NaHCo3,Confirmatory,17624791.0,
764,293297,7,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 min,Other,17166721.0,
765,293298,8,1,,103167027,5280343,Active,,,,IC50,Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method,Confirmatory,17166721.0,
766,293299,9,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production,Other,17166721.0,
767,293618,6,2,,103167027,5280343,Inconclusive,,,,IC50,Cytotoxicity against Vero cells,Confirmatory,17234303.0,
768,293619,3,3,,103167027,5280343,Unspecified,,,,,Apoptotic activity in human blood neutrophils after 24 hrs,Other,17234303.0,
769,293620,3,3,,103167027,5280343,Unspecified,,,,,Apoptotic activity in human blood neutrophils after 48 hrs,Other,17234303.0,
770,293621,3,3,,103167027,5280343,Unspecified,,,,,Apoptotic activity in human blood neutrophils after 72 hrs,Other,17234303.0,
771,294159,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.051 mM,Other,17287127.0,
772,295378,6,2,,103167027,5280343,Active,,,25.0,EC50,Decrease in androgen receptor protein expression in LNCaP cells by Western blotting,Confirmatory,17383188.0,
773,298196,6,3,,103167027,5280343,Active,,,7.81,IC50,Inhibition of ALR2 in Sprague-Dawley Albino rat lens,Confirmatory,17845019.0,
774,298197,9,5,,103167027,5280343,Active,1168407.0,24192.0,2.32,IC50,Inhibition of ALR1 in Sprague-Dawley Albino rat kidney,Confirmatory,17845019.0,
775,298693,9,2,,103167027,5280343,Active,,,40.0,IC50,Inhibition of CDK2,Confirmatory,17178224.0,
776,309798,9,2,,103167027,5280343,Active,,,0.44,IC50,Inhibition of 12-hLO,Confirmatory,17869117.0,
777,309799,9,2,,103167027,5280343,Active,,,2.2,IC50,Inhibition of 15-hLO1,Confirmatory,17869117.0,
778,309800,3,3,,103167027,5280343,Unspecified,,,,,Selectivity for 12h-LO over 15-hLO,Other,17869117.0,
779,309801,9,2,,103167027,5280343,Unspecified,,,100.0,IC50,Inhibition of 15-hLO2,Confirmatory,17869117.0,
780,309802,3,7,,103167027,5280343,Active,,,,,Reductive inhibition of 15-hLO1,Other,17869117.0,
781,310882,6,2,,103167027,5280343,Unspecified,,,100.0,EC50,Inhibition of HIV1 replication,Confirmatory,17189684.0,
782,310884,6,2,,103167027,5280343,Active,,,,,Solubility in Hanks balanced salt solution at 1 mg after 24 hrs,Other,17228866.0,
783,310886,3,3,,103167027,5280343,Unspecified,,,,,Permeability from apical to basolateral side of dog MDCK1 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs,Other,17228866.0,
784,310887,3,3,,103167027,5280343,Unspecified,,,,,Permeability from apical to basolateral side of dog MDCK2 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs,Other,17228866.0,
785,310888,3,4,,103167027,5280343,Unspecified,,,,,Permeability from apical to basolateral side of human Caco-2 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs,Other,17228866.0,
786,310889,6,2,,103167027,5280343,Active,,,15.0,Kd,Displacement of fluorescent quercetin from Escherichia coli BL21 (DE3) recombinant DNA gyrase B G24,Confirmatory,17228868.0,
787,311148,10,2,,103167027,5280343,Unspecified,,,,IC50,Inhibition of PIM1 kinase,Confirmatory,17637507.0,
788,311641,4,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins by TEAC assay,Other,17922550.0,
789,311864,6,2,,103167027,5280343,Active,,,5.3,IC50,Induction of mouse osteoclast apoptosis,Confirmatory,17994703.0,
790,311924,6,2,,103167027,5280343,Active,,,25.0,IC50,Inhibition of LPS and INF-alpha-induced nitric oxide production in mouse RAW264.7 cells after 16 hrs,Confirmatory,18027905.0,
791,311925,6,2,,103167027,5280343,Active,,,26.8,IC50,Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells,Confirmatory,18027905.0,
792,312786,6,2,,103167027,5280343,Active,,,8.5,IC50,Inhibition of NADH-induced lipid peroxidation in rat brain microsome,Confirmatory,18183943.0,
793,312787,6,2,,103167027,5280343,Active,,,10.7,IC50,Inhibition of Fe2+-induced lipid peroxidation in rat brain homogenate,Confirmatory,18183943.0,
794,314064,6,3,,103167027,5280343,Active,,,29.6,IC50,Inhibition of LPS-induced NO production in mouse BV2 cells,Confirmatory,18178435.0,
795,315606,3,4,,103167027,5280343,Unspecified,,,,,Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
796,315607,3,4,,103167027,5280343,Unspecified,,,,,Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
797,315608,3,4,,103167027,5280343,Unspecified,,,,,Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
798,315609,3,4,,103167027,5280343,Unspecified,,,,,Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
799,315610,3,4,,103167027,5280343,Active,,,,,Effect on cell morphology in human BGC823 cells assessed as chromosomal condensations at 50 uM,Other,17997321.0,
800,315611,3,4,,103167027,5280343,Active,,,,,Induction of apoptotic bodies in human BGC823 cells at 50 uM after 48 hrs,Other,17997321.0,
801,315612,3,4,,103167027,5280343,Active,,,,,Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation at 50 uM after 48 hrs,Other,17997321.0,
802,315613,3,4,,103167027,5280343,Active,,,,,Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation at 100 uM after 48 hrs,Other,17997321.0,
803,315614,4,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation by DNA ladder assay,Other,17997321.0,
804,315615,3,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human BGC823 cells at 100 uM after 12 hrs by flow cytometry,Other,17997321.0,
805,315616,3,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human BGC823 cells at 100 uM after 24 hrs by flow cytometry,Other,17997321.0,
806,315617,3,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human BGC823 cells at 100 uM after 36 hrs by flow cytometry,Other,17997321.0,
807,315618,3,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human BGC823 cells at 100 uM after 48 hrs by flow cytometry,Other,17997321.0,
808,317335,6,2,,103167027,5280343,Active,,,16.25,IC50,Effect on doxorubicin metabolism in human liver cytosolic fractions assessed as inhibition of formation of doxorubicinol,Confirmatory,18024139.0,
809,317345,3,5,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human MDA-MB-435 cells at 10 uM after 96 hrs by MTT assay,Other,18024139.0,
810,317346,3,3,,103167027,5280343,Unspecified,,,,,Decrease in [14C]DOX accumulation in human NCI-ADR-RES cells at 30 uM after 120 mins,Other,18024139.0,
811,317347,3,3,,103167027,5280343,Inactive,,,,,Effect on [14C]DOX efflux in human NCI-ADR-RES cells,Other,18024139.0,
812,317348,7,1,,103167027,5280343,Active,,,,,Drug level in human plasma,Other,18024139.0,
813,322409,8,7,,103167027,5280343,Active,172045824.0,77337.0,,IC50,Inhibition of mouse recombinant AKR1C21,Confirmatory,18165015.0,
814,322413,9,5,,103167027,5280343,Active,113596.0,231.0,2.2,IC50,Inhibition of human recombinant aldose reductase,Confirmatory,18165015.0,
815,325654,7,2,,103167027,5280343,Active,,,3.8,IC50,Inhibition of PI3K,Confirmatory,18077363.0,
816,325766,7,2,,103167027,5280343,Active,,,2.0,IC50,Inhibition of phospholipase A2,Confirmatory,18077363.0,
817,332233,4,2,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against ICR mouse assessed as inhibition of TPA-induced ear edema compound administered topically preincubated 30 mins before TPA challenge,Other,11858752.0,
818,332234,3,3,,103167027,5280343,Unspecified,,,,,"Antiinflammatory activity against ICR mouse assessed as inhibition ratio of TPA-induced ear edema at 1 mg/ear, topically preincubated 30 mins before TPA challenge relative to TPA",Other,11858752.0,
819,332640,3,9,,103167027,5280343,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to control,Other,7769390.0,
820,332642,3,4,,103167027,5280343,Inactive,,,,,Binding affinity to Escherichia coli pUC8 DNA assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis,Other,7769390.0,
821,332647,3,9,,103167027,5280343,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage after 30 mins by agarose gel electrophoresis,Other,7769390.0,
822,332648,3,9,,103167027,5280343,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to total DNA,Other,7769390.0,
823,332649,3,9,,103167027,5280343,Active,13959709.0,7153.0,,,Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting at 100 uM by agarose gel electrophoresis,Other,7769390.0,
824,332650,3,4,,103167027,5280343,Active,,,,,Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation at 100 uM after 30 mins by agarose gel electrophoresis,Other,7769390.0,
825,332651,6,3,,103167027,5280343,Unspecified,,,,,Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation after 30 mins by agarose gel electrophoresis,Other,7769390.0,
826,332652,6,7,,103167027,5280343,Unspecified,13959709.0,7153.0,,,Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting by agarose gel electrophoresis,Other,7769390.0,
827,332704,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM,Other,7775983.0,
828,332706,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM,Other,7775983.0,
829,332708,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes,Other,7775983.0,
830,332929,6,3,,103167027,5280343,Unspecified,,,132.0,EC50,Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay,Confirmatory,8158164.0,
831,332930,6,3,,103167027,5280343,Unspecified,,,132.0,IC50,Cytotoxicity against human H9 cells after 3 days,Confirmatory,8158164.0,
832,332931,3,5,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B",Other,8158164.0,
833,333311,11,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,15387666.0,
834,333523,8,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human A549 cells after 3 days by SRB assay,Other,15568778.0,
835,333524,8,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human MCF7 cells after 3 days by SRB assay,Other,15568778.0,
836,333525,3,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human A549 cells at 20 mcg/mL after 3 days by SRB assay,Other,15568778.0,
837,334634,3,5,,103167027,5280343,Unspecified,,,,,Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction,Other,3069957.0,
838,334635,3,5,,103167027,5280343,Unspecified,,,,,Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction,Other,3069957.0,
839,334637,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
840,334638,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
841,334639,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
842,334640,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
843,334641,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
844,334642,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
845,334643,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
846,334644,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
847,334645,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
848,334646,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 600 ug/plate after 72 hrs,Other,3069957.0,
849,334647,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs,Other,3069957.0,
850,334648,3,5,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs,Other,3069957.0,
851,336178,3,3,,103167027,5280343,Unspecified,,,,,Antiviral activity against Potato virus X in half leaf of Chenopodium quinoa at 9.3 mg/mL after 10 days,Other,12398535.0,
852,336443,9,1,,103167027,5280343,Unspecified,,,,IC50,Antiprotozoal activity against Plasmodium falciparum K1,Confirmatory,12398543.0,
853,336444,10,1,,103167027,5280343,Unspecified,,,,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei S427 blood stream trypomastigotes,Confirmatory,12398543.0,
854,336445,10,1,,103167027,5280343,Unspecified,,,,IC50,Cytotoxicity against human KB cells,Confirmatory,12398543.0,
855,336446,9,1,,103167027,5280343,Unspecified,,,,IC50,Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) promastigotes,Confirmatory,12398543.0,
856,336484,3,3,,103167027,5280343,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 1 mM by spectrophotometry,Other,12444671.0,
857,336485,9,2,,103167027,5280343,Active,,,3.0,IC50,Inhibition of xanthine oxidase-mediated formation of uric acid by spectrophotometry,Confirmatory,12444671.0,
858,336952,5,1,,103167027,5280343,Unspecified,,,,,Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation,Other,2607357.0,
859,337227,6,3,,103167027,5280343,Active,,,12.0,IC50,Antialgal activity against Microcystis aeruginosa NIES 44 after 24 hrs by fluorophotometric method,Confirmatory,,
860,337228,6,3,,103167027,5280343,Active,,,25.0,IC50,Antialgal activity against Anabaena flos-aquae NIES 73 after 48 hrs by fluorophotometric method,Confirmatory,,
861,337692,4,3,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
862,337693,4,3,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
863,338023,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
864,338024,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
865,338025,4,5,,103167027,5280343,Active,,,0.205,I50,Inhibition of rat liver mitochondrial ATPase assessed per mg of protein,Confirmatory,2959755.0,
866,338026,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control,Other,2959755.0,
867,338027,4,5,,103167027,5280343,Active,,,0.145,I50,Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein,Confirmatory,2959755.0,
868,338028,4,5,,103167027,5280343,Active,,,0.715,I50,Inhibition of beef heart mitochondrial succinoxidase assessed per mg of protein,Confirmatory,2959755.0,
869,338748,6,4,,103167027,5280343,Unspecified,,,,,Inhibition of phosphatidylinositol 4-kinase in human A431 cell membrane by liquid scintillation counting,Other,1666120.0,
870,338750,6,3,,103167027,5280343,Unspecified,,,,,Inhibition of bovine thymus p56LCK-catalyzed phosphorylation of angiotensin 1 by SDS-PAGE,Other,1800636.0,
871,339009,5,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,3404159.0,
872,339056,8,1,,103167027,5280343,Active,,,0.2,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
873,339057,8,1,,103167027,5280343,Active,,,0.17,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
874,339058,3,5,,103167027,5280343,Unspecified,,,,,Selectivity for Moloney murine leukemia virus reverse transcriptase over Escherichia coli DNA polymerase 1,Other,1378087.0,
875,339141,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of K(+)/Ca(2+)-induced Wistar rat thoracic aorta contraction at 100 ug/mL after 15 mins,Other,8350094.0,
876,339142,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 100 ug/mL after 15 mins,Other,8350094.0,
877,339143,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 50 ug/mL after 15 mins,Other,8350094.0,
878,339144,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 20 ug/mL after 15 mins,Other,8350094.0,
879,339145,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 10 ug/mL after 15 mins,Other,8350094.0,
880,339146,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 100 ug/mL after 15 mins,Other,8350094.0,
881,339147,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 50 ug/mL after 15 mins,Other,8350094.0,
882,339148,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 20 ug/mL after 15 mins,Other,8350094.0,
883,339149,3,6,,103167027,5280343,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 10 ug/mL after 15 mins,Other,8350094.0,
884,339150,11,1,,103167027,5280343,Unspecified,,,,,Inhibition of bovine thymus p56-LCK protein tyrosine kinase activity,Other,8350096.0,
885,340664,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents at 0.2 to 0.6 uM by ORAC-fluorescein assay,Other,18611049.0,
886,346253,9,1,,103167027,5280343,Active,,,24.4,EC50,Vasorelaxant activity in Sprague-Dawley rat aorta assessed as inhibition of phenylephrine-induced contraction after 15 to 20 mins,Confirmatory,19070497.0,
887,346254,3,4,,103167027,5280343,Unspecified,,,,,Vasorelaxant activity in Sprague-Dawley rat aorta assessed as inhibition of phenylephrine-induced contraction after 15 to 20 mins relative to phenylephrine,Other,19070497.0,
888,347252,3,12,,103167027,5280343,Unspecified,118519.0,873.0,,,Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor,Other,19097799.0,
889,347253,3,12,,103167027,5280343,Unspecified,118519.0,873.0,,,Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+,Other,19097799.0,
890,347254,3,12,,103167027,5280343,Unspecified,118519.0,873.0,,,Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH,Other,19097799.0,
891,347255,3,10,,103167027,5280343,Unspecified,6014959.0,874.0,,,Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor,Other,19097799.0,
892,347256,3,10,,103167027,5280343,Unspecified,6014959.0,874.0,,,Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+,Other,19097799.0,
893,347257,3,10,,103167027,5280343,Unspecified,6014959.0,874.0,,,Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH,Other,19097799.0,
894,351090,6,2,,103167027,5280343,Active,,,40.6,EC50,Antioxidant activity assessed as superoxide radical scavenging activity by spectrophotometry,Confirmatory,19362850.0,
895,351091,6,3,,103167027,5280343,Active,,,5.5,EC50,Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometry,Confirmatory,19362850.0,
896,351092,6,2,,103167027,5280343,Active,,,6.0,EC50,Antioxidant activity against FeSO4-induced lipid peroxidation in rat liver homogenate assessed as inhibition of malondialdehyde release after 1 hr by thiobarbituric acid assay,Confirmatory,19362850.0,
897,351093,4,4,,103167027,5280343,Unspecified,,,,,Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 8 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control,Other,19362850.0,
898,351094,4,4,,103167027,5280343,Unspecified,,,,,Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 16 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control,Other,19362850.0,
899,351095,4,4,,103167027,5280343,Unspecified,,,,,Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 32 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control,Other,19362850.0,
900,351096,6,2,,103167027,5280343,Unspecified,,,68.3,EC50,Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay,Confirmatory,19362850.0,
901,351097,4,7,,103167027,5280343,Inconclusive,,,,,Inhibition of xanthine oxidase assessed as formation of formazan after 2 hrs by spectrophotometry,Other,19362850.0,
902,353590,3,4,,103167027,5280343,Active,,,,,Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot,Other,19296652.0,
903,353591,3,10,,103167027,5280343,Active,19855073.0,3315.0,,,Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr,Other,19296652.0,
904,353592,3,10,,103167027,5280343,Inactive,462333.0,3297.0,,,Inhibition of HSF1 binding to heat shock element DNA assessed as HSF1/HSE complex formation in human HeLa cells at 50 ug/mL treated for 1 hr before heat induction,Other,19296652.0,
905,353593,3,10,,103167027,5280343,Active,462333.0,3297.0,,,Inhibition of HSF1 binding to heat shock element DNA assessed as HSF1/HSE complex formation in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction,Other,19296652.0,
906,353594,3,4,,103167027,5280343,Inactive,,,,,Inhibition of of heat-induced increase in nuclear HSF1 protein level in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot,Other,19296652.0,
907,353595,3,4,,103167027,5280343,Inactive,,,,,Inhibition of of heat-induced increase in nuclear HSF1 protein level in human HeLa cells at 50 ug/mL treated for 1 hr before heat induction by Western blot,Other,19296652.0,
908,353596,3,4,,103167027,5280343,Active,,,,,Inhibition of of heat-induced increase in nuclear HSF1 protein phosphorylation in human Jurkat cells assessed as decrease in protein mobility at 50 ug/mL treated for 1 hr before heat induction by EMSA,Other,19296652.0,
909,353597,3,4,,103167027,5280343,Active,,,,,Inhibition of of heat-induced increase in nuclear HSF1 protein phosphorylation in human HeLa cells assessed as decrease in protein mobility at 50 ug/mL treated for 1 hr before heat induction by EMSA,Other,19296652.0,
910,353598,6,2,,103167027,5280343,Active,,,5.6,IC50,Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay,Confirmatory,19296652.0,
911,353599,6,2,,103167027,5280343,Active,,,3.3,IC50,Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay,Confirmatory,19296652.0,
912,354608,9,5,,103167027,5280343,Unspecified,584742.0,396816.0,50.1,IC50,Inhibition of pig lens aldose reductase by spectrophotometry,Confirmatory,8699190.0,
913,354609,6,2,,103167027,5280343,Unspecified,,,91.0,IC50,Inhibition of pig kidney aldehyde reductase by spectrophotometry,Confirmatory,8699190.0,
914,354610,6,2,,103167027,5280343,Unspecified,,,65.3,IC50,Inhibition of bovine liver NADH oxidase,Confirmatory,8699190.0,
915,354858,3,7,,103167027,5280343,Active,,,,,Inhibition of DNA topoisomerase 1,Other,8759170.0,
916,354859,3,7,,103167027,5280343,Active,,,,,Inhibition of DNA topoisomerase 2,Other,8759170.0,
917,355885,6,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
918,355887,6,2,,103167027,5280343,Inactive,,,,,Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
919,355888,3,3,,103167027,5280343,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
920,355891,6,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against Bacillus cereus isolate after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
921,356212,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay,Other,12932124.0,
922,356646,6,3,,103167027,5280343,Active,,,39.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,14640528.0,
923,356713,3,3,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.10 mg/ear,Other,11473412.0,
924,356714,3,3,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.05 mg/ear,Other,11473412.0,
925,356716,4,2,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema,Other,11473412.0,
926,356717,3,3,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.50 mg/ear,Other,11473412.0,
927,356718,3,3,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 1 mg/ear,Other,11473412.0,
928,357035,6,2,,103167027,5280343,Active,,,0.5,IC50,Antioxidant activity assessed as radical scavenging activity in FMLP-stimulated human PMNC by chemiluminescence assay,Confirmatory,11473436.0,
929,357253,6,2,,103167027,5280343,Unspecified,,,,,Inhibition of Saccharomyces cerevisiae fatty acid synthase,Other,12502337.0,
930,357254,6,2,,103167027,5280343,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028,Other,12502337.0,
931,357255,6,2,,103167027,5280343,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans ATCC 90113,Other,12502337.0,
932,358170,7,3,,103167027,5280343,Active,,,6.0,Ki,Inhibition of Rous sarcoma virus p60 v-src,Confirmatory,1479375.0,
933,358174,14,1,,103167027,5280343,Unspecified,,,,IC50,Inhibition of p56 lck,Confirmatory,1479375.0,
934,359632,3,5,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 48.3 ug/ml,Other,1338212.0,
935,359633,3,5,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 60.4 ug/ml,Other,1338212.0,
936,359634,3,5,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 72.5 ug/ml,Other,1338212.0,
937,359635,3,5,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 5 ug/ml,Other,1338212.0,
938,359636,3,5,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 10.1 ug/ml,Other,1338212.0,
939,359646,6,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,1338212.0,
940,361173,6,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HL60 cells after 3 days by MTT assay,Other,11421746.0,
941,361174,7,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human SW1573 cells after 3 days by MTT assay,Other,11421746.0,
942,361175,6,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human CEM cells after 3 days by MTT assay,Other,11421746.0,
943,362787,3,9,,103167027,5280343,Unspecified,317373261.0,8654.0,,,Inhibition of human recombinant PDE5A1 expressed in COS7 cells at 10 uM,Other,18778098.0,
944,362986,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation at 50 uM after 30 mins by lucigenin enhanced chemiluminescence assay,Other,17804122.0,
945,362987,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation at 50 uM after 30 mins by luminol enhanced chemiluminescence assay,Other,17804122.0,
946,362988,9,1,,103167027,5280343,Active,,,4.7,IC50,Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation after 30 mins by lucigenin enhanced chemiluminescence assay,Confirmatory,17804122.0,
947,362989,9,1,,103167027,5280343,Active,,,2.4,IC50,Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation after 30 mins by luminol enhanced chemiluminescence assay,Confirmatory,17804122.0,
948,362990,3,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against New Zealand white rabbit neutrophils assessed as cell viability at 50 uM after 30 mins by trypan blue exclusion test,Other,17804122.0,
949,362991,3,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against New Zealand white rabbit neutrophils assessed as LDH release at 50 uM after 30 mins by spectrophotometry,Other,17804122.0,
950,365081,6,2,,103167027,5280343,Active,,,24.4,EC50,Vasorelaxant activity against phenylephrine-induced contraction in Sprague-Dawley rat aorta,Confirmatory,18678502.0,
951,365082,3,4,,103167027,5280343,Unspecified,,,,,Vasorelaxant activity against phenylephrine-induced contraction in Sprague-Dawley rat aorta relative to phenylephrine,Other,18678502.0,
952,365674,10,5,,103167027,5280343,Active,215273868.0,5550.0,13.0,IC50,Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli,Confirmatory,18650094.0,
953,365675,6,4,,103167027,5280343,Unspecified,,,130.0,IC50,Inhibition of DPP4,Confirmatory,18650094.0,
954,365954,9,3,,103167027,5280343,Unspecified,,,20.0,IC50,Inhibition of Cdk1/cyclin B,Confirmatory,18639462.0,
955,366284,6,2,,103167027,5280343,Unspecified,,,87.6,IC50,Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
956,366285,6,2,,103167027,5280343,Unspecified,,,58.4,IC50,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
957,366286,6,2,,103167027,5280343,Unspecified,,,67.5,IC50,Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
958,367703,3,3,,103167027,5280343,Active,,,,,Inhibition of human recombinant ALR2 expressed in bacterial cell expression system by Uncompetitive inhibition based Lineweaver-Burke plot,Other,19121944.0,
959,367704,9,5,,103167027,5280343,Active,1703236.0,396924.0,38.4,IC50,Inhibition of pig ALR1,Confirmatory,19121944.0,
960,367705,6,2,,103167027,5280343,Active,,,5.92,IC50,Inhibition of human recombinant ALR2 expressed in bacterial cell expression system,Confirmatory,19121944.0,
961,367707,3,3,,103167027,5280343,Unspecified,,,,,Selectivity ratio of IC50 for pig ALR1 to IC50 for human recombinant ALR2,Other,19121944.0,
962,367708,3,11,,103167027,5280343,Active,1703236.0,396924.0,,,Inhibition of pig ALR1 by Uncompetitive inhibition based Lineweaver-Burke plot,Other,19121944.0,
963,370284,3,10,,103167027,5280343,Unspecified,117225.0,1558.0,,,Effect on CYP2C8/CYP2C9 in human liver assessed as tolubutamide methylhydroxylation at 100 uM relative to control,Other,17132069.0,
964,370563,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of Escherichia coli D-alanine-D-alanine ligase B assessed as residual activity at 2 mM preincubated for 30 mins by malachite green assay,Other,18321716.0,
965,375988,6,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity relative to control,Other,16643034.0,
966,375989,6,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as superoxide anion scavenging activity by xanthine oxidase oxidation system relative to control,Other,16643034.0,
967,375991,3,3,,103167027,5280343,Unspecified,,,,,"Antioxidant activity assessed as inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride-induced lipid peroxidation at 3.125 ug/ml by ferric thiocyanate system relative to control",Other,16643034.0,
968,375992,7,2,,103167027,5280343,Inconclusive,,,,,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,Other,16643034.0,
969,376367,5,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity in brain homogenate assessed as drug level require to inhibit 50% of spontaneous lipid peroxidation relative to control,Other,10579855.0,
970,377040,3,6,,103167027,5280343,Active,,,,,Hepatoprotective activity against H2O2-induced hepatotoxicity in Wistar rat hepatocytes assessed as reduction in glutamic pyruvate transaminase release after 1 hr relative to control,Other,15679328.0,
971,377591,3,3,,103167027,5280343,Active,,,,,"Increase in duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
972,377592,3,3,,103167027,5280343,Active,,,,,"Increase in duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
973,377654,9,5,,103167027,5280343,Active,124028637.0,281293.0,0.01,IC50,Inhibition of bovine MAO-A by fluorimetric method,Confirmatory,16792415.0,
974,377655,9,5,,103167027,5280343,Active,124028638.0,338445.0,20.0,IC50,Inhibition of bovine MAO-B by fluorimetric method,Confirmatory,16792415.0,
975,377656,3,3,,103167027,5280343,Unspecified,,,,,"Selectivity index, IC50 for bovine MAO-B to IC50 for bovine MAO-A",Other,16792415.0,
976,377657,3,3,,103167027,5280343,Inactive,,,,,"Induction of behavioral effects in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
977,377658,3,3,,103167027,5280343,Inactive,,,,,"Induction of behavioral effects in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
978,377659,3,3,,103167027,5280343,Inactive,,,,,"Induction of behavioral effects in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
979,377660,3,3,,103167027,5280343,Inactive,,,,,"Induction of behavioral effects in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
980,377661,3,3,,103167027,5280343,Inactive,,,,,"Effect on duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
981,377662,3,3,,103167027,5280343,Inactive,,,,,"Effect on duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
982,377663,3,3,,103167027,5280343,Inactive,,,,,"Effect on duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
983,377664,3,3,,103167027,5280343,Inactive,,,,,"Effect on duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
984,377665,3,3,,103167027,5280343,Active,,,,,"Increase in duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control",Other,16792415.0,
985,377666,3,3,,103167027,5280343,Active,,,,,"Increase in duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose",Other,16792415.0,
986,377784,4,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins by TEAC method,Other,15844940.0,
987,377785,6,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as reduction of F3+/ferricyanide complex after 20 mins,Other,15844940.0,
988,377786,3,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 15 ug/mL after 30 to 45 mins,Other,15844940.0,
989,378674,8,1,,103167027,5280343,Unspecified,,,,IC50,Inhibition of thymocyte protein tyrosine kinase,Confirmatory,16441060.0,
990,378676,6,2,,103167027,5280343,Active,,,0.55,IC50,Inhibition of CK2,Confirmatory,16441060.0,
991,378677,6,2,,103167027,5280343,Active,,,3.8,IC50,Inhibition of PI3K,Confirmatory,16441060.0,
992,378681,9,2,,103167027,5280343,Active,,,13.0,IC50,Inhibition of LCK,Confirmatory,16441060.0,
993,378682,6,2,,103167027,5280343,Active,,,6.0,Ki,Inhibition of Rous sarcoma virus SRC,Confirmatory,16441060.0,
994,378807,6,2,,103167027,5280343,Active,,,2.39,IC50,Antioxidant activity assessed as inhibition of hydroxyl radical generation by fluorescence spectroscopy,Confirmatory,17067150.0,
995,378808,6,2,,103167027,5280343,Active,,,29.12,IC50,"Antioxidant activity assessed as inhibition of total reactive oxygen species generation in Wistar rat kidney by 2',7'-dichlorofluorescein based fluorescence spectroscopy",Confirmatory,17067150.0,
996,378809,6,2,,103167027,5280343,Active,,,1.38,IC50,Antioxidant activity assessed as peroxynitrite scavenging activity by fluorescence spectroscopy,Confirmatory,17067150.0,
997,379054,6,3,,103167027,5280343,Unspecified,,,120.0,IC50,Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA,Confirmatory,10096854.0,
998,379055,4,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity,Other,10096854.0,
999,379089,6,2,,103167027,5280343,Unspecified,,,217.0,IC50,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay,Confirmatory,10096863.0,
1000,379092,3,4,,103167027,5280343,Active,,,,,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay,Other,10096863.0,
1001,379094,3,4,,103167027,5280343,Unspecified,,,,,Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 0.1 ug/mL,Other,10096863.0,
1002,379312,3,3,,103167027,5280343,Unspecified,,,,,"Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity relative to Trolox",Other,10757712.0,
1003,379313,3,3,,103167027,5280343,Unspecified,,,,,"Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity",Other,10757712.0,
1004,380503,11,1,,103167027,5280343,Unspecified,231454.0,3350.0,,Ki,Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells,Confirmatory,16562853.0,
1005,381802,9,5,,103167027,5280343,Active,134039205.0,2739.0,3.2,IC50,Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system,Confirmatory,18258440.0,
1006,381804,3,4,,103167027,5280343,Active,,,,,Antiproliferative activity against human HL60 cells at 30 uM after 48 hrs by MTS assay,Other,18258440.0,
1007,382346,6,2,,103167027,5280343,Active,,,0.8,IC50,"Inhibition of amyloid beta (1 to 40) aggregation assessed as emission of thioflavin T fluorescence in presence of 1,1,1,3,3,3-hexaflouro-2-propanol",Confirmatory,18406152.0,
1008,383193,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent at 0.2 to 0.6 uM by ORAC-fluorescein assay,Other,18343123.0,
1009,385353,9,5,,103167027,5280343,Active,1168407.0,24192.0,7.21,IC50,Inhibition of rat lens aldose reductase,Confirmatory,18298080.0,
1010,387406,9,2,,103167027,5280343,Unspecified,,,64.0,IC50,Inhibition of PLK1,Confirmatory,18762425.0,
1011,388742,12,2,,103167027,5280343,Active,113596.0,231.0,0.0148,IC50,Inhibition of cataracted human eye lens aldose reductase,Confirmatory,18976928.0,
1012,388743,6,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins,Other,18976928.0,
1013,395150,9,1,,103167027,5280343,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity,Other,18403057.0,
1014,395151,7,3,,103167027,5280343,Unspecified,,,8500.0,IC50,Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of lipid peroxidation by TBA assay,Confirmatory,18403057.0,
1015,395316,9,5,,103167027,5280343,Unspecified,120679.0,,142.0,IC50,Inhibition of Trypanosoma cruzi recombinant glycosomal GAPDH expressed in Escherichia coli by spectrophotometry,Confirmatory,19254846.0,
1016,395317,6,2,,103167027,5280343,Unspecified,,,771.0,IC50,Antitrypanosomal activity against Trypanosoma cruzi amastigote forms,Confirmatory,19254846.0,
1017,397122,6,3,,103167027,5280343,Unspecified,,,,,Inhibition of HIV1 RT,Other,1710653.0,
1018,397831,4,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
1019,398374,8,1,,103167027,5280343,Unspecified,6686057.0,,70.0,ID50,"Inhibition of mushroom tyrosinase assessed as L-3,4-dihydroxyphenylalanine oxidation",Confirmatory,7623048.0,
1020,398376,3,10,,103167027,5280343,Active,6686057.0,,,,"Competitive inhibition of mushroom tyrosinase assessed as L-3,4-dihydroxyphenylalanine oxidation",Other,7623048.0,
1021,398393,6,3,,103167027,5280343,Active,,,7.1,IC50,Inhibition of bovine pancreas trypsin,Confirmatory,7673925.0,
1022,398394,9,5,,103167027,5280343,Active,113736.0,100739583.0,34.3,IC50,Inhibition of pig kidney cytosolic Leucyl aminopeptidase,Confirmatory,7673925.0,
1023,398957,3,3,,103167027,5280343,Active,,,,,Antimicrobial activity against Staphylococcus aureus,Other,6736972.0,
1024,398958,3,3,,103167027,5280343,Active,,,,,Antimicrobial activity against Escherichia coli,Other,6736972.0,
1025,398959,3,3,,103167027,5280343,Inactive,,,,,Antimicrobial activity against Candida albicans,Other,6736972.0,
1026,399340,9,2,,103167027,5280343,Active,,,2.62,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,Confirmatory,9461655.0,
1027,399341,6,2,,103167027,5280343,Active,,,1.63,IC50,Antioxidant activity assessed as superoxide-scavenging activity by nitrite method,Confirmatory,9461655.0,
1028,400266,9,6,,103167027,5280343,Unspecified,416783.0,140908.0,63.4,EC50,Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation,Confirmatory,15043421.0,
1029,400502,2,4,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Pseudomonas maltophilia at 100 ug by test disc paper method,Other,,
1030,400506,3,1,,103167027,5280343,Unspecified,,,,,Growth inhibition of tobacco budworm larvae assessed as percent of diet,Other,,
1031,400516,6,2,,103167027,5280343,Active,,,26.8,IC50,Inhibition of LPS and INF-gamma-induced NO production in mouse RAW264.7 cells,Confirmatory,15043424.0,
1032,400607,4,3,,103167027,5280343,Unspecified,,,,,Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells,Other,8882428.0,
1033,401236,6,2,,103167027,5280343,Unspecified,,,,,Inhibition of superoxide production in PMNCs by NBT reduction assay,Other,15104500.0,
1034,401616,7,6,,103167027,5280343,Unspecified,113596.0,231.0,,,Inhibition of human muscle recombinant aldose reductase by spectrophotometry,Other,15844965.0,
1035,402009,3,3,,103167027,5280343,Active,,,,,Antioxidant activity assessed as ABAP free radical scavenging measured at 3.2 mM by TRAP assay,Other,15921431.0,
1036,402229,6,3,,103167027,5280343,Unspecified,,,125.0,IC50,Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay,Confirmatory,15165145.0,
1037,402230,6,3,,103167027,5280343,Active,,,7.5,IC50,Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of hydroxyl radical-induced lipid peroxidation by TBARS assay,Confirmatory,15165145.0,
1038,402231,6,2,,103167027,5280343,Unspecified,,,80.0,IC50,Antioxidant activity in 1-alpha-phosphatidylcholine liposome assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay,Confirmatory,15165145.0,
1039,402232,3,3,,103167027,5280343,Inconclusive,,,,,Antioxidant activity in 1-alpha-phosphatidylcholine liposome assessed as inhibition of ascorbyl hydroxyl-induced lipid peroxidation by TBARS assay,Other,15165145.0,
1040,402233,6,2,,103167027,5280343,Unspecified,,,80.0,IC50,Antioxidant activity in asolectin liposome assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay,Confirmatory,15165145.0,
1041,402234,3,3,,103167027,5280343,Inconclusive,,,,,Antioxidant activity in asolectin liposome assessed as inhibition of ascorbyl hydroxyl-induced lipid peroxidation by TBARS assay,Other,15165145.0,
1042,402262,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity by spectrophotometry,Other,15165152.0,
1043,402263,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of free radical scavenging activity by chemiluminescence assay,Other,15165152.0,
1044,402267,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity against ABTS radical assessed as TEAC units,Other,15165156.0,
1045,402361,3,11,,103167027,5280343,Inactive,544257.0,2099.0,,,Activity at human estrogen receptor expressed in transgenic Arabidopsis plant at 400 uM by pER8-GFP reporter assay,Other,16038533.0,
1046,402473,6,2,,103167027,5280343,Active,,,20.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining,Confirmatory,9287415.0,
1047,402475,6,2,,103167027,5280343,Active,,,26.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay,Confirmatory,9287415.0,
1048,402483,3,4,,103167027,5280343,Active,,,,,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
1049,402484,3,4,,103167027,5280343,Active,,,,,Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
1050,402563,3,3,,103167027,5280343,Unspecified,,,,,Radical scavenging activity in CD mouse macrophages assessed as inhibition of superoxide anion generation at 25 uM relative to control,Other,15217273.0,
1051,402564,3,3,,103167027,5280343,Unspecified,,,,,Radical scavenging activity in CD mouse macrophages assessed as inhibition of superoxide anion generation at 50 uM relative to control,Other,15217273.0,
1052,402565,3,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against CD mouse macrophages assessed as cell viability at 25 uM by trypan blue exclusion test,Other,15217273.0,
1053,402566,3,3,,103167027,5280343,Unspecified,,,,,Cytotoxicity against CD mouse macrophages assessed as cell viability at 50 uM by trypan blue exclusion test,Other,15217273.0,
1054,402567,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of XOD at 25 uM relative to control,Other,15217273.0,
1055,402568,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of XOD at 125 uM relative to control,Other,15217273.0,
1056,402708,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of copper-induced lipid peroxidation by Fe3(CN)6 method at 300 uM,Other,16038556.0,
1057,403340,11,1,,103167027,5280343,Unspecified,,,,IC50,Inhibition of COX2,Confirmatory,16038536.0,
1058,403627,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of COX2 at 2.5 ug/mL,Other,16038536.0,
1059,403628,3,7,,103167027,5280343,Unspecified,,,,,Inhibition of COX1 at 2.5 ug/mL,Other,16038536.0,
1060,403636,6,2,,103167027,5280343,Unspecified,,,,IC50,Inhibition of COX2 mRNA expression in human DLD1 cells,Confirmatory,16038536.0,
1061,404008,5,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human KB cells,Other,469554.0,
1062,404028,6,2,,103167027,5280343,Active,,,26.8,IC50,Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells,Confirmatory,16378364.0,
1063,404068,3,4,,103167027,5280343,Active,,,,,In vivo antitumor activity against rat Walker 256 cells,Other,469554.0,
1064,404304,3,10,,103167027,5280343,Unspecified,308153583.0,1244.0,,,Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control,Other,18457386.0,
1065,404692,9,5,,103167027,5280343,Unspecified,1351933.0,276.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
1066,404692,9,5,,103167027,5280343,Unspecified,1351933.0,277.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
1067,404692,9,5,,103167027,5280343,Unspecified,1351933.0,278.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
1068,406716,3,3,,103167027,5280343,Unspecified,,,,,Photostability of compound assessed as sun protection factor after 120 mins,Other,18512988.0,
1069,406717,3,3,,103167027,5280343,Unspecified,,,,,Photostability of compound assessed as protection factor-UVA after 120 mins,Other,18512988.0,
1070,406994,3,12,,103167027,5280343,Unspecified,313104233.0,3292.0,,,Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 20 uM,Other,18533708.0,
1071,406995,10,2,,103167027,5280343,Inconclusive,313104233.0,3292.0,,IC50,Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol,Confirmatory,18533708.0,
1072,406996,3,11,,103167027,5280343,Unspecified,544152.0,3294.0,,,Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 40 uM,Other,18533708.0,
1073,406997,9,6,,103167027,5280343,Active,544152.0,3294.0,1.54,IC50,Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol,Confirmatory,18533708.0,
1074,414643,9,2,,103167027,5280343,Active,,,23.3,IC50,Inhibition of PTP1B,Confirmatory,19297174.0,
1075,417656,9,5,,103167027,5280343,Active,127825.0,,2.7,IC50,Inhibition of Clostridium perfringens neuraminidase by fluorimetry,Confirmatory,19285413.0,
1076,417659,9,5,,103167027,5280343,Inconclusive,127825.0,,,Ki,Competitive inhibition of Clostridium perfringens neuraminidase by Lineweaver-Burke plot and Dixon plot,Confirmatory,19285413.0,
1077,418378,7,2,,103167027,5280343,Active,,,1.1,IC50,Inhibition of Pim1,Confirmatory,19256503.0,
1078,420260,9,2,,103167027,5280343,Active,,,15.0,IC50,Inhibition of Src,Confirmatory,19041163.0,
1079,420262,9,2,,103167027,5280343,Active,,,0.9,IC50,Inhibition of EGFR,Confirmatory,19041163.0,
1080,423636,6,2,,103167027,5280343,Unspecified,,,10.0,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,19278239.0,
1081,424718,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,Km,Activity at bovine xanthine oxidase at 10 uM,Confirmatory,19388706.0,
1082,424719,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,Km,Activity at bovine xanthine oxidase at 25 uM,Confirmatory,19388706.0,
1083,424720,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,Km,Activity at bovine xanthine oxidase at 50 uM,Confirmatory,19388706.0,
1084,424721,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,Km,Activity at bovine xanthine oxidase at 25 uM preincubated for 10 mins,Confirmatory,19388706.0,
1085,424722,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Ratio of kcat to km for bovine xanthine oxidase at 10 uM,Other,19388706.0,
1086,424723,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Ratio of kcat to km for bovine xanthine oxidase at 25 uM,Other,19388706.0,
1087,424724,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Ratio of kcat to km for bovine xanthine oxidase at 50 uM,Other,19388706.0,
1088,424725,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Ratio of kcat to km for bovine xanthine oxidase at 25 uM preincubated for 10 mins,Other,19388706.0,
1089,424726,9,5,,103167027,5280343,Active,109940048.0,280960.0,1.2,Ki,Inhibition of bovine xanthine oxidase,Confirmatory,19388706.0,
1090,424727,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 10 uM,Other,19388706.0,
1091,424728,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 20 uM,Other,19388706.0,
1092,424729,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 50 uM,Other,19388706.0,
1093,424730,7,1,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 25 uM preincubated for 10 mins,Other,19388706.0,
1094,424734,3,10,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 10 uM relative to control,Other,19388706.0,
1095,424735,3,10,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 25 uM relative to control,Other,19388706.0,
1096,424736,3,10,,103167027,5280343,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 50 uM relative to control,Other,19388706.0,
1097,425005,3,3,,103167027,5280343,Unspecified,,,,,DPPH radical scavenging activity assessed as ratio of antioxidant concentration to drug level causing 50% decrease in DPPH level at steady state at 100 ug by TLC autographic assay,Other,19361168.0,
1098,425006,6,2,,103167027,5280343,Active,,,1.0,EC50,Antioxidant activity assessed as protection against peroxyl radical-induced alkaline phosphatase activity loss by microplate assay,Confirmatory,19361168.0,
1099,426319,6,2,,103167027,5280343,Active,,,9.6,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess reagent assay,Confirmatory,19555124.0,
1100,426324,10,1,,103167027,5280343,Active,,,18.0,ED50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by ELISA,Confirmatory,19555124.0,
1101,426989,6,2,,103167027,5280343,Unspecified,,,10.0,IC50,Cytotoxicity against human HepG2 cells by MTT assay,Confirmatory,19583252.0,
1102,426990,6,2,,103167027,5280343,Unspecified,,,10.0,IC50,Cytotoxicity against human MCF7 cells by MTT assay,Confirmatory,19583252.0,
1103,427748,9,1,,103167027,5280343,Active,,,2.4,Ki,Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay,Confirmatory,19725578.0,
1104,429118,3,10,,103167027,5280343,Inactive,121069.0,2908.0,,,Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay,Other,19592245.0,
1105,429128,3,10,,103167027,5280343,Inactive,1018618719.0,367.0,,,Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay,Other,19592245.0,
1106,429129,3,10,,103167027,5280343,Inactive,121069.0,2908.0,,,Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay,Other,19592245.0,
1107,429249,6,2,,103167027,5280343,Inconclusive,,,,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma/LPS-stimulated nitric oxide production after 17 to 20 hrs by Griess assay,Confirmatory,19359068.0,
1108,429250,6,3,,103167027,5280343,Inactive,,,,IC50,Antioxidant activity assessed as nitric oxide scavenging activity after 60 min by Griess assay,Confirmatory,19359068.0,
1109,429251,6,3,,103167027,5280343,Active,,,41.79,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,19359068.0,
1110,429252,9,2,,103167027,5280343,Inconclusive,,,,IC50,Inhibition of tyrosinase,Confirmatory,19359068.0,
1111,430139,9,6,,103167027,5280343,Unspecified,190360114.0,1489680.0,50.0,IC50,Inhibition of ATPase activity of SARS coronavirus helicase assessed as phosphate release by malachite green assay,Confirmatory,19625187.0,
1112,430140,9,6,,103167027,5280343,Active,190360114.0,1489680.0,8.1,IC50,Inhibition of SARS coronavirus helicase assessed as duplex-DNA unwinding by FRET based assay,Confirmatory,19625187.0,
1113,430217,6,2,,103167027,5280343,Unspecified,,,60.04,IC50,Antileishmanial activity against extracellular Leishmania peruviana promastigotes after 72 hrs,Confirmatory,19489596.0,
1114,430218,6,2,,103167027,5280343,Active,,,30.49,IC50,Antileishmanial activity against extracellular Leishmania braziliensis promastigotes after 72 hrs,Confirmatory,19489596.0,
1115,430311,6,2,,103167027,5280343,Unspecified,,,125.44,IC50,Cytotoxicity against BALB/c mouse J774.2 cells after 72 hrs by trypan blue assay,Confirmatory,19489596.0,
1116,434959,1,1,,85787280,5280343,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
1117,434959,1,1,,85787911,5280343,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
1118,435140,3,5,,103167027,5280343,Unspecified,,,,,Relative inhibition of I174A-mutated CK2 holoenzyme compared to wild-type,Other,12816539.0,
1119,435640,7,2,,103167027,5280343,Active,,,0.85,IC50,Inhibition of wild-type CK2 holoenzyme,Confirmatory,12816539.0,
1120,435763,8,2,,103167027,5280343,Active,,,1.18,Ki,Inhibitory constant against Zea mays CK2alpha,Confirmatory,12816539.0,
1121,435764,7,2,,103167027,5280343,Active,,,1.1,IC50,Inhibition of V66A-mutated CK2 holoenzyme,Confirmatory,12816539.0,
1122,435888,3,5,,103167027,5280343,Unspecified,,,,,Relative inhibition of V66A-mutated CK2 holoenzyme compared to wild-type,Other,12816539.0,
1123,436039,7,2,,103167027,5280343,Active,,,3.2,IC50,Inhibition of I174A-mutated CK2 holoenzyme,Confirmatory,12816539.0,
1124,436267,7,3,,103167027,5280343,Inconclusive,,,,,Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6,Other,18855442.0,
1125,436268,7,3,,103167027,5280343,Unspecified,,,,,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2,Other,18855442.0,
1126,436271,7,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by MTT assay,Other,18855442.0,
1127,436312,3,5,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ratio of drug concentration to DPPH concentration causing 50% DPPH radical scavenging activity by TLC assay,Other,18950229.0,
1128,436313,5,2,,103167027,5280343,Active,,,1.0,EC50,Antioxidant activity assessed as protection against peroxyl radical-induced alkaline phosphatase oxidation by fluorimetric assay,Confirmatory,18950229.0,
1129,439367,3,11,,103167027,5280343,Unspecified,13432234.0,5468.0,,,Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
1130,439368,3,11,,103167027,5280343,Unspecified,13432234.0,5468.0,,,Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
1131,441659,9,5,,103167027,5280343,Unspecified,116353.0,590.0,68.0,Ki,Inhibition of human plasma BChE by Ellman's method,Confirmatory,19879672.0,
1132,441660,9,5,,103167027,5280343,Active,113037.0,43.0,38.3,Ki,Inhibition of human recombinant AChE by Ellman's method,Confirmatory,19879672.0,
1133,441661,3,3,,103167027,5280343,Unspecified,,,,,Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry,Other,19879672.0,
1134,441664,3,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
1135,441665,3,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
1136,445113,3,3,,103167027,5280343,Active,,,,,Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at 11 to 45 uM after 4 hrs by agarose gel electrophoresis,Other,19822425.0,
1137,445114,3,3,,103167027,5280343,Inactive,,,,,Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at <5 uM after 4 hrs by agarose gel electrophoresis,Other,19822425.0,
1138,445116,3,3,,103167027,5280343,Active,,,,,Prooxidant effect on Cu2+-induced pBR322 DNA damage at 3 to 45 uM after 1 hr,Other,19822425.0,
1139,445119,3,3,,103167027,5280343,Inactive,,,,,Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at 5 uM after 4 hrs by agarose electrophoresis,Other,19822425.0,
1140,449288,5,3,,103167027,5280343,Active,,,3.4,EC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry,Confirmatory,19673490.0,
1141,449290,5,2,,103167027,5280343,Active,,,38.6,EC50,Antioxidant activity assessed as superoxide anion scavenging activity after 5 mins by spectrophotometry,Confirmatory,19673490.0,
1142,449291,5,2,,103167027,5280343,Active,,,4.6,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat liver homogenate assessed as malondialdehyde formation after 1 hr by TBARS assay,Confirmatory,19673490.0,
1143,449295,3,3,,103167027,5280343,Unspecified,,,,,Iron chelating activity assessed as inhibition of ferrozine-Fe2+ complex formation at 150 uM after 10 mins by spectrophotometry,Other,19673490.0,
1144,449296,5,2,,103167027,5280343,Unspecified,,,188.2,EC50,Iron chelating activity assessed as inhibition of ferrozine-Fe2+ complex formation after 10 mins by spectrophotometry,Confirmatory,19673490.0,
1145,449298,3,4,,103167027,5280343,Unspecified,,,,,Neuroprotective activity against H2O2-induced injury in rat PC12 cells assessed as increase in cell viability at 50 uM treated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay,Other,19673490.0,
1146,449299,5,2,,103167027,5280343,Unspecified,,,58.4,EC50,Neuroprotective activity against H2O2-induced injury in rat PC12 cells treated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay,Confirmatory,19673490.0,
1147,449725,1,1,,99460891,5280343,Inactive,,,,,IMR-90 (cell viability counter screen),Confirmatory,,
1148,450612,3,3,,103167027,5280343,Unspecified,,,,,Antitumor initiating activity in human Chang cells assessed as ratio of inhibition of cellular transformation in presence of NOR1 to compound and NOR1 at 350 nmol treated 1 min before NOR1 addition measured after 1 hr by light microscopy,Other,19646881.0,
1149,450962,5,3,,103167027,5280343,Active,,,5.5,EC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,19660956.0,
1150,450963,5,2,,103167027,5280343,Active,,,31.8,EC50,Antioxidant activity assessed as superoxide anion scavenging activity after 5 mins by NBT reduction assay,Confirmatory,19660956.0,
1151,450964,3,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/mL after 30 mins,Other,19660956.0,
1152,450965,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as superoxide anion scavenging activity at 100 ug/mL after 5 mins by NBT reduction assay,Other,19660956.0,
1153,450966,5,2,,103167027,5280343,Unspecified,,,236.1,EC50,Antioxidant activity assessed as ferrous ion chelating activity after 30 mins by spectrophotometry,Confirmatory,19660956.0,
1154,450967,5,2,,103167027,5280343,Active,,,1.8,IC50,Inhibition of FeSO4-induced lipid peroxidation in Sprague-Dawley rat liver homogenate assessed as decrease in malondialdehyde level after 1 hr by TBA assay,Confirmatory,19660956.0,
1155,452853,5,2,,103167027,5280343,Unspecified,,,162.0,IC50,Antioxidant activity assessed as hydrogen peroxide scavenging activity by peroxyoxalate chemiluminescent method,Confirmatory,19853459.0,
1156,454616,3,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM,Other,20005707.0,
1157,454617,4,3,,103167027,5280343,Inconclusive,,,,,Inhibition of trypsin at 10 uM,Other,20005707.0,
1158,454618,4,8,,103167027,5280343,Inconclusive,3914304.0,443460.0,,,Inhibition of ovine COX2 at 1 mM by colorimetric assay,Other,20005707.0,
1159,454619,4,6,,103167027,5280343,Inconclusive,,,,,Inhibition of beta-glucuronidase at 10 uM,Other,20005707.0,
1160,455702,8,5,,103167027,5280343,Active,127825.0,,1.7,IC50,Inhibition of Clostridium perfringens neuraminidase,Confirmatory,19729316.0,
1161,455703,7,1,,103167027,5280343,Active,,,,IC50,Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase,Confirmatory,19729316.0,
1162,455704,5,2,,103167027,5280343,Unspecified,,,253.8,CC50,Cytotoxicity against MDCK cells after 48 hrs by MTT assay,Confirmatory,19729316.0,
1163,455705,5,2,,103167027,5280343,Active,,,43.1,EC50,Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect,Confirmatory,19729316.0,
1164,455706,5,2,,103167027,5280343,Unspecified,,,133.6,EC50,Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect,Confirmatory,19729316.0,
1165,455707,3,4,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H1N1 A/PR/8/34",Other,19729316.0,
1166,455708,3,4,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H9N2 A/Chicken/Korea/MS96/96",Other,19729316.0,
1167,455764,8,5,,103167027,5280343,Active,32129605.0,55662.0,10.2,IC50,Inhibition of human recombinant FIH1,Confirmatory,19822432.0,
1168,456183,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation at 50 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Other,19931462.0,
1169,456187,5,2,,103167027,5280343,Active,,,13.6,IC50,Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
1170,456188,5,2,,103167027,5280343,Active,,,0.24,IC50,Inhibition of beta amyloid (1 to 40) fibril formation by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
1171,456189,5,2,,103167027,5280343,Active,,,0.72,IC50,Inhibition of beta amyloid (1 to 42) fibril formation by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
1172,456190,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of beta amyloid (1 to 42) fibril formation at 50 ug/mL by thioflavin T staining-based binding assay,Other,19931462.0,
1173,456191,4,3,,103167027,5280343,Active,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation assessed as formation of shorter and stunted fibrils at 1 uM by transmission electron microscopy,Other,19931462.0,
1174,456192,3,3,,103167027,5280343,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 40) fibril formation,Other,19931462.0,
1175,456193,3,3,,103167027,5280343,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 42) fibril formation,Other,19931462.0,
1176,456316,3,3,,103167027,5280343,Unspecified,,,,,ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
1177,456317,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent by TEAC assay,Other,19944611.0,
1178,456318,3,3,,103167027,5280343,Unspecified,,,,,DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
1179,456319,6,1,,103167027,5280343,Unspecified,,,,,ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity,Other,19944611.0,
1180,457184,5,2,,103167027,5280343,Unspecified,,,54.3,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by Griess reagent method,Confirmatory,20056545.0,
1181,461575,10,2,,103167027,5280343,Active,112826.0,58813.0,0.0453,Ki,Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method,Confirmatory,20146483.0,
1182,461721,8,2,,103167027,5280343,Active,,,2.8,IC50,Inhibition of human MAOA,Confirmatory,20045650.0,
1183,461722,8,2,,103167027,5280343,Unspecified,,,90.0,IC50,Inhibition of human MAOB,Confirmatory,20045650.0,
1184,462270,8,5,,103167027,5280343,Active,115449.0,759.0,2.68,Ki,Inhibition of human CA1 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1185,462271,8,5,,103167027,5280343,Active,115456.0,760.0,2.54,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1186,462272,8,5,,103167027,5280343,Active,134047703.0,761.0,8.1,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1187,462273,8,5,,103167027,5280343,Active,115465.0,762.0,7.89,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1188,462274,8,5,,103167027,5280343,Active,461680.0,763.0,6.81,Ki,Inhibition of human CA5A by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1189,462275,8,5,,103167027,5280343,Active,8928041.0,11238.0,11.9,Ki,Inhibition of human CA5B by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1190,462276,8,5,,103167027,5280343,Active,116241278.0,765.0,6.17,Ki,Inhibition of human CA6 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1191,462277,8,5,,103167027,5280343,Active,1168744.0,766.0,4.84,Ki,Inhibition of human CA7 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1192,462278,8,5,,103167027,5280343,Active,83300925.0,768.0,7.0,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1193,462279,8,5,,103167027,5280343,Active,5915866.0,771.0,9.39,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1194,462280,8,5,,103167027,5280343,Active,30580372.0,71934.0,9.03,Ki,Inhibition of mouse CA13 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1195,462281,8,5,,103167027,5280343,Active,8928036.0,23632.0,5.41,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
1196,462333,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs,Other,20189399.0,
1197,462334,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs,Other,20189399.0,
1198,462335,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs,Other,20189399.0,
1199,462336,3,3,,103167027,5280343,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs,Other,20189399.0,
1200,462338,5,2,,103167027,5280343,Active,,,15.0,IC50,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs,Confirmatory,20189399.0,
1201,462339,3,3,,103167027,5280343,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 1 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
1202,462340,4,2,,103167027,5280343,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 3 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
1203,462341,4,2,,103167027,5280343,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 10 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
1204,462342,3,3,,103167027,5280343,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
1205,462344,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 uM,Other,20189399.0,
1206,462345,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 3 uM,Other,20189399.0,
1207,462346,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,20189399.0,
1208,462347,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,20189399.0,
1209,462348,3,10,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,20189399.0,
1210,462349,8,5,,103167027,5280343,Active,6686057.0,,31.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,20189399.0,
1211,462367,4,9,,103167027,5280343,Inactive,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as inhibition of melanin production from dopachrome by autoxidation at 100 uM,Other,20189399.0,
1212,463096,1,1,,50104737,5280343,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
1213,463097,1,1,,50104737,5280343,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
1214,463106,1,2,,90341524,5280343,Inconclusive,188528692.0,9099.0,18.4927,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
1215,463189,1,1,,53778105,5280343,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
1216,464264,3,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 1 to 20 uM after 24 hrs by MTT assay relative to control,Other,20121165.0,
1217,464265,5,2,,103167027,5280343,Active,,,32.1,IC50,Antiinflammatory activity against mouse RAW264.7 cells assessed as Inhibition of LPS-induced nitric oxide production after 24 hrs by ELISA,Confirmatory,20121165.0,
1218,466937,5,2,,103167027,5280343,Unspecified,,,58.0,IC50,"Inhibition of Trypanosoma cruzi trans-sialidase containing catalytic domain (N58F, R200K) and lectin-like domain (S495 K, V496G, E520K, D593G, I597D, H599R) mutation expressed in Escherichia coli JM109 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay",Confirmatory,20097567.0,
1219,466938,9,5,,103167027,5280343,Unspecified,229462907.0,4759.0,160.0,IC50,Inhibition of human Neu2 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay,Confirmatory,20097567.0,
1220,466939,3,3,,103167027,5280343,Unspecified,,,,,Selectivity for Trypanosoma cruzi trans-sialidase mutant over human Neu2,Other,20097567.0,
1221,467543,4,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in ip dosed Swiss mouse assessed as inhibition of carrageenan-induced reduction in GSH level dosed 30 mins before carrageenan challenge measured after 3 hrs by fluorescence spectrophotometry,Other,19899776.0,
1222,467544,3,4,,103167027,5280343,Unspecified,,,,,"Inhibition of carrageenan-induced IL1-beta production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA",Other,19899776.0,
1223,467545,3,3,,103167027,5280343,Inactive,,,,,"Muscle relaxant activity in Swiss mouse assessed as motor response at 100 mg/kg, ip after 3 hrs 30 mins by rotarod test",Other,19899776.0,
1224,467546,4,3,,103167027,5280343,Unspecified,,,,,Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of acetic acid-induced writhing response administered 30 mins before acetic acid challenge measured for 20 mins,Other,19899776.0,
1225,467547,4,3,,103167027,5280343,Unspecified,,,,,Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of phenyl-p-benzoquinone-induced writhing response administered 30 mins before phenyl-p-benzoquinone challenge measured for 20 mins,Other,19899776.0,
1226,467548,3,3,,103167027,5280343,Active,,,,,"Antinociceptive activity against formalin-induced pain in Swiss mouse assessed as inhibition of hind paw flinching response during second phase of response at 100 mg/kg, ip dosed 30 mins before formalin challenge measured for 0 to 30 mins",Other,19899776.0,
1227,467549,3,3,,103167027,5280343,Active,,,,,"Antinociceptive activity against formalin-induced pain in Swiss mouse assessed as inhibition of paw licking response during second phase at 100 mg/kg, ip dosed 30 mins before formalin challenge measured for 0 to 30 mins",Other,19899776.0,
1228,467550,4,3,,103167027,5280343,Unspecified,,,,,Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception administered 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test,Other,19899776.0,
1229,467551,3,3,,103167027,5280343,Unspecified,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 3 to 100 mg/kg, ip administered 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1230,467552,3,3,,103167027,5280343,Unspecified,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 300 mg/kg, po dosed 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1231,467553,4,3,,103167027,5280343,Active,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 1 to 5 hrs by electronic pressure-meter test",Other,19899776.0,
1232,467554,4,3,,103167027,5280343,Active,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 100 mg/kg, ip dosed 3 hrs before carrageenan challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1233,467555,4,3,,103167027,5280343,Active,,,,,"Antiinflammatory activity in Swiss mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 0.5 to 3 hrs",Other,19899776.0,
1234,467847,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of carrageenan-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by spectrophotometry",Other,19899776.0,
1235,467848,4,3,,103167027,5280343,Unspecified,,,,,"Inhibition of carrageenan-induced TNFalpha production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA",Other,19899776.0,
1236,467849,4,3,,103167027,5280343,Unspecified,,,,,"Inhibition of carrageenan-induced CXCL1 production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA",Other,19899776.0,
1237,467850,3,3,,103167027,5280343,Unspecified,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of TNF-alpha-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before TNFalpha challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1238,467851,3,3,,103167027,5280343,Unspecified,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of CXCL1-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before CXCL1 challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1239,467852,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of TNF-alpha-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before TNFalpha challenge measured after 3 hrs by spectrophotometry",Other,19899776.0,
1240,467853,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before CXCL1 challenge measured after 3 hrs by spectrophotometry",Other,19899776.0,
1241,467854,3,3,,103167027,5280343,Inactive,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of PGE2-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before PGE2 challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1242,467855,3,3,,103167027,5280343,Inactive,,,,,"Antinociceptive activity in Swiss mouse assessed as inhibition of dopamine-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before dopamine challenge measured after 3 hrs by electronic pressure-meter test",Other,19899776.0,
1243,467856,3,3,,103167027,5280343,Inactive,,,,,"Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 100 mg/kg, ip after 30 mins of administration by hot plate test",Other,19899776.0,
1244,467857,3,3,,103167027,5280343,Inactive,,,,,"Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 100 mg/kg, ip after 60 mins of administration by hot plate test",Other,19899776.0,
1245,467858,3,3,,103167027,5280343,Active,,,,,"Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 8 mg/kg, ip after 30 mins of administration by hot plate test",Other,19899776.0,
1246,467859,3,3,,103167027,5280343,Active,,,,,"Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 8 mg/kg, ip after 60 mins of administration by hot plate test",Other,19899776.0,
1247,467951,3,4,,103167027,5280343,Active,,,,,Induction of CYP1A1 expression in human MCF7 cells at 0.5 uM to 10 uM after 24 hrs by RT PCR and DNA electrophoresis,Other,19601638.0,
1248,469266,5,2,,103167027,5280343,Active,,,11.4,IC50,Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method,Confirmatory,19778086.0,
1249,469283,6,1,,103167027,5280343,Unspecified,,,,,Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by crystal violet staining,Other,19778089.0,
1250,469284,3,4,,103167027,5280343,Active,,,,,Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay,Other,19778089.0,
1251,469935,5,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,19658431.0,
1252,475504,3,3,,103167027,5280343,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
1253,475505,3,3,,103167027,5280343,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
1254,477795,5,2,,103167027,5280343,Active,,,0.8,IC50,Inhibition of amyloid beta (1 to 40) aggregation assessed as inhibition of fibril formation by thioflavin T fluorescent dye assay,Confirmatory,20137834.0,
1255,478694,6,2,,103167027,5280343,Active,,,7.846,Ki,Binding affinity to dopamine D4 receptor,Confirmatory,20408551.0,
1256,479369,7,5,,103167027,5280343,Active,117293.0,1588.0,0.012,IC50,Inhibition of human placental microsome CYP19,Confirmatory,20413308.0,
1257,480503,8,5,,103167027,5280343,Active,113594.0,317748.0,2.85,IC50,Inhibition of aldose reductase from calf lense by AR assay,Confirmatory,20395149.0,
1258,480667,3,4,,103167027,5280343,Unspecified,,,,,Inhibition of anti-DNP-IgE-induced degranulation in rat RBL2H3 cells assessed as betahexosaminidase released at 10 uM after 20 mins by microplate reader assay,Other,20363129.0,
1259,480945,8,5,,103167027,5280343,Unspecified,127825.0,,,IC50,Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 10 mins by spectrofluorimetry,Confirmatory,20363636.0,
1260,480946,3,9,,103167027,5280343,Unspecified,127825.0,,,,Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis at 20 ug/mL after 10 mins by spectrofluorimetry,Other,20363636.0,
1261,480947,8,5,,103167027,5280343,Inconclusive,172044537.0,,,IC50,Inhibition of Vibrio cholerae neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 30 mins by spectrofluorimetry,Confirmatory,20363636.0,
1262,480948,3,10,,103167027,5280343,Unspecified,172044537.0,,,,Inhibition of Vibrio cholerae neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis at 30 ug/mL after 10 mins by spectrofluorimetry,Other,20363636.0,
1263,481170,5,2,,103167027,5280343,Active,,,2.1,IC50,Selectivity ratio of IC50 for Leishmania donovani DNA topoisomerase 1 treated simultaneously with DNA to IC50 for Leishmania donovani DNA topoisomerase 1 pretreated before addition of DNA,Confirmatory,20371180.0,
1264,481717,10,2,,103167027,5280343,Unspecified,143955315.0,,,,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Other,20116898.0,
1265,483707,8,5,,103167027,5280343,Unspecified,296434407.0,23621.0,,IC50,Inhibition of human recombinant BACE1 after 60 mins by FRET assay,Confirmatory,20462757.0,
1266,483708,8,5,,103167027,5280343,Active,296434407.0,23621.0,14.0,Ki,Noncompetitive inhibition of human recombinant BACE1 after 60 mins by Dixon plot analysis,Confirmatory,20462757.0,
1267,485290,1,1,,11113933,5280343,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1268,485290,1,1,,26747157,5280343,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1269,485290,1,1,,26752084,5280343,Inactive,20150581.0,,28.1838,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1270,485290,1,1,,26752085,5280343,Inactive,20150581.0,,25.1189,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1271,485290,1,1,,26752086,5280343,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1272,485290,1,1,,50104737,5280343,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1273,485290,1,1,,50104738,5280343,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1274,485295,1,2,,90341524,5280343,Active,30027657.0,,10.6213,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
1275,485297,1,1,,90341524,5280343,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1276,485298,1,1,,90341524,5280343,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1277,485313,1,2,,90341524,5280343,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1278,485314,1,1,,50104737,5280343,Active,4505931.0,5423.0,0.1995,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1279,485342,1,2,,90341524,5280343,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1280,485345,1,2,,90341524,5280343,Inconclusive,,,23.1093,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1281,485350,1,2,,92124965,5280343,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
1282,485350,1,2,,99300982,5280343,Active,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
1283,485366,1,2,,90341524,5280343,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1284,485368,1,2,,90341524,5280343,Active,72386991.0,3656265.0,6.7456,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1285,487730,3,4,,103167027,5280343,Unspecified,,,,,"Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 1 hr (RVb = 10.96 +/- 3.67 %)",Other,20346546.0,
1286,487731,3,4,,103167027,5280343,Unspecified,,,,,"Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 3 hrs (RVb = 1.39 +/- 5.895 %)",Other,20346546.0,
1287,487732,3,4,,103167027,5280343,Unspecified,,,,,"Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 5 hrs (RVb = 1.21+/- 3.64 %)",Other,20346546.0,
1288,487733,3,4,,103167027,5280343,Unspecified,,,,,"Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 7 hrs (RVb = -3.59 +/- 2.65 %)",Other,20346546.0,
1289,487734,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 1 hr (RVb = 20.18 % +/- 8.49%)",Other,20346546.0,
1290,487735,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 3 hrs (RVb = -9.83 % +/- 5.67%)",Other,20346546.0,
1291,487736,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 7 hrs (RVb = -10.51% +/- 5.53%)",Other,20346546.0,
1292,487737,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 5 hrs (RVb = -1.17% +/- 8.77%)",Other,20346546.0,
1293,487896,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 1 day relative to control",Other,20346546.0,
1294,487897,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 2 day relative to control",Other,20346546.0,
1295,487898,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 3 day relative to control",Other,20346546.0,
1296,487899,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 4 day relative to control",Other,20346546.0,
1297,487900,3,4,,103167027,5280343,Unspecified,,,,,"Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 5 day relative to control",Other,20346546.0,
1298,487901,3,11,,103167027,5280343,Unspecified,118569.0,3290.0,,,Inhibition of human 11beta HSD1 in HEK293 cells at 10 uM,Other,20346546.0,
1299,488645,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay,Other,20476748.0,
1300,488745,1,4,,85231204,5280343,Active,,,10.4179,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1301,488752,1,4,,85231204,5280343,Inconclusive,,,18.526,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1302,488772,1,1,,90341524,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1303,488773,1,2,,90341524,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1304,488816,1,1,,90341524,5280343,Active,4758356.0,2237.0,2.3778,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
1305,488837,1,1,,90341524,5280343,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1306,488949,1,2,,85231204,5280343,Active,41055989.0,54737.0,39.8107,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1307,488949,1,2,,90341524,5280343,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1308,488953,1,1,,90341524,5280343,Inconclusive,187960037.0,10951.0,44.6684,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1309,488978,1,1,,90341524,5280343,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
1310,488979,1,1,,50104737,5280343,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
1311,488980,1,1,,85231204,5280343,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
1312,488981,1,1,,90341524,5280343,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
1313,488982,1,1,,90341524,5280343,Active,4503383.0,1812.0,4.1092,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
1314,488983,1,1,,90341524,5280343,Inconclusive,4503383.0,1812.0,4.4668,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
1315,489015,1,1,,87693017,5280343,Inactive,,,,,Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (M18AAP): radiolabel-based cell-based assay to identify compounds that inhibit P. falciparum growth in RBCs,Other,,
1316,489317,5,2,,103167027,5280343,Inconclusive,,,,IC50,Antioxidant activity assessed as DPPH scavenging activity after 4 hrs by MTT assay,Confirmatory,20621727.0,
1317,489318,5,2,,103167027,5280343,Active,,,18.0,EC50,Cytoprotective activity against H2O2-induced cell injury in HUVEC cells,Confirmatory,20621727.0,
1318,492140,3,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay,Other,20565070.0,
1319,492951,1,2,,99460891,5280343,Active,4503951.0,2645.0,,,Human Glck Counter Screen Assay,Confirmatory,,
1320,492967,1,2,,99301573,5280343,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1321,492974,1,1,,87693017,5280343,Inactive,124507185.0,813594.0,,,Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Alanyl Aminopeptidase (PfM18AAP): fluorescence-based biochemical assay to identify inhibitors of rPfM18AAP,Screening,,
1322,492975,1,1,,87693017,5280343,Active,124507185.0,813594.0,,,Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Alanyl Aminopeptidase (PfM18AAP): fluorescence-based biochemical assay to identify inhibitors of malaria cell lysate,Screening,,
1323,493017,1,1,,103857316,5280343,Unspecified,,240.0,,,Wombat Data for BeliefDocking,Other,1848292.0,
1324,493033,1,2,,92124965,5280343,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
1325,493033,1,2,,99300982,5280343,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
1326,493106,1,1,,90341524,5280343,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1327,493107,1,1,,90341524,5280343,Active,116283940.0,79915.0,20.5878,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1328,493127,1,1,,50104737,5280343,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
1329,493153,1,1,,90341524,5280343,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1330,493153,1,1,,90341524,5280343,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1331,493162,1,2,,99301573,5280343,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
1332,493162,1,2,,99302502,5280343,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
1333,493164,1,2,,90341524,5280343,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1334,493164,1,2,,90341524,5280343,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1335,493164,1,2,,90341524,5280343,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1336,493189,1,1,,50104737,5280343,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
1337,494830,4,2,,103167027,5280343,Active,,,1.5,IC50,Inhibition of Plasmodium falciparum FabI,Confirmatory,20637612.0,
1338,494832,4,3,,103167027,5280343,Active,,,10.0,IC50,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54,Confirmatory,20637612.0,
1339,501209,7,1,,103167027,5280343,Unspecified,,,,IC50,Antiviral activity against HSV1 infected african green monkey Vero cells assessed as reduction of plaque formation after 3 days by using crystal violet stain,Confirmatory,20092288.0,
1340,501210,2,4,,103167027,5280343,Active,,,,,Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay,Other,20092288.0,
1341,501413,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against vancomycin-resistant Enterococcus FN-1 after 24 hrs by microdilution assay,Other,20655215.0,
1342,501414,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against vancomycin-resistant Enterococcus NCTC 12201 after 24 hrs by microdilution assay,Other,20655215.0,
1343,501415,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against vancomycin intermediate-resistant Staphylococcus aureus Mu50 after 24 hrs by microdilution assay,Other,20655215.0,
1344,501416,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution assay,Other,20655215.0,
1345,501417,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution assay,Other,20655215.0,
1346,501418,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution assay,Other,20655215.0,
1347,501419,5,4,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution assay,Other,20655215.0,
1348,501420,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 209P after 24 hrs by microdilution assay,Other,20655215.0,
1349,501421,6,1,,103167027,5280343,Active,,,,IC50,Inhibition of Escherichia coli DNA gyraseB assessed as inhibition of pBR322 supercoiling by densitometry,Confirmatory,20655215.0,
1350,501422,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by microdilution assay,Other,20655215.0,
1351,501423,5,2,,103167027,5280343,Unspecified,,,,,Antimicrobial activity against Escherichia coli K-12 after 24 hrs by microdilution assay,Other,20655215.0,
1352,502292,2,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DDPH radical scavenging activity,Other,20692831.0,
1353,502473,2,9,,103167027,5280343,Active,117144.0,1544.0,4.0969999999999995,IC50,Inhibition of human CYP1A2 by EROD assay,Confirmatory,20696580.0,
1354,502474,2,9,,103167027,5280343,Active,117139.0,1543.0,1.1909999999999998,IC50,Inhibition of human CYP1A1 by EROD assay,Confirmatory,20696580.0,
1355,502475,6,5,,103167027,5280343,Active,48429256.0,1545.0,0.077,IC50,Inhibition of human CYP1B1 by EROD assay,Confirmatory,20696580.0,
1356,502476,7,5,,103167027,5280343,Inconclusive,127825.0,,,Ki,Competitive inhibition of Clostridium perfringens neuraminidase by fluorimetry,Confirmatory,20696581.0,
1357,502478,6,7,,103167027,5280343,Active,127825.0,,9.8,IC50,Inhibition of Clostridium perfringens neuraminidase by fluorimetry,Confirmatory,20696581.0,
1358,504289,5,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,20806928.0,
1359,504290,5,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity by NBT method,Other,20806928.0,
1360,504291,5,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as nitric oxide scavenging activity after 150 mins by Griess assay,Other,20806928.0,
1361,504308,4,2,,103167027,5280343,Active,,,34.5,IC50,Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NO production after 24 hrs,Confirmatory,20825224.0,
1362,504311,2,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 12 to 16 hrs by spectrophotometry,Other,20863141.0,
1363,504312,2,5,,103167027,5280343,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation assessed as trolox equivalent of peroxy radical scavenging activity after 10 mins by ORAC assay,Other,20863141.0,
1364,504327,1,1,,90341524,5280343,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1365,504332,1,1,,50104737,5280343,Active,168985070.0,,28.1838,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1366,504332,1,1,,90341524,5280343,Active,168985070.0,,12.5893,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1367,504364,1,1,,85231204,5280343,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
1368,504536,1,1,,90341524,5280343,Inconclusive,5453898.0,5300.0,2.6855,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
1369,504547,1,1,,90341524,5280343,Active,115503961.0,4357161.0,7.5686,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1370,504548,1,2,,90341524,5280343,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
1371,504770,1,2,,92124965,5280343,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
1372,504810,1,2,,90341524,5280343,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1373,504812,1,2,,90341524,5280343,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1374,504821,1,1,,85231204,5280343,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
1375,504836,1,2,,90341524,5280343,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
1376,504845,1,1,,90341524,5280343,Inconclusive,86301163.0,5999.0,11.9173,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1377,504847,1,1,,90341524,5280343,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1378,504865,1,1,,90341524,5280343,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1379,506921,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-3 cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1380,506922,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-9 cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1381,506923,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of PARP cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1382,506933,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of caspase-3 cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1383,506934,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of caspase-9 cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1384,506935,2,10,,103167027,5280343,Inactive,17865718.0,3326.0,,,Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of PARP cleavage at 200 uM after 24 hrs by Western blot analysis,Other,17603540.0,
1385,506943,3,3,,103167027,5280343,Active,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of cell growth arrest after 72 hrs by propidium iodide staining-based flow cytometry,Other,17603540.0,
1386,506944,3,3,,103167027,5280343,Active,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as increase in caspase-3 activity after 24 hrs by Western blot analysis,Other,17603540.0,
1387,506945,3,3,,103167027,5280343,Active,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-3 cleavage after 24 hrs by Western blot analysis,Other,17603540.0,
1388,506946,3,3,,103167027,5280343,Active,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of PARP cleavage after 24 hrs by Western blot analysis,Other,17603540.0,
1389,506948,3,3,,103167027,5280343,Inactive,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as induction of caspase-3 cleavage after 24 hrs by Western blot analysis,Other,17603540.0,
1390,506949,3,3,,103167027,5280343,Inactive,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as induction of PARP cleavage after 24 hrs by Western blot analysis,Other,17603540.0,
1391,506950,3,3,,103167027,5280343,Inactive,,,,,Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as release of Apaf-1 from chaperon complex after 24 hrs by Western blot analysis,Other,17603540.0,
1392,510243,2,6,,103167027,5280343,Unspecified,,,,,Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay,Other,20731357.0,
1393,510244,7,1,,103167027,5280343,Active,,,0.68,IC50,Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay,Confirmatory,20731357.0,
1394,510245,1,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human free style HEK293 cells after 72 hrs,Other,20731357.0,
1395,510246,3,5,,103167027,5280343,Unspecified,,,,,Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay substituted with 3 uM H2O2,Other,20731357.0,
1396,511076,7,2,,103167027,5280343,Active,,,0.45,IC50,Inhibition of CDK1,Confirmatory,20638755.0,
1397,512275,2,3,,103167027,5280343,Unspecified,,,,,Inhibition of rabbit MKK1 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1398,512276,2,10,,103167027,5280343,Unspecified,119554.0,5594.0,,,Inhibition of His-tagged human MAPK2/ERK2 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1399,512277,2,10,,103167027,5280343,Unspecified,2507195.0,5599.0,,,Inhibition of His-tagged human JNK1a1/SAPK1c expressed in Escherichia coli at 20 uM,Other,10998351.0,
1400,512278,2,10,,103167027,5280343,Unspecified,2499600.0,1432.0,,,Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1401,512279,2,10,,103167027,5280343,Unspecified,134047835.0,5600.0,,,Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1402,512280,2,10,,103167027,5280343,Unspecified,2851522.0,6300.0,,,Inhibition of His-tagged human SAPK3/p38gamma expressed in Escherichia coli at 20 uM,Other,10998351.0,
1403,512281,2,10,,103167027,5280343,Unspecified,6685642.0,5603.0,,,Inhibition of His-tagged human SAPK4/p38delta expressed in Escherichia coli at 20 uM,Other,10998351.0,
1404,512282,2,4,,103167027,5280343,Unspecified,,,,,Inhibition of MAPKAPK1b from rabbit skeletal muscle at 20 uM,Other,10998351.0,
1405,512283,2,9,,103167027,5280343,Unspecified,1346538.0,9261.0,,,Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1406,512284,2,9,,103167027,5280343,Unspecified,37999482.0,9252.0,,,Inhibition of His-tagged human MSK1 expressed in Sf9 cells at 20 uM,Other,10998351.0,
1407,512285,2,9,,103167027,5280343,Unspecified,52000829.0,8550.0,,,Inhibition of His-tagged human PRAK expressed in Sf9 cells at 20 uM,Other,10998351.0,
1408,512286,2,3,,103167027,5280343,Unspecified,,,,,Inhibition of bovine heart PKA at 20 uM,Other,10998351.0,
1409,512287,2,10,,103167027,5280343,Unspecified,317373571.0,5578.0,,,Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 20 uM,Other,10998351.0,
1410,512288,2,11,,103167027,5280343,Unspecified,3183117.0,5163.0,,,Inhibition of His-tagged human PDK1 expressed in Sf21 cells at 20 uM,Other,10998351.0,
1411,512289,2,11,,103167027,5280343,Unspecified,60391226.0,207.0,,,Inhibition of human PKBalpha expressed in SF9 cells at 20 uM,Other,10998351.0,
1412,512290,2,9,,103167027,5280343,Unspecified,90185131.0,6446.0,,,Inhibition of His-tagged human SGK expressed in Sf9 cells at 20 uM,Other,10998351.0,
1413,512291,2,9,,103167027,5280343,Unspecified,54041234.0,6198.0,,,Inhibition of His-tagged human S6K1 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1414,512292,2,9,,103167027,5280343,Unspecified,20455502.0,2932.0,,,Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 20 uM,Other,10998351.0,
1415,512293,2,9,,103167027,5280343,Unspecified,347595694.0,25537.0,,,Inhibition of rat ROCK2 expressed in Sf9 cells at 20 uM,Other,10998351.0,
1416,512294,2,3,,103167027,5280343,Unspecified,,,,,Inhibition of rat liver AMPK at 20 uM,Other,10998351.0,
1417,512295,2,3,,103167027,5280343,Unspecified,,,,,Inhibition of His-tagged human CK2 expressed in Sf9 cells at 20 uM,Other,10998351.0,
1418,512296,2,4,,103167027,5280343,Unspecified,,,,,Inhibition of PHK from rabbit skeletal muscle at 20 uM,Other,10998351.0,
1419,512297,2,9,,103167027,5280343,Unspecified,125474.0,3932.0,,,Inhibition of His-tagged human LCK expressed in Sf9 cells at 20 uM,Other,10998351.0,
1420,512298,2,9,,103167027,5280343,Unspecified,317373343.0,1111.0,,,Inhibition of His-tagged human CHK1 expressed in Escherichia coli at 20 uM,Other,10998351.0,
1421,512448,2,10,,103167027,5280343,Unspecified,417433.0,282306.0,,,Inhibition of His-tagged bovine PI3K expressed in Sf9 cells at 20 uM,Other,10998351.0,
1422,515157,2,6,,103167027,5280343,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test,Other,20696502.0,
1423,515377,4,2,,103167027,5280343,Active,,,1.8,IC50,Antioxidant activity assessed as singlet oxygen scavenging activity by spectrophotometry,Confirmatory,20709556.0,
1424,517387,2,7,,103167027,5280343,Active,341940616.0,108079.0,,,Induction of AMPK phosphorylation in mouse 3T3L1 cells at 10 uM by Western blotting,Other,20822902.0,
1425,517388,2,7,,103167027,5280343,Active,341940616.0,108079.0,,,Induction of AMPK-mediated ACC phosphorylation in mouse 3T3L1 cells at 10 uM by Western blotting,Other,20822902.0,
1426,517389,2,7,,103167027,5280343,Active,341940616.0,108079.0,,,Inhibition of AMPK-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
1427,517390,2,10,,103167027,5280343,Active,13432235.0,19016.0,,,Inhibition of PPAR-gamma-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
1428,517391,2,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse 3T3L1 cells at 20 uM after 24 hrs,Other,20822902.0,
1429,527148,2,5,,103167027,5280343,Active,,,,,Reduction of gastrocnemius muscle weight loss in C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days relative to whole body weight,Other,20853873.0,
1430,527149,2,5,,103167027,5280343,Active,,,,,Reduction of atrogin-1 mRNA expression in gastrocnemius muscle of C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis,Other,20853873.0,
1431,527150,2,5,,103167027,5280343,Active,,,,,Reduction of MuRF-1 mRNA expression in gastrocnemius muscle of C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis,Other,20853873.0,
1432,527151,2,5,,103167027,5280343,Active,,,,,Increase of lipid peroxidation in gastrocnemius muscle of C57BL/6 mouse tail suspension model assessed as decrease of thiobarbituric acid-reactive substance level at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis,Other,20853873.0,
1433,528480,4,3,,103167027,5280343,Active,,,1.3,IC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometric analysis,Confirmatory,21038854.0,
1434,537123,4,2,,103167027,5280343,Active,,,23.8,IC50,Inhibition of SARS coronavirus 3C-like protease after 60 mins by FRET assay,Confirmatory,20934345.0,
1435,537627,4,2,,103167027,5280343,Active,,,3.9,IC50,Inhibition of Schistosoma mansoni recombinant NAD+ glycohydrolase expressed in Pichia pastoris by continuous fluorometric method,Confirmatory,20951593.0,
1436,537628,2,9,,103167027,5280343,Unspecified,55977782.0,952.0,,,Inhibition of human recombinant CD38 expressed in Pichia pastoris by continuous fluorometric method,Other,20951593.0,
1437,537629,4,2,,103167027,5280343,Active,,,37.9,IC50,Selectivity ratio of IC50 for human recombinant CD38 to IC50 for Schistosoma mansoni recombinant NAD+ glycohydrolase,Confirmatory,20951593.0,
1438,537733,2,3,,103167027,5280343,Inactive,,,,,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,Other,20739103.0,
1439,537734,5,2,,103167027,5280343,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,Other,20739103.0,
1440,537735,2,3,,103167027,5280343,Inactive,,,,,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,Other,20739103.0,
1441,537736,5,2,,103167027,5280343,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,Other,20739103.0,
1442,540209,4,3,,103167027,5280343,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
1443,540210,4,3,,103167027,5280343,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
1444,540211,2,5,,103167027,5280343,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
1445,540212,4,3,,103167027,5280343,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
1446,540213,4,3,,103167027,5280343,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
1447,540256,1,2,,50104737,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1448,540256,1,2,,90341524,5280343,Inconclusive,,,1.2538,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1449,540276,1,2,,11111704,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1450,540276,1,2,,11111705,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1451,540276,1,2,,11111706,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1452,540276,1,2,,11113933,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1453,540276,1,2,,26747157,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1454,540276,1,2,,26752084,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1455,540276,1,2,,26752085,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1456,540276,1,2,,26752086,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1457,540276,1,2,,50104737,5280343,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1458,540276,1,2,,50104738,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1459,540276,1,2,,50104739,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1460,540276,1,2,,50113478,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1461,540276,1,2,,50113479,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1462,540276,1,2,,50113480,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1463,540276,1,2,,50113481,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1464,540276,1,2,,85231204,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1465,540276,1,2,,90341524,5280343,Inconclusive,420597.0,,2.807,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1466,540299,1,2,,92124965,5280343,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
1467,540299,1,2,,99302502,5280343,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
1468,550020,5,2,,103167027,5280343,Unspecified,,,162.5,IC50,Vasorelaxant activity in Wistar rat endothelium-intact thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins,Confirmatory,21129983.0,
1469,550021,5,2,,103167027,5280343,Unspecified,,,222.47,IC50,Vasorelaxant activity in Wistar rat endothelium-denuded thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins,Confirmatory,21129983.0,
1470,550022,2,4,,103167027,5280343,Unspecified,,,,,Vasorelaxant activity in Wistar rat endothelium-intact thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins relative to control,Other,21129983.0,
1471,550023,2,4,,103167027,5280343,Unspecified,,,,,Vasorelaxant activity in Wistar rat endothelium-denuded thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins relative to control,Other,21129983.0,
1472,550024,8,5,,103167027,5280343,Unspecified,49037474.0,,,IC50,Inhibition of human recombinant calmodulin assessed as inhibition of calmodulin-sensitive cAMP phosphodiesterase activation after 15 mins by spectrophotometric analysis,Confirmatory,21129983.0,
1473,550025,2,11,,103167027,5280343,Unspecified,49037474.0,,,,Ratio of chlorpromazine IC50 to compound IC50 for human recombinant calmodulin,Other,21129983.0,
1474,551407,1,5,,103167027,5280343,Unspecified,,,,,Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 15 mM after 2 hrs,Other,21190861.0,
1475,551408,1,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay,Other,21190861.0,
1476,551409,1,4,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity at 50 uM after 2 hrs by benzoic acid method,Other,21190861.0,
1477,568209,7,2,,103167027,5280343,Active,,,2.85,IC50,Inhibition of aldose reductase by spectrophotometric analysis,Confirmatory,21256748.0,
1478,578564,4,2,,103167027,5280343,Unspecified,,,63.0,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method,Confirmatory,21353543.0,
1479,578565,4,2,,103167027,5280343,Unspecified,,,66.6,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs,Confirmatory,21353543.0,
1480,578568,1,4,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability by MTT assay,Other,21353543.0,
1481,578570,2,4,,103167027,5280343,Active,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as nitrite level at 1 to 100 uM after 24 hrs by Griess method,Other,21353543.0,
1482,578664,1,4,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as TNF-alpha level at 1 to 100 uM after 18 hrs,Other,21353543.0,
1483,578759,7,1,,103167027,5280343,Active,,,6.9,IC50,Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining,Confirmatory,21354800.0,
1484,578760,7,1,,103167027,5280343,Active,,,7.6,IC50,Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining,Confirmatory,21354800.0,
1485,578765,3,3,,103167027,5280343,Inactive,,,,,Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil,Other,21354800.0,
1486,578843,1,4,,103167027,5280343,Inactive,,,,,Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry,Other,21354800.0,
1487,578844,1,4,,103167027,5280343,Inactive,,,,,Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry,Other,21354800.0,
1488,587299,3,3,,103167027,5280343,Active,,,,,"Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1489,587300,3,3,,103167027,5280343,Active,,,,,"Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1490,587301,3,3,,103167027,5280343,Active,,,,,"Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1491,587302,3,3,,103167027,5280343,Active,,,,,"Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1492,587303,3,3,,103167027,5280343,Active,,,,,"Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1493,587304,3,3,,103167027,5280343,Active,,,,,"Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1494,587305,3,3,,103167027,5280343,Active,,,,,"Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1495,587306,3,3,,103167027,5280343,Active,,,,,"Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1496,587307,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1497,587308,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1498,587309,3,3,,103167027,5280343,Inactive,,,,,"Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1499,587310,3,3,,103167027,5280343,Active,,,,,"Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammtory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain",Other,21275387.0,
1500,587311,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1501,587312,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1502,587313,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1503,587314,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1504,587315,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1505,587316,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1506,587317,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1507,587318,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1508,587319,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1509,587320,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1510,587321,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1511,587322,3,3,,103167027,5280343,Active,,,,,Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v,Other,21275387.0,
1512,587323,3,3,,103167027,5280343,Inactive,,,,,Inhibition of CXCR1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry,Other,21275387.0,
1513,587324,3,3,,103167027,5280343,Inactive,,,,,Inhibition of CXCR2 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry,Other,21275387.0,
1514,587325,3,3,,103167027,5280343,Inactive,,,,,Inhibition of BLT1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry,Other,21275387.0,
1515,587326,3,3,,103167027,5280343,Inactive,,,,,Inhibition of FLPR1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry,Other,21275387.0,
1516,587327,3,3,,103167027,5280343,Active,,,,,Inhibition of CXCL8-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence,Other,21275387.0,
1517,587328,3,3,,103167027,5280343,Active,,,,,Inhibition of LTB4-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence,Other,21275387.0,
1518,587329,3,3,,103167027,5280343,Active,,,,,Inhibition of fMLP-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence,Other,21275387.0,
1519,587344,4,2,,103167027,5280343,Active,,,0.55,IC50,Inhibition of recombinant human CK2 activity assessed as [gamma-32P]ATP incorporation into substrate peptide after 20 mins in presence of 50 uM ATP,Confirmatory,21276643.0,
1520,588151,1,4,,103167027,5280343,Unspecified,,,,,Permeability across MDCK cells from apical to basolateral side assessed as relative permeation rate at 10 to 100 uM after 1 hr,Other,21319803.0,
1521,588349,1,1,,90341524,5280343,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
1522,588378,1,1,,90341524,5280343,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
1523,588379,1,2,,124881263,5280343,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
1524,588453,1,1,,85231204,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1525,588453,1,1,,90341524,5280343,Inconclusive,8659577.0,58819.0,23.7781,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1526,588453,1,1,,124881272,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1527,588456,1,1,,90341524,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1528,588456,1,1,,124881272,5280343,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1529,588519,1,2,,92124965,5280343,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
1530,588519,1,2,,99300982,5280343,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
1531,588519,1,2,,99302502,5280343,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
1532,588579,1,1,,90341524,5280343,Active,7705344.0,51426.0,0.9466,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1533,588579,1,1,,124881262,5280343,Active,7705344.0,51426.0,0.1995,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1534,588579,1,1,,124881263,5280343,Active,7705344.0,51426.0,1.122,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1535,588579,1,1,,124881264,5280343,Active,7705344.0,51426.0,0.4467,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1536,588579,1,1,,124881266,5280343,Active,7705344.0,51426.0,0.1995,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1537,588579,1,1,,124881267,5280343,Active,7705344.0,51426.0,0.2818,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1538,588579,1,1,,124881272,5280343,Active,7705344.0,51426.0,2.8184,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1539,588590,1,1,,50104737,5280343,Active,154350220.0,11201.0,0.5623,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1540,588590,1,1,,124881272,5280343,Active,154350220.0,11201.0,79.4328,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1541,588591,1,1,,50104737,5280343,Active,5729982.0,5429.0,0.7943,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1542,588795,1,1,,90341524,5280343,Active,4758356.0,2237.0,2.3778,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1543,588795,1,1,,124881272,5280343,Active,4758356.0,2237.0,39.8107,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1544,588834,2,1,,50104737,5280343,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1545,588855,1,1,,124881272,5280343,Inconclusive,18418623.0,4088.0,35.4813,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1546,588856,1,1,,124881272,5280343,Inactive,,,35.4813,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1547,589043,1,11,,103167027,5280343,Unspecified,117225.0,1558.0,,,"Clinically relevant inhibitors of human liver microsomal P450 enzymes, isoform CYP2C8",Other,,
1548,592413,4,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,21070009.0,
1549,592417,1,4,,103167027,5280343,Unspecified,,,,,Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level after 4 hrs,Other,21070009.0,
1550,592419,1,4,,103167027,5280343,Unspecified,,,,,Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level at 32 ug/ml after 4 hrs,Other,21070009.0,
1551,592728,2,5,,103167027,5280343,Unspecified,,,,,Antioxidant activity in rat liver microsomes assessed as inhibition of lipid peroxidation after 30 mins,Other,21459003.0,
1552,596670,1,4,,103167027,5280343,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control,Other,21493073.0,
1553,596671,1,4,,103167027,5280343,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control,Other,21493073.0,
1554,596672,1,4,,103167027,5280343,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control,Other,21493073.0,
1555,596673,1,4,,103167027,5280343,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control,Other,21493073.0,
1556,596753,3,3,,103167027,5280343,Active,,,38.1,CC50,Cytotoxicity against human HepG2(2.2.15) cells after 8 days by MTT assay,Confirmatory,21401115.0,
1557,596755,2,4,,103167027,5280343,Unspecified,,,,,Antiviral activity against HBV transfected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion at nontoxic concentration by ELISA,Other,21401115.0,
1558,598341,3,4,,103167027,5280343,Active,,,0.66,Ki,Inhibition of CYP1A1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin,Confirmatory,21482471.0,
1559,598342,3,4,,103167027,5280343,Active,,,0.023,Ki,Inhibition of CYP1B1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin,Confirmatory,21482471.0,
1560,600288,3,2,,103167027,5280343,Unspecified,,,244.0,EC50,Vasorelaxant activity in rat aortic ring assessed as inhibition of phenylephrine-induced contraction,Confirmatory,19442520.0,
1561,600289,1,4,,103167027,5280343,Inconclusive,,,,,Neuroprotective activity against oxygen-glucose deprivation-induced cell injury in rat PC12 cells assessed as cell viability at 1 uM,Other,19442520.0,
1562,600292,1,4,,103167027,5280343,Unspecified,,,,,Vasorelaxant activity in rat aortic ring assessed as inhibition of phenylephrine-induced contraction relative to control,Other,19442520.0,
1563,601455,2,6,,103167027,5280343,Active,,,,,Inhibition of xanthine oxidase assessed as reduction of uric acid production from xanthine at 10 to 50 uM preincubated for 15 mins measured after 30 mins by spectrophotometry,Other,21474216.0,
1564,602310,1,2,,124881272,5280343,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1565,602314,1,2,,92124965,5280343,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1566,602314,1,2,,99300982,5280343,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1567,602332,1,1,,90341524,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1568,602332,1,1,,124881262,5280343,Inconclusive,168984549.0,,50.1187,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1569,602332,1,1,,124881263,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1570,602332,1,1,,124881264,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1571,602332,1,1,,124881266,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1572,602332,1,1,,124881267,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1573,602332,1,1,,124881272,5280343,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1574,603318,6,5,,103167027,5280343,Active,55977782.0,952.0,37.9,IC50,"Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method",Confirmatory,21641214.0,
1575,603362,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against vancomycin resistant Enterococcus FN-1 after 24 hrs by microdilution method,Other,21534606.0,
1576,603363,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against vancomycin resistant Enterococcus NCTC 12201 after 24 hrs by microdilution method,Other,21534606.0,
1577,603364,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by microdilution method,Other,21534606.0,
1578,603365,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution method,Other,21534606.0,
1579,603366,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution method,Other,21534606.0,
1580,603367,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution method,Other,21534606.0,
1581,603368,3,4,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution method,Other,21534606.0,
1582,603457,3,4,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae R6 after 24 hrs by microdilution method,Other,21534606.0,
1583,603458,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by microdilution method,Other,21534606.0,
1584,603459,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Escherichia coli K-12 after 24 hrs by microdilution method,Other,21534606.0,
1585,603461,3,2,,103167027,5280343,Active,,,0.14,IC50,Inhibition of Escherichia coli DNA gyrase assessed as inhibition of pBR322 supercoiling by densitometry,Confirmatory,21534606.0,
1586,603462,3,2,,103167027,5280343,Inconclusive,,,,IC50,Inhibition of Staphylococcus aureus DNA Topoisomerase 4-mediated decatenation of kDNA after 30 mins by densitometry,Confirmatory,21534606.0,
1587,603463,3,2,,103167027,5280343,Active,,,6.42,IC50,Inhibition of Escherichia coli DNA topoisomerase 4 subunit ParC/DNA topoisomerase 4 subunit ParE-mediated decatenation of kDNA by densitometry,Confirmatory,21534606.0,
1588,603475,3,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 209P after 24 hrs by microdilution method,Other,21534606.0,
1589,603831,1,4,,103167027,5280343,Active,,,,,Increase in c-Fos protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis,Other,21652208.0,
1590,603832,1,4,,103167027,5280343,Active,,,,,Increase in Egr-1 protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis,Other,21652208.0,
1591,603833,1,4,,103167027,5280343,Inactive,,,,,Effect on p38 kinase protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
1592,603834,1,4,,103167027,5280343,Inactive,,,,,Effect on JNK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
1593,603835,1,4,,103167027,5280343,Inactive,,,,,Effect on JNK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
1594,603836,1,4,,103167027,5280343,Inactive,,,,,Effect on ERK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
1595,603837,1,4,,103167027,5280343,Inactive,,,,,Effect on ERK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis,Other,21652208.0,
1596,603838,1,5,,103167027,5280343,Unspecified,2499600.0,1432.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1597,603838,1,5,,103167027,5280343,Unspecified,2851522.0,6300.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1598,603838,1,5,,103167027,5280343,Unspecified,6685642.0,5603.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1599,603838,1,5,,103167027,5280343,Unspecified,134047835.0,5600.0,,,Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1600,603839,1,9,,103167027,5280343,Unspecified,85700366.0,5601.0,,,Increase in JNK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1601,603840,1,9,,103167027,5280343,Unspecified,119554.0,5594.0,,,Increase in ERK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1602,603841,1,9,,103167027,5280343,Unspecified,2507195.0,5599.0,,,Increase in JNK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1603,603842,1,10,,103167027,5280343,Unspecified,232066.0,5595.0,,,Increase in ERK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis,Other,21652208.0,
1604,603843,1,4,,103167027,5280343,Active,,,,,Induction of apoptosis in human MDA-MB-231 cells assessed as cleaved caspase-7 accumulation at 20 uM after 12 hrs by Western blot analysis,Other,21652208.0,
1605,603844,1,3,,103167027,5280343,Unspecified,,,,,Stability of the compound in DMEM media assessed as compound degradation at 25 ppm after 3 hrs by HPLC,Other,21652208.0,
1606,604941,1,4,,103167027,5280343,Unspecified,,,,,Chemical stability of the compound in buffer at pH 2 assessed as half life by HPLC analysis,Other,21090565.0,
1607,604942,1,4,,103167027,5280343,Unspecified,,,,,Chemical stability of the compound in PBS buffer at pH 7.4 assessed as half life by HPLC analysis,Other,21090565.0,
1608,604943,1,4,,103167027,5280343,Unspecified,,,,,Chemical stability of the compound in cell-free DMEM culture media assessed as half life by HPLC analysis in presence of FBS,Other,21090565.0,
1609,605031,3,2,,103167027,5280343,Unspecified,,,,,Aqueous solubility of the compound in PBS assessed as forward light scattering by compound by microplate neplhelometric analysis,Other,21090565.0,
1610,605032,3,2,,103167027,5280343,Unspecified,,,,,Solubility of the compound in DMEM media assessed as forward light scattering by compound by microplate neplhelometric analysis,Other,21090565.0,
1611,605033,3,2,,103167027,5280343,Unspecified,,,,,Solubility of the compound in cell-free DMEM media assessed as forward light scattering by compound by microplate neplhelometric analysis in presence of FBS,Other,21090565.0,
1612,605034,1,4,,103167027,5280343,Active,,,,,Cellular uptake in human HCT116 cells assessed a bright fluorescence light at 5 uM after 1 hr by fluorescence microscopic analysis,Other,21090565.0,
1613,605035,1,4,,103167027,5280343,Inactive,,,,,Cellular uptake in human HCT116 cells assessed a bright fluorescence light at 5 uM after 12 hrs by fluorescence microscopic analysis,Other,21090565.0,
1614,605036,1,4,,103167027,5280343,Unspecified,,,,,Permeability of the compound measured on donor plate of PAMPA membrane at 50 uM after 1 hr by HPLC analysis,Other,21090565.0,
1615,605037,1,4,,103167027,5280343,Unspecified,,,,,Permeability of the compound measured on donor plate of PAMPA membrane at 50 uM after 5 hrs by HPLC analysis,Other,21090565.0,
1616,605038,1,4,,103167027,5280343,Unspecified,,,,,Permeability of the compound measured on acceptor plate of PAMPA membrane at 50 uM after 1 hr by HPLC analysis,Other,21090565.0,
1617,605039,1,4,,103167027,5280343,Unspecified,,,,,Permeability of the compound measured on acceptor plate of PAMPA membrane at 50 uM after 5 hrs by HPLC analysis,Other,21090565.0,
1618,605042,1,4,,103167027,5280343,Unspecified,,,,,Cellular uptake in human MCF7 cells assessed as compound remaining in culture media at 10 uM after 1 hr by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1619,605043,1,4,,103167027,5280343,Unspecified,,,,,Cellular uptake in human MCF7 cells assessed as compound remaining in culture media at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1620,605044,1,4,,103167027,5280343,Unspecified,,,,,Cellular uptake in human MCF7 cells assessed as compound remaining in cell lysates at 10 uM after 1 hr by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1621,605045,1,4,,103167027,5280343,Unspecified,,,,,Cellular uptake in human MCF7 cells assessed as compound remaining in cell lysates at 10 uM after 12 hr by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1622,605046,1,4,,103167027,5280343,Active,,,,,Cellular uptake in human MCF7 cells assessed as formation of quercetin glucuronide in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1623,605047,1,4,,103167027,5280343,Active,,,,,Cellular uptake in human MCF7 cells assessed as formation of quercetin sulphate in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1624,605048,1,4,,103167027,5280343,Active,,,,,Cellular uptake in human MCF7 cells assessed as formation of oxidised quercetin in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1625,605049,1,4,,103167027,5280343,Active,,,,,Cellular uptake in human MCF7 cells assessed as formation of methylated quercetin in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1626,605052,1,6,,103167027,5280343,Inactive,,,,,Cellular uptake in human HuH7 cells assessed as intracellular accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1627,605053,1,6,,103167027,5280343,Unspecified,,,,,Cellular uptake in human HuH7 cells assessed as quercetin-sulphate accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1628,605054,1,6,,103167027,5280343,Unspecified,,,,,Cellular uptake in human HuH7 cells assessed as methyl-quercetin accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis,Other,21090565.0,
1629,605055,3,2,,103167027,5280343,Unspecified,,,100.0,EC50,Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay,Confirmatory,21090565.0,
1630,605056,3,2,,103167027,5280343,Unspecified,,,100.0,EC50,Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay,Confirmatory,21090565.0,
1631,605129,3,2,,103167027,5280343,Unspecified,,,100.0,EC50,Antiproliferative activity against human DU145 cells after 24 hrs by MTT assay,Confirmatory,21090565.0,
1632,605130,3,2,,103167027,5280343,Unspecified,,,100.0,EC50,Antiproliferative activity against human HS27 cells after 24 hrs by MTT assay,Confirmatory,21090565.0,
1633,605131,1,4,,103167027,5280343,Inactive,,,,,Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay in presence of antioxidative stabilizer ascorbic acid,Other,21090565.0,
1634,605132,1,4,,103167027,5280343,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as decrease in accumulation at G0/G1 phase at 50 uM after 12 hrs by propidium iodide staining based flow cytometric analysis relative to untreated control,Other,21090565.0,
1635,605133,1,4,,103167027,5280343,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as increase in accumulation at S phase at 50 uM after 14 hrs by propidium iodide staining based flow cytometric analysis relative to untreated control,Other,21090565.0,
1636,615921,3,2,,103167027,5280343,Active,,,7.079460000000001,Kd,Binding affinity to ABCB1 nucleotide binding domain 2,Confirmatory,21723648.0,
1637,616482,2,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21821414.0,
1638,622872,6,5,,103167027,5280343,Inconclusive,127825.0,,,Ki,Non-competitive inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by Lineweaver-Burk plot analysis,Confirmatory,21911291.0,
1639,622873,6,5,,103167027,5280343,Active,127825.0,,10.06,IC50,Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by fluorimetry,Confirmatory,21911291.0,
1640,624101,1,2,,85787280,5280343,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1641,624101,1,2,,85789376,5280343,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1642,624137,1,1,,85787280,5280343,Inactive,881546.0,3400.0,,,SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity,Screening,,
1643,624146,1,1,,90341524,5280343,Inconclusive,71051501.0,2744.0,0.4467,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1644,624147,1,1,,90341524,5280343,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1645,624148,1,2,,90341524,5280343,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1646,624149,1,1,,90341524,5280343,Inconclusive,693842.0,4780.0,20.5962,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1647,624151,1,1,,85789376,5280343,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
1648,624156,1,1,,85787280,5280343,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1649,624156,1,1,,85787911,5280343,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1650,624173,1,3,,124881274,5280343,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1651,624178,1,1,,124881272,5280343,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1652,624202,1,1,,124881272,5280343,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1653,624260,1,1,,85787280,5280343,Inactive,109633019.0,7468.0,,,NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1654,624263,1,1,,124881262,5280343,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1655,624263,1,1,,124881262,5280343,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1656,624263,1,1,,124881272,5280343,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1657,624263,1,1,,124881272,5280343,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1658,624414,1,1,,124881272,5280343,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1659,624455,1,1,,90341524,5280343,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1660,624476,1,1,,124881274,5280343,Inactive,,,,Potency,Cytotoxicity counterscreen for NFkB agonists and antagonists,Confirmatory,,
1661,624478,1,1,,124881274,5280343,Inactive,,,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway.,Confirmatory,,
1662,624479,1,1,,124881274,5280343,Active,,,14.9477,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway.,Confirmatory,,
1663,624606,1,9,,103167027,5280343,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
1664,624607,1,9,,103167027,5280343,Unspecified,549152.0,54659.0,,,Specific activity of expressed human recombinant UGT1A3,Other,10836148.0,
1665,624608,3,2,,103167027,5280343,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
1666,624609,1,9,,103167027,5280343,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
1667,624611,1,9,,103167027,5280343,Unspecified,29839637.0,54576.0,,,Specific activity of expressed human recombinant UGT1A8,Other,10836148.0,
1668,624612,1,9,,103167027,5280343,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
1669,624613,1,9,,103167027,5280343,Unspecified,29839636.0,54575.0,,,Specific activity of expressed human recombinant UGT1A10,Other,10836148.0,
1670,624616,1,8,,103167027,5280343,Unspecified,332278237.0,7366.0,,,Specific activity of expressed human recombinant UGT2B15,Other,10836148.0,
1671,630145,3,4,,103167027,5280343,Active,,,6.91,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,21958738.0,
1672,630873,3,2,,103167027,5280343,Unspecified,,,51.0,IC50,Inhibition of soybean arachidonate 15-lipoxygenase,Confirmatory,21937153.0,
1673,630874,5,5,,103167027,5280343,Active,126397.0,100009114.0,37.0,IC50,Inhibition of rabbit reticulocytes arachidonate 15-lipoxygenase,Confirmatory,21937153.0,
1674,638568,2,1,,103167027,5280343,Active,,,48.2,ED50,Antiviral activity against influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7 infected in MDCK cells assessed as inhibition of viral replication after 4 days by quantitative RT-PCR,Confirmatory,22115591.0,
1675,638569,2,1,,103167027,5280343,Unspecified,,,83.4,TD50,Cytotoxicity against MDCK cells after 4 days,Confirmatory,22115591.0,
1676,638570,1,4,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of TD50 for MDCK cells to ED50 for influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7",Other,22115591.0,
1677,639825,5,5,,103167027,5280343,Active,113596.0,231.0,2.2,IC50,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Confirmatory,22261024.0,
1678,641152,3,2,,103167027,5280343,Active,,,23.0,IC50,Growth inhibition of human HCT116 cells overexpressing PI3Kalpha after 48 hrs by MTT assay,Confirmatory,22212721.0,
1679,641153,3,2,,103167027,5280343,Active,,,5.7,IC50,Growth inhibition of human HCT116 cells overexpressing PI3Kalpha H1047R mutant after 48 hrs by MTT assay,Confirmatory,22212721.0,
1680,641154,3,2,,103167027,5280343,Active,,,6.7,IC50,Growth inhibition of human HCT116 cells after 48 hrs by MTT assay,Confirmatory,22212721.0,
1681,641156,1,9,,103167027,5280343,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha in human HCT116 cells using [32P]ATP at 25 uM after 10 mins,Other,22212721.0,
1682,641158,1,5,,103167027,5280343,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells using [32P]ATP at 25 uM after 10 mins,Other,22212721.0,
1683,641161,1,9,,103167027,5280343,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 25 uM by immunoblot analysis,Other,22212721.0,
1684,641162,1,5,,103167027,5280343,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 25 uM by immunoblot analysis,Other,22212721.0,
1685,641163,1,4,,103167027,5280343,Inactive,,,,,Inhibition of Akt expression in human HCT116 cells at 10 uM by immunoblot analysis,Other,22212721.0,
1686,641164,1,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human HCT116 cells assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1687,641165,1,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1688,641166,1,4,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha H1047R mutant assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1689,642414,1,9,,103167027,5280343,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1690,642415,1,9,,103167027,5280343,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1691,649085,1,3,,103167027,5280343,Unspecified,,,,,Inhibition of soybean lipoxygenase using arachidonic acid as substrate at 4 uM,Other,22356737.0,
1692,651548,1,1,,85787280,5280343,Active,21361095.0,2146.0,,,EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1693,651631,4,1,,144209506,5280343,Active,269849759.0,7157.0,48.953,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1694,651631,4,1,,144210605,5280343,Inconclusive,269849759.0,7157.0,68.5896,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1695,651632,4,1,,144209506,5280343,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1696,651632,4,1,,144210605,5280343,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1697,651633,4,1,,144209506,5280343,Inconclusive,,,61.6282,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1698,651633,4,1,,144210605,5280343,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1699,651634,4,1,,144209506,5280343,Inconclusive,,,27.5283,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1700,651634,4,1,,144210605,5280343,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1701,651635,1,3,,90341524,5280343,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1702,651645,1,1,,124881274,5280343,Inactive,,,37.2212,Potency,Cell Proliferation Assay against the TMD8 Cell Line,Confirmatory,,
1703,651646,1,1,,124881274,5280343,Inactive,,,33.1734,Potency,Cell Proliferation Assay against the HBL1 Cell Line,Confirmatory,,
1704,651696,1,1,,124881274,5280343,Inactive,,,0.4176,Potency,Cell Proliferation Assay against a hMSC Cell Line,Confirmatory,,
1705,651712,1,1,,124881274,5280343,Inconclusive,,,20.930999999999997,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs),Confirmatory,,
1706,651713,1,1,,124881274,5280343,Inconclusive,,,23.485,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs),Confirmatory,,
1707,651828,1,2,,121361903,5280343,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1708,651965,1,1,,124881272,5280343,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1709,652106,1,1,,90341524,5280343,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1710,652106,1,1,,124881272,5280343,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1711,654478,2,2,,103167027,5280343,Active,,,37.12,IC50,Inhibition of lipoxygenase using linoleic acid as substrate after 10 mins preincubation,Confirmatory,22436389.0,
1712,654746,6,2,,103167027,5280343,Unspecified,137757.0,1489078.0,20.0,IC50,Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique,Confirmatory,22300659.0,
1713,658253,2,4,,103167027,5280343,Active,,,19.8,EC50,Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay,Confirmatory,22445328.0,
1714,658255,2,3,,103167027,5280343,Unspecified,,,50.0,CC50,Cytotoxicity against human Huh7.5.1 cells by MTT assay,Confirmatory,22445328.0,
1715,663856,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity against ABTS radical assessed as trolox equivalents by TEAC assay,Other,22506638.0,
1716,663955,3,6,,103167027,5280343,Active,68068087.0,2859.0,8.02,EC50,Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay,Confirmatory,24900447.0,
1717,663956,3,6,,103167027,5280343,Active,68068087.0,2859.0,5.93,EC50,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay,Confirmatory,24900447.0,
1718,663957,1,8,,103167027,5280343,Active,68068087.0,2859.0,,,Partial agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay,Other,24900447.0,
1719,663959,1,8,,103167027,5280343,Inactive,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells at 32 uM after 10 mins by dynamic mass redistribution assay in the presence of SPB05142,Other,24900447.0,
1720,663960,5,5,,103167027,5280343,Active,68068087.0,2859.0,15.4,IC50,Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins,Confirmatory,24900447.0,
1721,663961,1,8,,103167027,5280343,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells assessed as shift in resonant wavelength of biosensor stimulation after 10 mins by dynamic mass redistribution assay relative to control,Other,24900447.0,
1722,663962,1,8,,103167027,5280343,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay relative to control,Other,24900447.0,
1723,666768,1,7,,103167027,5280343,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry,Other,22647223.0,
1724,666769,1,7,,103167027,5280343,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry,Other,22647223.0,
1725,666770,1,7,,103167027,5280343,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry,Other,22647223.0,
1726,666771,1,7,,103167027,5280343,Unspecified,75057499.0,,,,Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry,Other,22647223.0,
1727,666853,2,3,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against human LCC-6 cells after 5 days by MTS assay,Confirmatory,22743241.0,
1728,666854,2,3,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against multidrug resistant human LCC-6 cells after 5 days by MTS assay,Confirmatory,22743241.0,
1729,666855,2,2,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against mouse L929 cells after 5 days by MTS assay,Confirmatory,22743241.0,
1730,666856,1,2,,103167027,5280343,Unspecified,,,,,Reversal of p-glycoprotein-mediated drug resistant in human LCC-6/MDR cells assessed as potentiation of paclitaxel-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
1731,666857,1,8,,103167027,5280343,Unspecified,67462103.0,9429.0,,,Reversal of BCRP-mediated drug resistant in human HEK293/R2 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
1732,666858,1,8,,103167027,5280343,Unspecified,67462103.0,9429.0,,,Reversal of BCRP-mediated drug resistant in human MCF7-MX100 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
1733,666859,1,8,,103167027,5280343,Unspecified,296439301.0,4363.0,,,Reversal of MRP1-mediated drug resistant in human 2008/MRP1 cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
1734,670310,5,5,,103167027,5280343,Inconclusive,116852.0,4312.0,,IC50,Inhibition of human recombinant MMP1 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1735,670311,5,5,,103167027,5280343,Active,116856.0,4313.0,6.68,IC50,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1736,670312,5,5,,103167027,5280343,Active,116857.0,4314.0,5.57,IC50,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1737,670313,5,5,,103167027,5280343,Active,269849668.0,4318.0,1.61,IC50,Inhibition of human recombinant MMP9 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1738,670314,5,5,,103167027,5280343,Active,729179.0,4321.0,10.23,IC50,Inhibition of human recombinant MMP12 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1739,670315,5,5,,103167027,5280343,Active,1168998.0,4322.0,8.46,IC50,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,Confirmatory,22658537.0,
1740,670317,1,7,,103167027,5280343,Unspecified,116856.0,4313.0,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,Other,22658537.0,
1741,670318,1,7,,103167027,5280343,Unspecified,116857.0,4314.0,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,Other,22658537.0,
1742,670319,1,7,,103167027,5280343,Unspecified,269849668.0,4318.0,,,Inhibition of human recombinant MMP9 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,Other,22658537.0,
1743,670320,1,8,,103167027,5280343,Unspecified,729179.0,4321.0,,,Inhibition of human recombinant MMP12 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,Other,22658537.0,
1744,670321,1,7,,103167027,5280343,Unspecified,1168998.0,4322.0,,,Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,Other,22658537.0,
1745,671213,2,2,,103167027,5280343,Active,,,15.5,IC50,Antiproliferative activity against human 22Rv1 cells incubated up to 144 hrs by Coulter particle count and size analyzer,Confirmatory,22789812.0,
1746,671217,1,3,,103167027,5280343,Unspecified,,,,,Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 10 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1747,671218,1,3,,103167027,5280343,Unspecified,,,,,Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 20 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1748,671219,1,3,,103167027,5280343,Unspecified,,,,,Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 10 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1749,671220,1,3,,103167027,5280343,Unspecified,,,,,Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 20 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1750,671261,2,2,,103167027,5280343,Unspecified,,,530.0,IC50,Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 5 mins prior to substrate addition measured after 35 mins by spectrophotocolorimetric assay,Confirmatory,22587572.0,
1751,673629,2,2,,103167027,5280343,Active,,,5.6,IC50,Inhibition of CK2 using RRRADDSDDDDD as substrate after 30 mins by PKLight assay,Confirmatory,21798748.0,
1752,673630,5,1,,103167027,5280343,Active,334302890.0,816.0,3.0,IC50,Inhibition of CAMK2 using autocamtide-2 as substrate after 30 mins by PKLight assay,Confirmatory,21798748.0,
1753,673631,1,3,,103167027,5280343,Active,,,,,Inhibition of heat shock-induced HSP70 expression in human Jurkat cells at 145 uM treated 2 hrs before beat shock challenge measured after 8 hrs by Western blotting,Other,21798748.0,
1754,676963,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 3.16 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1755,676965,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 5.62 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1756,676984,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.32 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1757,676985,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.56 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1758,676986,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 1 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1759,676987,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 1.78 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1760,677268,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity against APPH radical assessed as trolox equivalent incubated for 15 mins prior to APPH addition measured every 1 min by 120 mins by fluorescein-based ORAC method,Other,22832320.0,
1761,677748,1,5,,103167027,5280343,Active,,,,,Antioxidant activity assessed as inhibition of DPPH radical at 5 mM after 15 mins,Other,22853996.0,
1762,678023,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 10 uM by spectrophotometry based TBARS assay relative to untreated control,Other,22858298.0,
1763,678024,2,2,,103167027,5280343,Active,,,1.496,IC50,Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation by spectrophotometry based TBARS assay,Confirmatory,22858298.0,
1764,679336,3,6,,103167027,5280343,Unspecified,296439301.0,4363.0,8.1,Ki,TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicle from MRP1-expressing HeLa cells,Confirmatory,11306701.0,
1765,680150,1,8,,103167027,5280343,Unspecified,238054374.0,5243.0,,,TP_TRANSPORTER: cell accumulation in MDR1-expressing MDCK cells,Other,14980703.0,
1766,680281,1,8,,103167027,5280343,Unspecified,238054374.0,5243.0,,,"TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Quercetin: 200 uM) in MDR1-expressing NIH-3T3 cells",Other,14985103.0,
1767,680498,1,8,,103167027,5280343,Unspecified,238054374.0,5243.0,,,"TP_TRANSPORTER: inhibition of Hoechst 33342 efflux (Hoechst 33342: 25 uM, Quercetin: 25 uM) in purified and reconstituted P-gp, flow cytometry",Other,9105411.0,
1768,680911,1,8,,103167027,5280343,Unspecified,238054374.0,5243.0,,,TP_TRANSPORTER: cell accumulation of colchicine in the presence of Quercetin at a concentration of 100uM in MDR1-expressing MDCK cells,Other,14980703.0,
1769,681123,3,6,,103167027,5280343,Unspecified,81884247.0,,,IC50,TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes,Confirmatory,10417314.0,
1770,681133,3,6,,103167027,5280343,Unspecified,1709076.0,25027.0,,IC50,TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes,Confirmatory,10417314.0,
1771,681162,3,6,,103167027,5280343,Unspecified,238054374.0,5243.0,52.5,IC50,TP_TRANSPORTER: drug resistance (vincristine) in AML-2/D100 cells,Confirmatory,15240100.0,
1772,681181,1,8,,103167027,5280343,Unspecified,67462103.0,9429.0,,,"TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 20 uM, Quercetin: 50 uM) in BCRP-expressing NCI-H460 cells",Other,15102949.0,
1773,681196,1,8,,103167027,5280343,Unspecified,67462103.0,9429.0,,,"TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 100 uM, Quercetin: 50 uM) in BCRP-expressing MCF-7 cells",Other,15102949.0,
1774,681309,1,8,,103167027,5280343,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: increase in Vinblastine intracellular accumulation (Vinblastine: 0.05 uM, Quercetin: 100 uM) in PANC-1 cells",Other,12532374.0,
1775,681320,1,8,,103167027,5280343,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, Quercetin: 100 uM) in PANC-1 cells",Other,12532374.0,
1776,681338,1,8,,103167027,5280343,Unspecified,313104012.0,11309.0,,,TP_TRANSPORTER: inhibition of glibenclamide uptake (glibenclamide: 10nM) in OATP2B1-expressing HEK293 cells,Other,15640378.0,
1777,681339,1,8,,103167027,5280343,Unspecified,313104012.0,11309.0,,,TP_TRANSPORTER: inhibition of Estrone-3-sulfate uptake (Estrone-3-sulfate: 10nM) in OATP2B1-expressing HEK293 cells,Other,15640378.0,
1778,681519,1,8,,103167027,5280343,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: Western blot, MCF-7 cells",Other,11836020.0,
1779,681520,1,8,,103167027,5280343,Unspecified,296439301.0,4363.0,,,TP_TRANSPORTER: RT-PCR in MCF-7 cells,Other,11836020.0,
1780,681614,1,8,,103167027,5280343,Unspecified,238054374.0,5243.0,,,TP_TRANSPORTER: inhibition of Saquinavir transepithelial transport (basal to apical) in Caco-2 cells,Other,10583025.0,
1781,682124,1,8,,103167027,5280343,Unspecified,308153583.0,1244.0,,,TP_TRANSPORTER: Immunoblot analysis in Caco-2 cells,Other,10660112.0,
1782,682234,1,8,,103167027,5280343,Unspecified,27735247.0,80900.0,,,"TP_TRANSPORTER: inhibition of Fexofenadine uptake (Fexofenadine: 1? uM, Quercetin: 5 uM) in Oatp3-expressing HeLa cells",Other,11823753.0,
1783,683739,1,5,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 15 uM after 2 hrs by spectrophotometric analysis,Other,22126405.0,
1784,686947,2,2,,124881274,5280343,Active,4885661.0,7525.0,15.4103,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen,Confirmatory,23787099.0,
1785,686950,1,1,,124881274,5280343,Inactive,,,,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Counter Assay,Other,,
1786,686977,2,1,,49698528,5280343,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1787,686978,1,1,,124881262,5280343,Inconclusive,79154014.0,55775.0,5.8048,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1788,686978,1,1,,124881263,5280343,Inconclusive,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1789,686978,1,1,,124881266,5280343,Active,79154014.0,55775.0,12.5893,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1790,686978,1,1,,124881267,5280343,Active,79154014.0,55775.0,14.581,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1791,686978,1,1,,124881272,5280343,Inconclusive,79154014.0,55775.0,17.7828,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1792,686979,1,1,,124881262,5280343,Active,79154014.0,55775.0,1.8356,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1793,686979,1,1,,124881263,5280343,Active,79154014.0,55775.0,26.6086,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1794,686979,1,1,,124881266,5280343,Active,79154014.0,55775.0,12.5893,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1795,686979,1,1,,124881267,5280343,Inconclusive,79154014.0,55775.0,18.3564,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1796,686979,1,1,,124881272,5280343,Inconclusive,79154014.0,55775.0,25.1189,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1797,687035,1,1,,163564953,5280343,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1798,687037,1,3,,163564953,5280343,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1799,690143,1,2,,103167027,5280343,Active,,,,,Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control,Other,21824690.0,
1800,690144,1,2,,103167027,5280343,Active,,,,,Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control,Other,21824690.0,
1801,690145,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay,Other,21824690.0,
1802,690148,1,2,,103167027,5280343,Unspecified,,,,,Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay,Other,21824690.0,
1803,690149,1,2,,103167027,5280343,Unspecified,,,,,Reducing activity by cyclic voltammetry,Other,21824690.0,
1804,692831,1,4,,103167027,5280343,Active,,,,,Neuroprotective activity against glutamate-induced oxidative stress in mouse HT22 cells assessed as reduction of intracellular ROS formation at 25 uM after 24 hrs by MTT assay,Other,24900407.0,
1805,693702,1,2,,103167027,5280343,Active,,,,,Inhibition of amyloid beta (1-42) aggregation at 100 uM measured at 8 hrs and 24 hrs by thioflavin T fluorescence method,Other,23108363.0,
1806,696432,1,7,,103167027,5280343,Unspecified,585716.0,280977.0,,,Activation of bovine kidney LMW-PTPase at 400 uM using pNPP substrate,Other,21988196.0,
1807,696769,2,2,,103167027,5280343,Active,,,30.9,IC50,Cytotoxicity against human HepG2 cells by MTT assay,Confirmatory,21726077.0,
1808,697064,2,2,,103167027,5280343,Active,,,4.29,IC50,Inhibition of duck liver FASN,Confirmatory,21726077.0,
1809,697852,1,7,,103167027,5280343,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1810,697853,1,7,,103167027,5280343,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1811,699539,1,7,,103167027,5280343,Unspecified,12643959.0,10599.0,,,Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting,Other,22541068.0,
1812,699540,1,7,,103167027,5280343,Unspecified,27734563.0,28234.0,,,Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting,Other,22541068.0,
1813,699541,1,7,,103167027,5280343,Unspecified,313104012.0,11309.0,,,Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting,Other,22541068.0,
1814,700818,1,2,,103167027,5280343,Unspecified,,,,,Increase of SIRT1 mRNA expression in mouse brain at 25 mg/kg qd for 7 days by RT-PCR analysis,Other,21080630.0,
1815,700819,1,2,,103167027,5280343,Unspecified,,,,,Increase of SIRT1 mRNA expression in mouse brain at 12.5 mg/kg qd for 7 days by RT-PCR analysis,Other,21080630.0,
1816,700825,1,3,,103167027,5280343,Unspecified,,,,,Increase of SIRT1 mRNA expression in mouse soleus muscle at 12.5 to 25 mg/kg qd for 7 days by RT-PCR analysis,Other,21080630.0,
1817,701064,3,5,,103167027,5280343,Active,1174527.0,6850.0,35.0,EC50,Inhibition of SYK in human mast cells assessed as reduction in mast cell degranulation,Confirmatory,22257213.0,
1818,701071,5,2,,103167027,5280343,Active,1174527.0,6850.0,20.0,IC50,Inhibition of SYK,Confirmatory,22257213.0,
1819,701372,3,2,,103167027,5280343,Active,,,1.27,IC50,Inhibition of myeloperoxidase,Confirmatory,22793255.0,
1820,703474,1,2,,103167027,5280343,Unspecified,,,,,Selectivity ratio of IC50 for Leishmania donovani promastigote to IC50 for SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages,Other,22989363.0,
1821,703476,1,2,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages",Other,22989363.0,
1822,703481,1,2,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for SSG-resistant Leishmania donovani 39 promastigote",Other,22989363.0,
1823,703482,1,2,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for pentamidine-resistant Leishmania donovani AG83PentR50 promastigote",Other,22989363.0,
1824,703483,1,2,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of IC50 for mouse PEM cells to IC50 for wild-type Leishmania donovani AG83 promastigote",Other,22989363.0,
1825,703484,2,3,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay,Confirmatory,22989363.0,
1826,703485,2,2,,103167027,5280343,Unspecified,,,95.6,IC50,Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay,Confirmatory,22989363.0,
1827,703486,2,2,,103167027,5280343,Active,,,6.0,IC50,Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,Confirmatory,22989363.0,
1828,703487,2,2,,103167027,5280343,Unspecified,,,69.6,IC50,Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Confirmatory,22989363.0,
1829,703620,2,2,,103167027,5280343,Unspecified,,,100.0,IC50,Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Confirmatory,22989363.0,
1830,703621,2,2,,103167027,5280343,Unspecified,,,102.9,IC50,Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Confirmatory,22989363.0,
1831,706714,3,2,,103167027,5280343,Active,,,1.1,IC50,Competitive inhibition of PIM1 in presence of ATP,Confirmatory,22924342.0,
1832,710226,1,2,,103167027,5280343,Unspecified,,,,,Prevention of apoptosis in rat H9c2 cells assessed as protection against oxidative stress-induced cytotoxicity at 100 nM pM by Alamar blue assay,Other,23151013.0,
1833,710227,1,2,,103167027,5280343,Inconclusive,,,,,Prevention of apoptosis in rat H9c2 cells assessed as reduction in fall of mitochondrial membrane potential at 100 nM after 1 hr,Other,23151013.0,
1834,710228,1,2,,103167027,5280343,Inconclusive,,,,,Cytotoxicity against rat H9c2 cells assessed as cell viability in absence of H2O2,Other,23151013.0,
1835,710229,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity of the compound assessed as DHR radical scavenging activity at 10 uM by fluorescence assay,Other,23151013.0,
1836,710230,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity of the compound assessed as DPPH radical scavenging at 10 uM after 30 secs by spectrophotometry,Other,23151013.0,
1837,710231,2,3,,103167027,5280343,Active,,,0.61,IC50,Antioxidant activity assessed as scavenging of morpholino sydononimine based nitric oxide release by chemiluminescence assay,Confirmatory,23151013.0,
1838,710235,2,2,,103167027,5280343,Active,,,0.06,IC50,Antioxidant activity assessed as scavenging of glucose oxidase-generated H2O2 and hydroxyl radicals by chemiluminescence assay,Confirmatory,23151013.0,
1839,716425,1,3,,103167027,5280343,Active,,,,,Neuroprotective activity against glutamate induced oxidative stress in mouse hippocampal HT22 cells assessed as cell viability at 25 uM after 24 hrs by MTT assay,Other,22624880.0,
1840,720516,2,1,,144209506,5280343,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1841,720516,2,1,,144210605,5280343,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1842,720532,1,1,,90341524,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1843,720532,1,1,,124881262,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1844,720532,1,1,,124881263,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1845,720532,1,1,,124881264,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1846,720532,1,1,,124881266,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1847,720532,1,1,,124881267,5280343,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1848,720533,1,1,,90341524,5280343,Inactive,,,1.2538,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1849,720533,1,1,,124881262,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1850,720533,1,1,,124881263,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1851,720533,1,1,,124881264,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1852,720533,1,1,,124881266,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1853,720533,1,1,,124881267,5280343,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1854,720538,1,2,,90341524,5280343,Inconclusive,220983390.0,410.0,33.8078,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1855,720552,2,1,,144209506,5280343,Active,269849759.0,7157.0,50.8682,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1856,720552,2,1,,144210605,5280343,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1857,720559,1,2,,90341524,5280343,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1858,720572,1,2,,90341524,5280343,Inconclusive,3063388.0,5071.0,8.1995,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1859,720573,1,2,,90341524,5280343,Inconclusive,3063388.0,5071.0,5.1735,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1860,720579,2,1,,124881262,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1861,720579,2,1,,124881266,5280343,Inconclusive,222762.0,3707576.0,39.8107,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1862,720579,2,1,,124881267,5280343,Inconclusive,222762.0,3707576.0,11.2202,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1863,720579,2,1,,124881272,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1864,720580,1,1,,124881262,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1865,720580,1,1,,124881266,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1866,720580,1,1,,124881267,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1867,720580,1,1,,124881272,5280343,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1868,720634,2,1,,144209506,5280343,Inactive,,,4.3629,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1869,720634,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1870,720635,2,1,,144209506,5280343,Active,,,0.8705,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1871,720635,2,1,,144210605,5280343,Active,,,2.4337,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1872,720637,2,1,,144209506,5280343,Active,,,1.60859,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1873,720637,2,1,,144210605,5280343,Active,,,4.49702,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1874,720674,2,2,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1875,720674,2,2,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1876,720675,2,2,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1877,720675,2,2,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1878,720678,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1879,720678,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1880,720679,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1881,720679,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1882,720680,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1883,720680,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1884,720681,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1885,720681,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1886,720682,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1887,720682,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1888,720683,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1889,720683,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1890,720684,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1891,720684,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1892,720685,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1893,720685,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1894,720686,2,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1895,720686,2,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1896,720687,2,2,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1897,720687,2,2,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1898,720691,4,1,,144209506,5280343,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1899,720691,4,1,,144210605,5280343,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1900,720692,3,1,,144209506,5280343,Active,311348376.0,2908.0,49.3919,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1901,720692,3,1,,144210605,5280343,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1902,720693,3,1,,144209506,5280343,Inconclusive,,,55.4186,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1903,720693,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1904,720717,1,3,,92124965,5280343,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1905,720717,1,3,,92310070,5280343,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1906,720719,2,1,,144209506,5280343,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1907,720719,2,1,,144210605,5280343,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1908,720725,2,1,,144209506,5280343,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1909,720725,2,1,,144210605,5280343,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1910,725981,1,3,,103167027,5280343,Unspecified,,,300.0,IC50,Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli by FRET assay,Confirmatory,23394144.0,
1911,729305,1,6,,103167027,5280343,Active,267256.0,554.0,,,Inhibition of vasopressin V2 receptor (unknown origin) assessed as change in intracellular calcium levels incubated with compound treated with Tween-80 by fluorometric analysis,Other,23437772.0,
1912,729306,1,6,,103167027,5280343,Active,267256.0,554.0,,,Inhibition of vasopressin V2 receptor (unknown origin) assessed as change in intracellular calcium levels treated with centrifuged compound solution by fluorometric analysis,Other,23437772.0,
1913,729307,4,2,,103167027,5280343,Active,267256.0,554.0,15.2,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1914,729308,4,2,,103167027,5280343,Active,267256.0,554.0,37.8,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1915,729309,4,2,,103167027,5280343,Active,267256.0,554.0,7.0,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1916,729310,4,2,,103167027,5280343,Unspecified,108936015.0,3577.0,32.0,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1917,729311,4,2,,103167027,5280343,Inactive,108936015.0,3577.0,,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1918,729312,4,2,,103167027,5280343,Active,108936015.0,3577.0,4.5,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1919,729313,4,2,,103167027,5280343,Unspecified,1705894.0,1233.0,100.0,IC50,Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1920,729314,4,2,,103167027,5280343,Unspecified,1705894.0,1233.0,100.0,IC50,Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1921,729315,4,2,,103167027,5280343,Active,1705894.0,1233.0,10.2,IC50,Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,Confirmatory,23437772.0,
1922,730326,1,3,,103167027,5280343,Active,,,21.6,GI50,Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay,Confirmatory,23411073.0,
1923,730327,1,2,,103167027,5280343,Active,,,13.1,GI50,Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay,Confirmatory,23411073.0,
1924,730328,2,5,,103167027,5280343,Active,156630887.0,2322.0,0.59,IC50,Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay,Confirmatory,23411073.0,
1925,731031,1,2,,103167027,5280343,Active,,,,,Inhibition of A2E photooxidation at 100 uM after 5 mins by reversed-phase HPLC analysis,Other,23346866.0,
1926,731032,1,2,,103167027,5280343,Active,,,,,Inhibition of intracellular A2E photooxidation in human ARPE19 cells at 20 uM after 18 days,Other,23346866.0,
1927,732541,1,6,,103167027,5280343,Active,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as cytosolic accumulation at 50 uM after 3 hrs by Western blotting analysis,Other,23294286.0,
1928,732542,1,6,,103167027,5280343,Active,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as nuclear accumulation at 50 uM after 3 hrs by Western blotting analysis,Other,23294286.0,
1929,732547,1,6,,103167027,5280343,Unspecified,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of HO1 protein expression at 50 uM after 6 hrs by Western blotting analysis,Other,23294286.0,
1930,732550,1,6,,103167027,5280343,Unspecified,6093533.0,18024.0,,,Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of Hmox1 gene expression at 50 uM after 6 hrs by real-time PCR analysis relative to GAPDH mRNA expression,Other,23294286.0,
1931,732559,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as decreased cell viability at 50 uM after 6 hrs by MTT assay,Other,23294286.0,
1932,732560,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as decreased cell viability at 10 uM after 6 hrs by MTT assay,Other,23294286.0,
1933,735123,4,1,,103167027,5280343,Unspecified,,,530.0,IC50,Inhibition of baker's yeast alpha-glucosidase,Confirmatory,23398496.0,
1934,735304,2,5,,103167027,5280343,Active,266649.0,18126.0,16.4,IC50,Inhibition of iNOS-mediated nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 24 hrs by Griess reaction analysis,Confirmatory,23517145.0,
1935,735837,1,2,,103167027,5280343,Active,,,1.3,IC50,Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs,Confirmatory,23540981.0,
1936,743012,3,1,,144209506,5280343,Inconclusive,,,61.6282,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1937,743012,3,1,,144210605,5280343,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1938,743014,3,1,,144209506,5280343,Active,,,27.5283,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1939,743014,3,1,,144210605,5280343,Active,,,61.1306,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1940,743015,3,1,,144209506,5280343,Active,,,24.5346,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1941,743015,3,1,,144210605,5280343,Active,,,61.1306,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1942,743033,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1943,743033,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1944,743035,2,1,,144209506,5280343,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1945,743035,2,1,,144210605,5280343,Inconclusive,124375976.0,367.0,8.7076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1946,743036,2,1,,144209506,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1947,743036,2,1,,144210605,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1948,743040,3,1,,144209506,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1949,743040,3,1,,144210605,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1950,743041,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1951,743041,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1952,743042,3,1,,144209506,5280343,Inconclusive,124375976.0,367.0,38.8848,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1953,743042,3,1,,144210605,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1954,743053,2,1,,144209506,5280343,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1955,743053,2,1,,144210605,5280343,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1956,743054,2,1,,144209506,5280343,Active,124375976.0,367.0,38.8848,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1957,743054,2,1,,144210605,5280343,Inconclusive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1958,743063,2,1,,144209506,5280343,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1959,743063,2,1,,144210605,5280343,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1960,743064,3,1,,144209506,5280343,Active,,,30.8873,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1961,743064,3,1,,144210605,5280343,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1962,743065,3,1,,144209506,5280343,Active,399498506.0,24831.0,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1963,743065,3,1,,144210605,5280343,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1964,743066,3,1,,144209506,5280343,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1965,743066,3,1,,144210605,5280343,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1966,743067,2,1,,144209506,5280343,Inconclusive,399498506.0,24831.0,54.9262,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1967,743067,2,1,,144210605,5280343,Inconclusive,399498506.0,24831.0,72.6538,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1968,743069,2,1,,144209506,5280343,Inconclusive,348019627.0,2099.0,4.9392,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1969,743069,2,1,,144210605,5280343,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1970,743074,2,1,,144209506,5280343,Inconclusive,,,62.1807,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1971,743074,2,1,,144210605,5280343,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1972,743075,2,1,,144209506,5280343,Active,348019627.0,2099.0,11.0575,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1973,743075,2,1,,144210605,5280343,Active,348019627.0,2099.0,17.3739,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1974,743077,2,1,,144209506,5280343,Active,348019627.0,2099.0,13.3975,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1975,743077,2,1,,144210605,5280343,Active,348019627.0,2099.0,10.9649,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1976,743078,2,1,,144209506,5280343,Inconclusive,348019627.0,2099.0,5.13242,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1977,743078,2,1,,144210605,5280343,Inconclusive,348019627.0,2099.0,19.4938,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1978,743079,3,1,,144209506,5280343,Active,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1979,743079,3,1,,144210605,5280343,Inconclusive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1980,743080,3,1,,144209506,5280343,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1981,743080,3,1,,144210605,5280343,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1982,743081,3,1,,144209506,5280343,Inconclusive,,,61.6282,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1983,743081,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1984,743083,3,1,,144209506,5280343,Inconclusive,119597822.0,1588.0,17.3692,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1985,743083,3,1,,144210605,5280343,Inconclusive,119597822.0,1588.0,34.3762,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1986,743084,3,1,,144209506,5280343,Inconclusive,,,30.8873,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1987,743084,3,1,,144210605,5280343,Inconclusive,,,34.3762,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1988,743085,3,1,,144209506,5280343,Active,51095037.0,196.0,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1989,743085,3,1,,144210605,5280343,Active,51095037.0,196.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1990,743086,3,1,,144209506,5280343,Inconclusive,,,43.6294,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1991,743086,3,1,,144210605,5280343,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1992,743091,2,1,,144209506,5280343,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1993,743091,2,1,,144210605,5280343,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1994,743094,3,1,,144209506,5280343,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1995,743094,3,1,,144210605,5280343,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1996,743122,2,1,,144209506,5280343,Active,51095037.0,196.0,41.9868,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1997,743122,2,1,,144210605,5280343,Active,51095037.0,196.0,35.7211,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1998,743139,2,1,,144209506,5280343,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1999,743139,2,1,,144210605,5280343,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2000,743140,2,1,,144209506,5280343,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2001,743140,2,1,,144210605,5280343,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2002,743191,3,1,,144209506,5280343,Inconclusive,216409692.0,5468.0,55.4186,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2003,743191,3,1,,144210605,5280343,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2004,743194,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2005,743194,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2006,743199,2,1,,144209506,5280343,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2007,743199,2,1,,144210605,5280343,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2008,743202,4,1,,144209506,5280343,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2009,743202,4,1,,144210605,5280343,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2010,743203,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2011,743203,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2012,743205,1,1,,90341524,5280343,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
2013,743205,1,1,,90341524,5280343,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
2014,743206,1,1,,90341524,5280343,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
2015,743206,1,1,,90341524,5280343,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
2016,743207,1,1,,90341524,5280343,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
2017,743207,1,1,,90341524,5280343,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
2018,743209,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2019,743209,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2020,743210,4,1,,144209506,5280343,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2021,743210,4,1,,144210605,5280343,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2022,743211,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2023,743211,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2024,743212,3,1,,144209506,5280343,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2025,743212,3,1,,144210605,5280343,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2026,743213,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2027,743213,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2028,743215,3,1,,144209506,5280343,Inconclusive,216409690.0,5467.0,44.0206,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2029,743215,3,1,,144210605,5280343,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2030,743217,3,1,,144209506,5280343,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2031,743217,3,1,,144210605,5280343,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2032,743218,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2033,743218,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2034,743219,3,1,,144209506,5280343,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2035,743219,3,1,,144210605,5280343,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2036,743220,3,1,,144209506,5280343,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2037,743220,3,1,,144210605,5280343,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2038,743221,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2039,743221,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2040,743222,3,1,,144209506,5280343,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2041,743222,3,1,,144210605,5280343,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2042,743223,3,1,,144209506,5280343,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2043,743223,3,1,,144210605,5280343,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2044,743224,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2045,743224,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2046,743225,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2047,743225,3,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2048,743226,2,1,,144209506,5280343,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2049,743226,2,1,,144210605,5280343,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2050,743227,2,1,,144209506,5280343,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2051,743227,2,1,,144210605,5280343,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2052,743228,3,1,,144209506,5280343,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2053,743228,3,1,,144210605,5280343,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2054,743239,2,1,,144209506,5280343,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2055,743239,2,1,,144210605,5280343,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2056,743240,2,1,,144209506,5280343,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2057,743240,2,1,,144210605,5280343,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2058,743241,2,1,,144209506,5280343,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2059,743241,2,1,,144210605,5280343,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2060,743242,2,1,,144209506,5280343,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2061,743242,2,1,,144210605,5280343,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2062,743244,1,1,,90341524,5280343,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
2063,743244,1,1,,124881274,5280343,Inactive,,,14.818,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
2064,743322,2,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2065,743322,2,1,,124881274,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2066,743323,2,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2067,743323,2,1,,124881274,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2068,743324,2,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2069,743324,2,1,,124881274,5280343,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2070,743344,1,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2071,743345,1,1,,124881272,5280343,Inactive,,,14.9502,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2072,743346,1,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
2073,743347,1,1,,124881272,5280343,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2074,745311,1,1,,103167027,5280343,Active,,,11.0,IC50,Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method,Confirmatory,23567958.0,
2075,749997,1,5,,103167027,5280343,Active,308153572.0,5444.0,,,Activation of recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli assessed as delaying of Cu2+-induced LDL oxidation time after 15 mins by UV ELISA,Other,23623675.0,
2076,749998,1,5,,103167027,5280343,Unspecified,308153572.0,5444.0,,,Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli,Other,23623675.0,
2077,749999,1,5,,103167027,5280343,Unspecified,308153572.0,5444.0,,,Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli after 5 mins by Trp-fluorescence quenching method,Other,23623675.0,
2078,752786,1,1,,103167027,5280343,Active,,,,,Antiobesity activity in mouse 3T3L1 cells assessed as reduction of fat accumulation at 100 uM by oil Red O staining-based ELISA,Other,23642481.0,
2079,752787,1,5,,103167027,5280343,Active,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using para-nitrophenyl butyrate as substrate at 100 uM by ELISA,Other,23642481.0,
2080,754153,1,1,,103167027,5280343,Unspecified,,,110.0,IC50,Antioxidant activity assessed as hydroxyl radical scavenging activity,Confirmatory,23713723.0,
2081,754355,1,1,,103167027,5280343,Active,,,,,Cytotoxicity against human HCT116 cells at 1 to 100 uM after 12 hrs by MTT assay,Other,23434132.0,
2082,754357,1,1,,103167027,5280343,Active,,,,,Cytotoxicity against human MCF7 cells at 1 to 100 uM after 12 hrs by MTT assay,Other,23434132.0,
2083,754413,1,1,,103167027,5280343,Unspecified,,,,,Permeability of the compound after 5 hrs by PAMPA assay,Other,23434132.0,
2084,754415,1,1,,103167027,5280343,Unspecified,,,,,Permeability of the compound after 1 hr by PAMPA assay,Other,23434132.0,
2085,754420,1,1,,103167027,5280343,Unspecified,,,,,Half life of the compound in DMEM cell-free cell culture medium at 50 uM by HPLC analysis,Other,23434132.0,
2086,754421,1,1,,103167027,5280343,Unspecified,,,,,Half life of the compound in PBS buffer at pH 7.4 at 50 uM by HPLC analysis,Other,23434132.0,
2087,755045,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity measured at 10 mins by ESR spectrometric analysis,Other,23673214.0,
2088,755047,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced peroxyl radical formation by ORAC-FL assay relative to trolox,Other,23673214.0,
2089,758732,1,1,,103167027,5280343,Unspecified,,,77.1,IC50,Cytotoxicity against human NALM6 cells after 46 hrs by MTT assay,Confirmatory,23756061.0,
2090,758733,1,1,,103167027,5280343,Unspecified,,,177.5,IC50,Cytotoxicity against human WM115 cells after 46 hrs by MTT assay,Confirmatory,23756061.0,
2091,758734,1,1,,103167027,5280343,Unspecified,,,58.0,IC50,Cytotoxicity against human HL60 cells after 46 hrs by MTT assay,Confirmatory,23756061.0,
2092,759070,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HCT116 cells assessed as cell viability at 30 uM after 48 hrs by MTT assay relative to control,Other,23771043.0,
2093,760688,2,3,,103167027,5280343,Active,113594.0,317748.0,2.85,IC50,Inhibition of bovine lens aldose reductase using DL-glyceraldehyde as substrate assessed as NADPH oxidation measured for 10 mins by spectrophotometric analysis,Confirmatory,23683835.0,
2094,762875,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as peroxyl radical scavenging activity by ORAC assay relative to trolox,Other,23859213.0,
2095,762907,1,2,,103167027,5280343,Inactive,,,,,Induction of intracellular RPS production in Swiss mouse peritoneal macrophages up to 12 uM after 72 hrs by spectrofluorometric analysis,Other,23876028.0,
2096,762908,1,2,,103167027,5280343,Unspecified,,,,,Induction of intracellular RPS production in promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected Swiss mouse peritoneal macrophages at 12 uM after 72 hrs by spectrofluorometric analysis relative to control,Other,23876028.0,
2097,762909,1,2,,103167027,5280343,Unspecified,,,,,Induction of intracellular RPS production in promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected Swiss mouse peritoneal macrophages after 72 hrs by spectrofluorometric analysis,Other,23876028.0,
2098,762910,1,1,,103167027,5280343,Unspecified,,,80.2,IC50,Cytotoxicity against Swiss mouse peritoneal macrophages after 72 hrs by AlamarBlue assay,Confirmatory,23876028.0,
2099,762911,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for Swiss mouse peritoneal macrophages to IC50 for promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016",Other,23876028.0,
2100,762913,1,1,,103167027,5280343,Unspecified,,,,,Antileishmanial activity against promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as parasite growth inhibition at 12 uM after 72 hrs,Other,23876028.0,
2101,762914,1,1,,103167027,5280343,Active,,,3.4,IC50,Antileishmanial activity against promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as reduction of infection index after 72 hrs,Confirmatory,23876028.0,
2102,765674,1,1,,103167027,5280343,Active,,,0.7,IC50,Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay,Confirmatory,23871908.0,
2103,765677,1,1,,103167027,5280343,Active,,,8.0,IC50,Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of H2O2-induced oxidation of amplex red incubated for 5 mins prior to PMA challenge by fluorescence assay,Confirmatory,23871908.0,
2104,765679,1,1,,103167027,5280343,Active,,,11.3,IC50,Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of superoxide anion radical-induced lucigenin oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay,Confirmatory,23871908.0,
2105,765681,1,1,,103167027,5280343,Active,,,26.0,IC50,Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay,Confirmatory,23871908.0,
2106,765682,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human neutrophils assessed as cell viability at 100 uM after 1 hr by trypan blue exclusion assay,Other,23871908.0,
2107,768888,2,3,,103167027,5280343,Active,254763341.0,5328.0,12.1,IC50,Inhibition of urokinase amidolytic activity (unknown origin),Confirmatory,24610996.0,
2108,768889,2,1,,103167027,5280343,Active,136408.0,5644.0,15.4,IC50,Inhibition of trypsin amidolytic activity (unknown origin),Confirmatory,24610996.0,
2109,768889,2,1,,103167027,5280343,Active,136413.0,5645.0,15.4,IC50,Inhibition of trypsin amidolytic activity (unknown origin),Confirmatory,24610996.0,
2110,768889,2,1,,103167027,5280343,Active,209572698.0,5646.0,15.4,IC50,Inhibition of trypsin amidolytic activity (unknown origin),Confirmatory,24610996.0,
2111,768890,2,3,,103167027,5280343,Active,135807.0,2147.0,30.0,IC50,Inhibition of thrombin (unknown origin) assessed as hydrolysis of N-benzoyl-phenylalanylvalyl-arginine-paranitroanilide,Confirmatory,24610996.0,
2112,768892,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Competitive inhibition of human thrombin using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by Lineweaver-Burk plot analysis,Other,24610996.0,
2113,768893,3,2,,103167027,5280343,Unspecified,135807.0,2147.0,,,Inhibition of human thrombin assessed as equilibrium association constant at 50 to 1000 uM by BIAcore analysis,Other,24610996.0,
2114,768894,4,2,,103167027,5280343,Active,135807.0,2147.0,0.0387,Kd,Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis,Confirmatory,24610996.0,
2115,768895,1,5,,103167027,5280343,Unspecified,135807.0,2147.0,,,Inhibition of human thrombin assessed as response unit at 1000 uM by BIAcore analysis,Other,24610996.0,
2116,768901,1,5,,103167027,5280343,Unspecified,135807.0,2147.0,,,Inhibition of human thrombin assessed as decrease in platelet aggregation at 50 uM preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis relative to control,Other,24610996.0,
2117,768903,1,5,,103167027,5280343,Unspecified,135807.0,2147.0,,,Inhibition of human thrombin assessed as decrease in platelet aggregation preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis,Other,24610996.0,
2118,768911,1,5,,103167027,5280343,Inactive,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at IC50 after 30 mins by SDS-PAGE analysis,Other,24610996.0,
2119,768912,1,5,,103167027,5280343,Inactive,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at IC50 after 30 mins by SDS-PAGE analysis,Other,24610996.0,
2120,768913,1,5,,103167027,5280343,Inactive,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen alpha polymer formation at IC50 after 15 mins by SDS-PAGE analysis,Other,24610996.0,
2121,768914,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at IC50 after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2122,768915,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2123,768916,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at 15 uM after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2124,768918,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at 15 uM after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2125,768920,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at 15 uM after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2126,768922,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at 15 uM after 5 mins by SDS-PAGE analysis,Other,24610996.0,
2127,768923,1,5,,103167027,5280343,Inactive,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 15 mins by SDS-PAGE analysis,Other,24610996.0,
2128,768925,1,5,,103167027,5280343,Active,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization at 50 uM preincubated for 10 mins followed by fibrionogen addition measured for 20 mins,Other,24610996.0,
2129,768927,1,5,,103167027,5280343,Unspecified,135807.0,2147.0,,,Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization preincubated for 10 mins followed by fibrionogen addition measured for 20 mins,Other,24610996.0,
2130,768929,2,3,,103167027,5280343,Unspecified,135807.0,2147.0,,IC50,Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis,Confirmatory,24610996.0,
2131,770923,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ferric ion reducing ability after 20 mins by FRAP assay,Other,23973822.0,
2132,770924,3,2,,103167027,5280343,Active,,,8.12,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,23973822.0,
2133,771082,1,1,,103167027,5280343,Active,,,11.2,IC50,Inhibition of Helicobacter pylori urease,Confirmatory,23974021.0,
2134,772993,1,1,,103167027,5280343,Active,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at pH 7.4 by spectrophotometry,Other,23994869.0,
2135,775750,1,1,,103167027,5280343,Active,,,,,Inhibition of supercoiling activity of calf thymus topoisomerase 1 using relaxed pBR322 as substrate after 15 mins by ethidium bromide staining,Other,24060488.0,
2136,779048,1,1,,103167027,5280343,Active,,,2.0,IC50,Inhibition of phospholipase A2 (unknown origin),Confirmatory,24011954.0,
2137,779049,1,1,,103167027,5280343,Active,,,3.8,IC50,Inhibition of PI3 kinase (unknown origin),Confirmatory,24011954.0,
2138,779050,1,1,,103167027,5280343,Active,,,0.55,IC50,Inhibition of CK2 (unknown origin),Confirmatory,24011954.0,
2139,977599,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2140,977602,1,2,,103167027,5280343,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2141,977608,3,1,,310263042,5280343,Active,,,33.5,IC50,Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB,Other,24556570.0,
2142,977610,3,1,,87557642,5280343,Active,217035384.0,,12.7,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,18780820.0,
2143,977610,3,1,,87557642,5280343,Active,217035385.0,,12.7,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,18780820.0,
2144,977610,3,1,,170484825,5280343,Active,374977985.0,,25.1,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,22195561.0,
2145,1053194,1,1,,124881274,5280343,Inactive,,,,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Independent  ATL cell lines,Confirmatory,,
2146,1053195,1,1,,124881274,5280343,Active,,,16.6261,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Dependent  ATL cell lines,Confirmatory,,
2147,1056591,1,1,,103167027,5280343,Unspecified,,,,,"Antimicrobial activity against Aggregatibacter actinomycetemcomitans infected in Balb/c mouse measured per 10'6 colonies at 100 mg/kg, sc measured 14 days post-infection by Gram staining technique (Rvb = 6.41 +/- 0.96 No_unit)",Other,24246038.0,
2148,1056592,1,1,,103167027,5280343,Unspecified,,,,,"Effect on OPG expression in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis",Other,24246038.0,
2149,1056593,1,1,,103167027,5280343,Active,,,,,"Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as downregulation of RANKL expression at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis",Other,24246038.0,
2150,1056594,1,1,,103167027,5280343,Active,,,,,"Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as downregulation of ICAM-1 expression at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis",Other,24246038.0,
2151,1056595,1,1,,103167027,5280343,Active,,,,,"Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of IL-17 production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA",Other,24246038.0,
2152,1056596,1,1,,103167027,5280343,Active,,,,,"Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of TNFalpha production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA",Other,24246038.0,
2153,1056597,1,1,,103167027,5280343,Active,,,,,"Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of alveolar bone loss at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by methylene blue staining-based microscopic analysis",Other,24246038.0,
2154,1056598,1,1,,103167027,5280343,Active,,,,,"Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of IL-1beta production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA",Other,24246038.0,
2155,1063038,2,3,,103167027,5280343,Active,9087218.0,3791.0,0.28,IC50,Inhibition of VEGFR2 (unknown origin),Confirmatory,24328302.0,
2156,1063039,2,3,,103167027,5280343,Active,125711.0,6714.0,0.12,IC50,Inhibition of SRC (unknown origin),Confirmatory,24328302.0,
2157,1063040,2,3,,103167027,5280343,Active,259016304.0,5585.0,5.8,IC50,Inhibition of PRK1 (unknown origin),Confirmatory,24328302.0,
2158,1063041,2,3,,103167027,5280343,Active,83305339.0,5292.0,0.5,IC50,Inhibition of PIM1 (unknown origin),Confirmatory,24328302.0,
2159,1063042,2,3,,103167027,5280343,Active,1709658.0,5347.0,5.75,IC50,Inhibition of PLK1 (unknown origin),Confirmatory,24328302.0,
2160,1063043,2,3,,103167027,5280343,Active,37537993.0,10783.0,4.23,IC50,Inhibition of NEK6 (unknown origin),Confirmatory,24328302.0,
2161,1063044,2,3,,103167027,5280343,Active,251757497.0,4233.0,0.58,IC50,Inhibition of wild type MET (unknown origin),Confirmatory,24328302.0,
2162,1063045,2,3,,103167027,5280343,Active,1709252.0,4751.0,5.73,IC50,Inhibition of NEK2 (unknown origin),Confirmatory,24328302.0,
2163,1063046,2,3,,103167027,5280343,Active,124240.0,3480.0,0.3,IC50,Inhibition of IGF1R (unknown origin),Confirmatory,24328302.0,
2164,1063047,2,3,,103167027,5280343,Unspecified,400274.0,5604.0,10.0,IC50,Inhibition of wild type MEK1 (unknown origin),Confirmatory,24328302.0,
2165,1063048,2,3,,103167027,5280343,Active,3183518.0,5747.0,1.2,IC50,Inhibition of FAK (unknown origin),Confirmatory,24328302.0,
2166,1063049,2,3,,103167027,5280343,Active,317373473.0,9212.0,0.91,IC50,Inhibition of aurora-B (unknown origin),Confirmatory,24328302.0,
2167,1063050,2,3,,103167027,5280343,Active,239938818.0,558.0,0.96,IC50,Inhibition of AXL (unknown origin),Confirmatory,24328302.0,
2168,1063051,2,3,,103167027,5280343,Active,14424095.0,9891.0,5.09,IC50,Inhibition of ARK5 (unknown origin),Confirmatory,24328302.0,
2169,1063052,2,3,,103167027,5280343,Active,60391226.0,207.0,5.39,IC50,Inhibition of AKT1 (unknown origin),Confirmatory,24328302.0,
2170,1063053,2,3,,103167027,5280343,Active,296439447.0,238.0,3.32,IC50,Inhibition of ALK (unknown origin),Confirmatory,24328302.0,
2171,1063712,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against HUVEC assessed as cell viability at 10 uM after 24 to 72 hrs by WST-1 assay relative to untreated control,Other,24361522.0,
2172,1063732,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against HUVEC assessed as cell viability at 10 to 50 uM after 24 to 72 hrs by WST-1 assay relative to untreated control,Other,24361522.0,
2173,1063733,1,2,,103167027,5280343,Unspecified,,,,,Cytotoxicity against HUVEC assessed as cell detachment at 10 to 50 uM after 72 hrs by phase-contrast microscopy,Other,24361522.0,
2174,1063896,2,3,,103167027,5280343,Unspecified,126398.0,547923.0,106.7,Ki,Uncompetitive inhibition of soybean LOX-1 using linoleic acid as substrate preincubated for 5 mins followed by substrate addition by Lineweaver-Burk plot analysis,Confirmatory,24368208.0,
2175,1063897,1,4,,103167027,5280343,Unspecified,126398.0,547923.0,100.4,Km,Activity at soybean LOX-1 using linoleic acid as substrate at 100 uM preincubated for 5 mins followed by substrate addition by Michaelis-Menten plot analysis,Confirmatory,24368208.0,
2176,1063899,1,4,,103167027,5280343,Unspecified,126398.0,547923.0,129.2,Km,Activity at soybean LOX-1 using linoleic acid as substrate at 25 uM preincubated for 5 mins followed by substrate addition by Michaelis-Menten plot analysis,Confirmatory,24368208.0,
2177,1063904,2,3,,103167027,5280343,Active,126407.0,240.0,4.0,IC50,Inhibition of 5-LOX-mediated LTB4 production in human neutrophils using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 8 mins by enzyme immunoassay,Confirmatory,24368208.0,
2178,1065977,1,4,,103167027,5280343,Unspecified,67462103.0,9429.0,,,Inhibition of human ABCG2 ATPase activity expressed in Sf9 insect cell membranes at 2 uM after 30 mins by colorimetric analysis relative to basal control in presence of sodium orthovanadate,Other,24304387.0,
2179,1066694,2,3,,103167027,5280343,Active,74764753.0,,4.0,IC50,Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry,Confirmatory,24521209.0,
2180,1070383,1,1,,103167027,5280343,Unspecified,,,,,Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 4.5 hrs by MTT assay,Other,24245939.0,
2181,1070384,1,1,,103167027,5280343,Active,,,,,Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 9 hrs by MTT assay,Other,24245939.0,
2182,1070388,1,1,,103167027,5280343,Active,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay,Other,24245939.0,
2183,1070391,1,1,,103167027,5280343,Unspecified,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis,Other,24245939.0,
2184,1070455,1,2,,103167027,5280343,Active,,,11.0,IC50,Antioxidant activity in human HepG2 cells assessed as inhibition of ABAP-induced intracellular peroxyl radical scavenging activity by measuring ROS production measured every 5 mins for 1 hr by absorbance assay,Confirmatory,24471493.0,
2185,1070497,1,1,,103167027,5280343,Active,,,4.86,IC50,Antioxidant activity in human neutrophils assessed as inhibition of oxidative burst-induced ROS production by chemiluminescence assay,Confirmatory,24588269.0,
2186,1080598,1,1,,103167027,5280343,Unspecified,,,396500.0,EC50,Phytotoxic activity against Trifolium repens assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2187,1080600,1,1,,103167027,5280343,Unspecified,,,12813.0,EC50,Phytotoxic activity against Sinapis alba assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2188,1080602,1,1,,103167027,5280343,Unspecified,,,183.0,EC50,Phytotoxic activity against Lolium perenne (perennial ryegrass) assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2189,1080603,1,1,,103167027,5280343,Unspecified,,,156000.0,EC50,Phytotoxic activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2190,1080605,1,1,,103167027,5280343,Unspecified,,,364000.0,EC50,Phytotoxic activity against Trifolium repens assessed as inhibition of root growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2191,1080607,1,1,,103167027,5280343,Unspecified,,,7050.0,EC50,Phytotoxic activity against Sinapis alba assessed as inhibition of root growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2192,1080609,1,1,,103167027,5280343,Unspecified,,,273.0,EC50,Phytotoxic activity against Lolium perenne (perennial ryegrass) assessed as inhibition of root growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2193,1080610,1,1,,103167027,5280343,Unspecified,,,171500.0,EC50,Phytotoxic activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root growth at 22 +/-2 degC after 72 hr,Confirmatory,19253962.0,
2194,1082323,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2195,1082324,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2196,1082325,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2197,1082326,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2198,1082327,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2199,1082328,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2200,1082329,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2201,1082330,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2202,1082331,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2203,1082332,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2204,1082333,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
2205,1082334,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2206,1082335,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2207,1082336,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2208,1082337,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2209,1082338,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2210,1082339,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2211,1082340,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2212,1082341,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2213,1082342,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2214,1082343,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2215,1082344,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2216,1082345,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2217,1082346,1,1,,103167027,5280343,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
2218,1082347,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2219,1082348,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2220,1082349,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2221,1082350,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2222,1082351,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2223,1082352,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2224,1082355,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2225,1082356,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
2226,1082357,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2227,1082358,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2228,1082359,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2229,1082360,1,1,,103167027,5280343,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
2230,1082425,1,1,,103167027,5280343,Unspecified,,,,,Stimulation of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL,Other,21905729.0,
2231,1082430,1,1,,103167027,5280343,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL,Other,21905729.0,
2232,1082435,1,1,,103167027,5280343,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 0.1 mg/mL,Other,21905729.0,
2233,1082436,1,1,,103167027,5280343,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 1 mg/mL,Other,21905729.0,
2234,1082437,1,1,,103167027,5280343,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 10 mg/mL,Other,21905729.0,
2235,1083154,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2236,1083155,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2237,1083156,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2238,1083157,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2239,1083158,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2240,1083159,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2241,1083160,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2242,1083161,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2243,1083162,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
2244,1083163,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control,Other,23145924.0,
2245,1083167,1,1,,103167027,5280343,Active,,,,,Induction of Eutypa lata BX1-10 growth at 500 uM,Other,23145924.0,
2246,1083171,1,1,,103167027,5280343,Inactive,,,,,Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days,Other,23145924.0,
2247,1084085,1,2,,103167027,5280343,Active,,,21.46,IC50,Antioxidant activity assessed as DPPH scavenging activity after 30 min by spectrophotometry,Confirmatory,,
2248,1084086,1,2,,103167027,5280343,Inconclusive,,,,IC50,Anti-inflammatory activity in Mus musculus (mouse) RAW264.7 cells assessed as inhibition of IFN-gamma/LPS-induced nitric oxide production after 17 to 20 hr by Griess assay,Confirmatory,,
2249,1084380,1,4,,103167027,5280343,Unspecified,75651200.0,,,,Inhibition of Avian myeloblastosis virus reverse transcriptase,Other,,
2250,1087143,1,4,,103167027,5280343,Unspecified,126716.0,,,,Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry,Other,,
2251,1090647,1,1,,103167027,5280343,Unspecified,,,,,Antifungal activity against Verticillium dahliae assessed as inhibition of mycelial radial growth measured after 350 hr,Other,17394331.0,
2252,1094164,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production at 33 uM after 5 min by spectrophotometric analysis,Other,,
2253,1094850,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in plasma assessed as ABTS radical scavenging activity relative to trolox,Other,,
2254,1094851,1,2,,103167027,5280343,Unspecified,,,,,Plasma concentration in Homo sapiens (human),Other,,
2255,1094852,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Homo sapiens (human) erythrocytes assessed as protection against t-BHP-induced oxidative stress at 0.1 to 100 uM,Other,,
2256,1094853,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Homo sapiens (human) erythrocytes assessed as protection against t-BHP-induced oxidative stress measured up to 180 min,Other,,
2257,1095182,1,2,,103167027,5280343,Inactive,,,,,Antioxidant activity assessed as ferric ion reducing activity measured as trolox equivalents by FRAP assay,Other,,
2258,1095183,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity,Other,,
2259,1095184,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 min,Other,,
2260,1095229,2,3,,103167027,5280343,Active,266423.0,1021.0,25.0,IC50,Inhibition of Homo sapiens (human) cyclin-dependent kinase 6,Confirmatory,,
2261,1097036,1,2,,103167027,5280343,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
2262,1100608,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
2263,1100609,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
2264,1100871,1,1,,103167027,5280343,Inactive,,,,,Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves by Choice Leaf-Disk Bioassay,Other,10820110.0,
2265,1102124,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2266,1102125,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2267,1102126,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2268,1102127,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2269,1102128,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2270,1102129,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2271,1102130,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Bassia scoparia assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2272,1102131,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2273,1102132,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2274,1102133,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2275,1102134,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Arabidopsis thaliana assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2276,1102135,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Arabidopsis thaliana assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2277,1102136,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea diffusa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2278,1102137,1,1,,103167027,5280343,Unspecified,,,,,Phytotoxicity in Arabidopsis thaliana assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2279,1102138,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea diffusa assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2280,1102139,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea diffusa assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2281,1102140,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Bassia scoparia assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2282,1102141,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Bassia scoparia assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2283,1102142,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea maculosa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2284,1102143,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea maculosa assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2285,1102144,1,1,,103167027,5280343,Inactive,,,,,Phytotoxicity in Centaurea maculosa assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
2286,1102356,1,3,,103167027,5280343,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 5 to 100 uM after 30 min by spectrophotometric analysis,Other,12720372.0,
2287,1103942,1,1,,103167027,5280343,Unspecified,,,,,Antifeedant activity against third-instar Xanthogaleruca luteola assessed per cm2 leaf disk after 24 hr by leaf-disk choice test,Other,19342224.0,
2288,1103943,1,1,,103167027,5280343,Unspecified,,,,,Antifeedant activity against third-instar Epilachna paenulata measured assessed per cm2 leaf disk after 24 hr by leaf disk choice test,Other,19342224.0,
2289,1103947,1,1,,103167027,5280343,Inactive,,,,,Antifeedant activity against third-instar Spodoptera litura assessed per cm2 leaf disk,Other,19342224.0,
2290,1107070,1,2,,103167027,5280343,Inconclusive,,,,,Antifungal activity against Rhizopus oryzae MTCC 262 assessed as growth inhibition after 48 hr by broth dilution method,Other,,
2291,1107071,1,2,,103167027,5280343,Inconclusive,,,,,Antifungal activity against Aspergillus niger ATCC 16404 assessed as growth inhibition after 48 hr by broth dilution method,Other,,
2292,1107072,1,2,,103167027,5280343,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 10231 assessed as growth inhibition after 48 hr by broth dilution method,Other,,
2293,1107073,1,2,,103167027,5280343,Inconclusive,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition after 24 hr by broth dilution method,Other,,
2294,1107074,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 24 hr by broth dilution method,Other,,
2295,1107075,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 24 hr by broth dilution method,Other,,
2296,1110806,1,1,,103167027,5280343,Active,,,10.0,IC50,Inhibition of xanthine oxidase assessed as conversion of xanthine to uric acid incubated for 3 min,Confirmatory,15652581.0,
2297,1113388,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity,Other,,
2298,1113389,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of H2O2/Fe2+-induced radical generation,Other,,
2299,1113390,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,,
2300,1113792,2,1,,103167027,5280343,Active,,,12.9,Kd,Binding affinity to Helicobacter pylori Ddl by surface plasmon resonance biosensor technology,Confirmatory,,
2301,1113793,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Escherichia coli 25922 assessed as growth inhibition,Other,,
2302,1113794,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Helicobacter pylori 43504 assessed as growth inhibition,Other,,
2303,1113795,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Escherichia coli JM019 assessed as growth inhibition,Other,,
2304,1113796,1,2,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Helicobacter pylori SS1 assessed as growth inhibition,Other,,
2305,1113797,2,1,,103167027,5280343,Active,,,,IC50,Competitive inhibition of Helicobacter pylori Ddl using ATP as substrate,Confirmatory,,
2306,1113798,2,1,,103167027,5280343,Active,,,19.9,IC50,Competitive inhibition of Escherichia coli DdlB using ATP as substrate,Confirmatory,,
2307,1114438,1,2,,103167027,5280343,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured every 24 hr by BACTEC 460 radiometric assay,Other,,
2308,1115334,1,2,,103167027,5280343,Unspecified,,,100.0,IC50,Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells,Confirmatory,,
2309,1115335,2,3,,103167027,5280343,Active,20455502.0,2932.0,2.0,IC50,Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay,Confirmatory,,
2310,1115336,2,3,,103167027,5280343,Active,296434407.0,23621.0,5.4,IC50,Inhibition of BACE1 (unknown origin),Confirmatory,,
2311,1115337,2,3,,103167027,5280343,Unspecified,116353.0,590.0,420.76,IC50,Inhibition of BuChE (unknown origin),Confirmatory,,
2312,1115338,2,3,,103167027,5280343,Unspecified,113037.0,43.0,353.86,IC50,Inhibition of AChE (unknown origin),Confirmatory,,
2313,1115536,2,1,,103167027,5280343,Active,136408.0,5644.0,13.1,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
2314,1115536,2,1,,103167027,5280343,Active,136413.0,5645.0,13.1,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
2315,1115536,2,1,,103167027,5280343,Active,209572698.0,5646.0,13.1,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
2316,1115537,2,1,,103167027,5280343,Active,136408.0,5644.0,19.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
2317,1115537,2,1,,103167027,5280343,Active,136413.0,5645.0,19.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
2318,1115537,2,1,,103167027,5280343,Active,209572698.0,5646.0,19.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
2319,1115538,1,3,,103167027,5280343,Unspecified,136408.0,5644.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
2320,1115538,1,3,,103167027,5280343,Unspecified,136413.0,5645.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
2321,1115538,1,3,,103167027,5280343,Unspecified,209572698.0,5646.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
2322,1116049,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 20 min,Other,,
2323,1116050,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 10 min,Other,,
2324,1116051,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 20 min,Other,,
2325,1116052,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 20 min,Other,,
2326,1116053,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 10 min,Other,,
2327,1116054,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 10 min,Other,,
2328,1116061,1,3,,103167027,5280343,Unspecified,,,,,Antioxidant activity in Wistar albino Rattus norvegicus (rat) liver microsomes assessed as inhibition of lipid peroxidation after 1 hr by TBARS method,Other,,
2329,1118023,1,3,,103167027,5280343,Active,1352311.0,1803.0,32.73,IC50,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,Confirmatory,,
2330,1120054,3,1,,103167027,5280343,Active,,,3.8,IC50,Inhibition of PI3K (unknown origin),Confirmatory,,
2331,1125769,1,2,,103167027,5280343,Active,,,10.3,EC50,Antioxidant activity assessed as DPPH radical scavenging activity after 2 hrs by absorbance analysis,Confirmatory,24657052.0,
2332,1125770,1,1,,103167027,5280343,Active,,,49.9,EC50,Antioxidant activity assessed as superoxide anion radical scavenging activity by non-enzymatic phenazine methosulfate NADH-system,Confirmatory,24657052.0,
2333,1126471,1,3,,103167027,5280343,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method,Other,24679441.0,
2334,1126472,3,2,,103167027,5280343,Active,67476665.0,2053.0,33.54,IC50,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method,Confirmatory,24679441.0,
2335,1126473,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS,Other,24679441.0,
2336,1126474,1,1,,103167027,5280343,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
2337,1126475,1,1,,103167027,5280343,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
2338,1126476,1,1,,103167027,5280343,Active,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
2339,1126477,1,1,,103167027,5280343,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
2340,1126478,1,1,,103167027,5280343,Unspecified,,,50.0,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis,Confirmatory,24679441.0,
2341,1127134,1,1,,103167027,5280343,Active,,,10.0,IC50,Antiinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced nitric oxide production by Griess assay,Confirmatory,24707938.0,
2342,1127213,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:10 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
2343,1127214,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity to 0.5 mg/ml of DPPC multilamellar vesicles at 100 uM after 2 hrs by centrifugation method,Other,24727463.0,
2344,1127215,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles after 2 hrs by centrifugation method,Other,24727463.0,
2345,1127218,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:20 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
2346,1127219,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:5 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
2347,1127220,1,1,,103167027,5280343,Unspecified,,,,,Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:2 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC),Other,24727463.0,
2348,1127221,1,1,,103167027,5280343,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 323 K by nuclear magnetic resonance analysis,Other,24727463.0,
2349,1127222,1,1,,103167027,5280343,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 303 K by nuclear magnetic resonance analysis,Other,24727463.0,
2350,1127223,1,1,,103167027,5280343,Active,,,,,Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 333 K by nuclear magnetic resonance analysis,Other,24727463.0,
2351,1127224,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,24727463.0,
2352,1127225,1,1,,103167027,5280343,Unspecified,,,,,Antiproliferative activity against human K562 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
2353,1127226,1,1,,103167027,5280343,Unspecified,,,,,Antiproliferative activity against human HepG2 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
2354,1127227,1,1,,103167027,5280343,Unspecified,,,,,Antiproliferative activity against human MCF7 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control,Other,24727463.0,
2355,1128712,1,1,,103167027,5280343,Active,,,20.0,IC50,Antioxidant activity in rat liver microsome membrane assessed as inhibition of lipid peroxidation after 45 mins by TBARS-based spectrophotometric assay,Confirmatory,24568631.0,
2356,1128714,1,2,,103167027,5280343,Unspecified,,,96.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,24568631.0,
2357,1128731,1,3,,103167027,5280343,Inconclusive,399484.0,29580.0,,IC50,Inhibition of squalene synthase in rat liver microsomes assessed as decrease in conversion of [3H]FPP to squalene,Confirmatory,24568631.0,
2358,1128732,1,3,,103167027,5280343,Inconclusive,166897622.0,282022.0,,,Inhibition of bovine COX-1 assessed as PGF2-alpha formation using arachidonic acid as substrate at 20 uM by enzyme immunoassay,Other,24568631.0,
2359,1128733,1,3,,103167027,5280343,Inconclusive,3915797.0,5743.0,,,Inhibition of human recombinant COX-2 assessed as PGF2-alpha formation using arachidonic acid as substrate at 20 uM by enzyme immunoassay,Other,24568631.0,
2360,1128737,1,1,,103167027,5280343,Inconclusive,,,,,"In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in total cholesterol level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 hrs",Other,24568631.0,
2361,1128738,1,1,,103167027,5280343,Inconclusive,,,,,"In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in LDL-cholesterol level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 hrs",Other,24568631.0,
2362,1128739,1,1,,103167027,5280343,Inconclusive,,,,,"In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in triglyceride level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 hrs",Other,24568631.0,
2363,1129462,1,2,,103167027,5280343,Active,,,11.52,EC50,Cytotoxicity against mouse HT22 cells after 24 hrs by MTT assay,Confirmatory,24602904.0,
2364,1129463,3,2,,103167027,5280343,Active,,,3.13,EC50,Neuroprotective activity in mouse HT22 cells assessed as protection against glutamate-induced oxidative damage after 24 hrs by MTT assay,Confirmatory,24602904.0,
2365,1129464,1,1,,103167027,5280343,Unspecified,,,,,Ratio of EC50 for cytotoxicity against mouse HT22 cells to EC50 for neuroprotective activity in glutamate-induced mouse HT22 cells,Other,24602904.0,
2366,1129472,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity,Other,24602904.0,
2367,1130099,1,3,,103167027,5280343,Unspecified,117293.0,1588.0,,,Inhibition of human aromatase using androstenedione as substrate assessed as remaining estrone level at 10 uM after 30 mins by LC-MS/MS analysis relative to control,Other,24630560.0,
2368,1143308,1,2,,103167027,5280343,Active,,,,,Neuroprotection against glutamate challenged mouse HT22 cells assessed as reduction in cell viability at 5 uM after 48 hrs by MTT assay,Other,24819955.0,
2369,1151279,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of BacLight Green labeled Escherichia coli adherence to human UEC after 1 hr by flow cytometry analysis,Other,24749980.0,
2370,1151281,1,1,,103167027,5280343,Active,,,,,Inhibition of BacLight Green labeled Escherichia coli adherence to human UEC at 0.1 ug/ml after 1 hr by flow cytometry analysis,Other,24749980.0,
2371,1151282,1,1,,103167027,5280343,Unspecified,,,,,Bactericidal activity against BacLight Green labeled Escherichia coli up to 30 ug/ml,Other,24749980.0,
2372,1152249,1,3,,103167027,5280343,Unspecified,82312013.0,,20.0,IC50,Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,Confirmatory,24794743.0,
2373,1152250,1,3,,103167027,5280343,Active,82312013.0,,8.0,IC50,Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis,Confirmatory,24794743.0,
2374,1152251,1,1,,103167027,5280343,Unspecified,,,,,Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis,Other,24794743.0,
2375,1152252,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay,Other,24794743.0,
2376,1152253,1,1,,103167027,5280343,Unspecified,,,,,"Therapeutic index, ratio of CC50 for human C8166 cells to EC50 for HIV-1 3B infected in human C8166 cells",Other,24794743.0,
2377,1152254,1,3,,103167027,5280343,Active,82312013.0,,0.6,IC50,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,Confirmatory,24794743.0,
2378,1155651,1,1,,103167027,5280343,Active,,,18.0,IC50,Inhibition of soybean 15-LOX1 by UV spectrophotometric analysis,Confirmatory,24927051.0,
2379,1155653,1,1,,103167027,5280343,Active,,,,,Neuroprotective activity against H2O2-induced rat differentiated PC12 cell death assessed as increase in cell viability at 5 uM after 24 hrs by MTT assay,Other,24927051.0,
2380,1156024,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ measured per gram of protein by FRAP assay,Other,24941128.0,
2381,1156027,1,1,,103167027,5280343,Active,,,,,Neuroprotective activity in rat PC12 cells assessed as inhibition H2O2-induced reduction of cell viability at 5 uM after 24 hrs by MTT assay,Other,24941128.0,
2382,1159509,1,1,,144209506,5280343,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2383,1159509,1,1,,144210605,5280343,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2384,1159510,3,1,,124881274,5280343,Inconclusive,,,23.485,Potency,Immunotoxin (HA22) sensitization/mitigation study. Vehicle arm (PBS),Confirmatory,,
2385,1159511,3,1,,124881274,5280343,Inconclusive,,,0.4686,Potency,Immunotoxin (SS1P) sensitization/mitigation study - treatment arm,Confirmatory,,
2386,1159512,3,1,,124881274,5280343,Inconclusive,,,26.3506,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (low dose),Confirmatory,,
2387,1159513,3,1,,124881274,5280343,Inconclusive,,,33.1734,Potency,Immunotoxin (SS1P) sensitization/mitigation study. Vehicle arm (DMEM),Confirmatory,,
2388,1159515,1,1,,144209506,5280343,Inconclusive,,,55.4186,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2389,1159515,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2390,1159516,1,1,,144209506,5280343,Inconclusive,119611100.0,22926.0,3.1164,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2391,1159516,1,1,,144210605,5280343,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2392,1159517,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2393,1159517,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2394,1159518,1,1,,144209506,5280343,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2395,1159518,1,1,,144210605,5280343,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2396,1159519,1,1,,144209506,5280343,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2397,1159519,1,1,,144210605,5280343,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2398,1159520,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2399,1159520,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2400,1159521,1,1,,144209506,5280343,Active,15928672.0,19885.0,43.6294,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2401,1159521,1,1,,144210605,5280343,Active,15928672.0,19885.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2402,1159523,1,1,,144209506,5280343,Inconclusive,15928672.0,19885.0,48.953,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2403,1159523,1,1,,144210605,5280343,Inconclusive,15928672.0,19885.0,54.4827,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2404,1159524,1,1,,124881262,5280343,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2405,1159524,1,1,,124881266,5280343,Inactive,,,5.6234,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2406,1159524,1,1,,124881267,5280343,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2407,1159525,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2408,1159525,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2409,1159526,1,1,,144209506,5280343,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2410,1159526,1,1,,144210605,5280343,Inconclusive,119627033.0,3725.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2411,1159527,1,1,,144209506,5280343,Inconclusive,325495497.0,6256.0,22.0625,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2412,1159527,1,1,,144210605,5280343,Inconclusive,325495497.0,6256.0,9.77,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2413,1159528,1,1,,144209506,5280343,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2414,1159528,1,1,,144210605,5280343,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2415,1159529,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2416,1159529,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2417,1159530,2,1,,124881274,5280343,Active,,,20.930999999999997,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (High Dose),Confirmatory,,
2418,1159531,1,1,,144209506,5280343,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2419,1159531,1,1,,144210605,5280343,Active,325495497.0,6256.0,16.0903,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2420,1159550,3,1,,252401616,5280343,Active,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
2421,1159551,1,1,,144209506,5280343,Inconclusive,,,27.5283,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2422,1159551,1,1,,144210605,5280343,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2423,1159552,1,1,,144209506,5280343,Inactive,325495463.0,5914.0,17.3692,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2424,1159552,1,1,,144210605,5280343,Inactive,325495463.0,5914.0,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2425,1159553,2,1,,144209506,5280343,Inconclusive,325495463.0,5914.0,48.953,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2426,1159553,2,1,,144210605,5280343,Inconclusive,325495463.0,5914.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2427,1159555,1,1,,144209506,5280343,Inconclusive,325495463.0,5914.0,19.4886,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2428,1159555,1,1,,144210605,5280343,Inconclusive,325495463.0,5914.0,8.63492,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2429,1159580,2,1,,268735743,5280343,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2430,1159580,2,1,,273002966,5280343,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2431,1159607,2,1,,312596550,5280343,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
2432,1161231,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human neutrophils assessed as cell viability at 50 uM after 4 hrs by trypan blue assay,Other,25151578.0,
2433,1161232,1,1,,103167027,5280343,Active,,,2.8,IC50,Inhibition of PMA-induced oxidative burst in human neutrophils by chemiluminescence assay,Confirmatory,25151578.0,
2434,1161233,1,1,,103167027,5280343,Active,,,2.7,IC50,Inhibition of PMA-induced oxidative burst in human neutrophils by amplex red assay,Confirmatory,25151578.0,
2435,1161234,1,1,,103167027,5280343,Active,,,1.8,IC50,Inhibition of PMA-induced oxidative burst in human neutrophils by APF assay,Confirmatory,25151578.0,
2436,1161235,1,1,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human neutrophils assessed as necrotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 0.1%),Other,25151578.0,
2437,1161236,1,1,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human neutrophils assessed as late apoptotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 0.5%),Other,25151578.0,
2438,1161237,1,1,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human neutrophils assessed as early apoptotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 9.7%),Other,25151578.0,
2439,1161238,1,1,,103167027,5280343,Unspecified,,,,,Induction of apoptosis in human neutrophils assessed as viable cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 89.8%),Other,25151578.0,
2440,1161379,1,2,,103167027,5280343,Active,113596.0,231.0,2.9,IC50,"Inhibition of human recombinant aldose reductase using DL-glyceraldehyde, HRAR and beta-NADPH incubated for 10 mins by spectrophotometry",Confirmatory,25152999.0,
2441,1162595,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
2442,1162595,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
2443,1162595,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
2444,1162602,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2445,1162602,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2446,1162602,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2447,1162605,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2448,1162605,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2449,1162605,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2450,1162607,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in COX2 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2451,1162607,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in COX2 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2452,1162607,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in COX2 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2453,1162608,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2454,1162608,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2455,1162608,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control,Other,25190466.0,
2456,1162612,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2457,1162612,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2458,1162612,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2459,1162613,1,2,,103167027,5280343,Active,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2460,1162613,1,2,,103167027,5280343,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2461,1162613,1,2,,103167027,5280343,Active,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
2462,1162624,1,1,,103167027,5280343,Inactive,,,,,Inhibition of cell migration of PMA-stimulated human MDA-MB-231 cells,Other,25190466.0,
2463,1162631,1,1,,103167027,5280343,Active,,,,,Induction apoptosis in PMA-stimulated human MDA-MB-231 cells assessed as mitochondrial disruption 3.125 to 25 uM uM after 48 hrs by JC1 staining based fluorescence assay,Other,25190466.0,
2464,1164705,1,1,,103167027,5280343,Active,,,2.5,ED50,Antioxidant activity assessed as DPPH scavenging activity after 30 mins by spectrophotometry,Confirmatory,25226568.0,
2465,1165539,1,1,,103167027,5280343,Active,,,16.6,IC50,Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of lipopolysaccharide-induced nitric oxide production incubated for 24 hrs by Griess reagent based assay,Confirmatory,25245917.0,
2466,1167300,1,2,,103167027,5280343,Active,,,0.00011,IC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry,Confirmatory,25278230.0,
2467,1168861,1,1,,103167027,5280343,Active,,,23.0,IC50,Inhibition of soybean 15-LOX incubated for 4 mins before linoleic acid substrate addition by spectrophotometry,Confirmatory,25310714.0,
2468,1171178,1,1,,103167027,5280343,Active,,,,,Cytotoxicity against human HCT116 cells at 1.25 to 20 uM after 96 hrs by MTT assay,Other,25397870.0,
2469,1171179,1,1,,103167027,5280343,Active,,,,,Induction of apoptosis in human HCT116 cells assessed as PARP cleavage at 20 uM after 72 hrs by immunoblotting,Other,25397870.0,
2470,1171180,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as delayed hatching at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2471,1171181,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as skeletal deformities at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2472,1171182,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as abnormal heart at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2473,1171183,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as abnormal head at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2474,1171184,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as slow heartbeat at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2475,1171185,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as heart sac edema at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2476,1171186,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as abnormal development of yolk sac at 160 uM after 72 hrs by microscopy,Other,25397870.0,
2477,1171187,1,1,,103167027,5280343,Unspecified,,,,,Teratogenic effect in zebrafish assessed as developmental toxicity at 40 to 80 uM after 72 hrs by microscopy,Other,25397870.0,
2478,1171188,1,1,,103167027,5280343,Active,,,,,Antitumor activity against human HCT116 cells xenografted in 48 hpf zebrafish embryo assessed as inhibition of cancer cell proliferation at 80 uM treated for 4 days,Other,25397870.0,
2479,1171190,1,1,,103167027,5280343,Unspecified,,,,,Drug metabolism assessed as zebrafish intestinal beta-glucosidase-mediated deglycosylation of compound at 80 uM after 2.5 hrs by resorufin-beta-D-glucopyranoside-based fluorescence assay,Other,25397870.0,
2480,1172632,1,2,,103167027,5280343,Active,,,0.31,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins,Confirmatory,25442301.0,
2481,1172639,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
2482,1172640,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
2483,1172641,1,1,,103167027,5280343,Unspecified,,,,IC50,Inhibition of cell proliferation of human U251 cells assessed as cell viability after 72 hrs by sulforhodamine B assay,Confirmatory,25442304.0,
2484,1172642,1,1,,103167027,5280343,Unspecified,,,,IC50,Inhibition of cell proliferation of rat C6 cells assessed as cell viability after 72 hrs by sulforhodamine B assay,Confirmatory,25442304.0,
2485,1172643,1,1,,103167027,5280343,Inconclusive,,,,IC50,Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay,Confirmatory,25442304.0,
2486,1174275,1,1,,103167027,5280343,Unspecified,,,,,Neuroprotective activity against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control,Other,25462245.0,
2487,1175716,1,1,,103167027,5280343,Active,,,,,Aqueous solubility of the compound at 1 mM by UV spectroscopic assay,Other,25488841.0,
2488,1175717,1,1,,103167027,5280343,Active,,,2.9,IC50,Antimalarial activity against chloroquine-resistant/mefloquine-sensitive Plasmodium falciparum W2 by malaria SYBR green 1-based fluorescence (MSF) assay,Confirmatory,25488841.0,
2489,1175718,1,1,,103167027,5280343,Active,,,9.0,IC50,Antimalarial activity against chloroquine-sensitive/mefloquine-resistant Plasmodium falciparum D6 by malaria SYBR green 1-based fluorescence (MSF) assay,Confirmatory,25488841.0,
2490,1175719,1,1,,103167027,5280343,Active,,,13.0,IC50,Antimalarial activity against chloroquine /mefloquine/pyrimethamine-resistant Plasmodium falciparum C235 by malaria SYBR green 1-based fluorescence (MSF) assay,Confirmatory,25488841.0,
2491,1176142,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay,Other,25497988.0,
2492,1176143,1,1,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 10 uM after 24 hrs by Griess assay,Other,25497988.0,
2493,1176146,1,1,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 10 uM by ELISA,Other,25497988.0,
2494,1176148,1,1,,103167027,5280343,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 0.4 to 2 uM by ELISA,Other,25497988.0,
2495,1176149,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of iNOS protein expression in LPS-stimulated mouse RAW264.7 cells by Western blot analysis,Other,25497988.0,
2496,1176150,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of COX2 protein expression in LPS-stimulated mouse RAW264.7 cells by Western blot analysis,Other,25497988.0,
2497,1182100,1,1,,103167027,5280343,Active,,,,,Inhibition of H2O2-induced oxidative stress in human HLF1 cells assessed as increase in cell viability at 2 to 5 uM pretreated for 24 hrs followed by addition of 300 uM H2O2 for 2.5 hrs,Other,24996137.0,
2498,1182104,1,1,,103167027,5280343,Inactive,,,,,Antiaging activity in Caenorhabditis elegans Bristol isolate N2 assessed as lifespan at 10 uM,Other,24996137.0,
2499,1183093,1,1,,103167027,5280343,Active,,,47.0,IC50,Cytotoxicity against human HL60 cells after 72 hrs by MTT assay,Confirmatory,25014747.0,
2500,1185177,1,2,,103167027,5280343,Active,92090623.0,5294.0,13.79,IC50,Inhibition of PI3Kgamma (unknown origin) assessed as decrease in fluorescence intensity using phosphorylated substrate,Confirmatory,25050878.0,
2501,1185433,1,2,,103167027,5280343,Active,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction in glutamate-induced cytotoxicity at 25 uM by MTT assay,Other,25059502.0,
2502,1185460,1,2,,103167027,5280343,Active,109940048.0,280960.0,,Ki,Inhibition of bovine milk xanthine oxidoreductase by spectrophotometry,Confirmatory,25060641.0,
2503,1185463,1,2,,103167027,5280343,Active,2506326.0,7498.0,0.28,Ki,Inhibition of xanthine oxidase (unknown origin) at 37 degC at ph 7..8,Confirmatory,25060641.0,
2504,1186044,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HL60 cells assessed as cell survival at 50 uM after 72 hrs by CCK8 assay,Other,25074815.0,
2505,1186051,1,1,,103167027,5280343,Unspecified,,,,,Retention time of the compound by UPLC analysis,Other,25074815.0,
2506,1186739,1,2,,103167027,5280343,Active,6648082.0,5836.0,4.8,IC50,Inhibition of glycogen phosphorylase a (unknown origin),Confirmatory,25092521.0,
2507,1187092,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against LPS-stimulated mouse RAW264.7 cells assessed as cell viability at 1.5 uM after 24 hrs by MTT assay (Rvb = 100%),Other,25106885.0,
2508,1187093,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against LPS-stimulated mouse RAW264.7 cells assessed as cell viability at 3 uM after 24 hrs by MTT assay (Rvb = 100%),Other,25106885.0,
2509,1187099,1,1,,103167027,5280343,Active,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 1.5 uM after 24 hrs by Griess method based ELISA (Rvb = 52.4 +/- 0.9 uM),Other,25106885.0,
2510,1187100,1,1,,103167027,5280343,Active,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 3 uM after 24 hrs by Griess method based ELISA (Rvb = 52.4 +/- 0.9 uM),Other,25106885.0,
2511,1187101,1,1,,103167027,5280343,Unspecified,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production after 24 hrs by Griess method based ELISA,Other,25106885.0,
2512,1187903,1,1,,103167027,5280343,Active,,,4.3,IC50,Inhibition of LPS-stimulated NO production in human BV2 cells after 24 hrs by Griess assay,Confirmatory,25127164.0,
2513,1187904,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against LPS-stimulated human BV2 cells assessed as cell viability at 40 uM by MTT assay,Other,25127164.0,
2514,1188607,1,1,,103167027,5280343,Active,,,6.2,IC50,Anticancer activity against human A549 cells by HTS assay,Confirmatory,25139569.0,
2515,1188608,1,1,,103167027,5280343,Active,,,6.0,IC50,Anticancer activity against human NCI-H157 cells by HTS assay,Confirmatory,25139569.0,
2516,1188609,1,1,,103167027,5280343,Active,,,9.62,IC50,Anticancer activity against human H460 cells by HTS assay,Confirmatory,25139569.0,
2517,1188610,1,1,,103167027,5280343,Active,,,3.85,IC50,Anticancer activity against human NCI-H1792 cells by HTS assay,Confirmatory,25139569.0,
2518,1188611,1,1,,103167027,5280343,Active,,,10.18,IC50,Anticancer activity against human NCI-H1944 cells by HTS assay,Confirmatory,25139569.0,
2519,1188612,1,1,,103167027,5280343,Active,,,16.87,IC50,Anticancer activity against human H266 cells by HTS assay,Confirmatory,25139569.0,
2520,1188613,1,1,,103167027,5280343,Active,,,5.77,IC50,Anticancer activity against human NCI-H522 cells by HTS assay,Confirmatory,25139569.0,
2521,1188614,1,2,,103167027,5280343,Active,,,7.52,IC50,Anticancer activity against human HOP62 cells by HTS assay,Confirmatory,25139569.0,
2522,1188615,1,1,,103167027,5280343,Active,,,13.6,IC50,Anticancer activity against human H1299 cells by HTS assay,Confirmatory,25139569.0,
2523,1188616,1,1,,103167027,5280343,Unspecified,,,50.0,IC50,Anticancer activity against human 292G cells by HTS assay,Confirmatory,25139569.0,
2524,1188617,1,1,,103167027,5280343,Active,,,23.58,IC50,Anticancer activity against human Calu1 cells by HTS assay,Confirmatory,25139569.0,
2525,1188618,1,1,,103167027,5280343,Active,,,21.71,IC50,Anticancer activity against human M4E cells by HTS assay,Confirmatory,25139569.0,
2526,1188619,1,1,,103167027,5280343,Active,,,4.65,IC50,Anticancer activity against human LOXIMVI cells by HTS assay,Confirmatory,25139569.0,
2527,1188620,1,1,,103167027,5280343,Active,,,12.77,IC50,Anticancer activity against human M14 cells by HTS assay,Confirmatory,25139569.0,
2528,1188621,1,1,,103167027,5280343,Active,,,16.71,IC50,Anticancer activity against human SKBR cells by HTS assay,Confirmatory,25139569.0,
2529,1188622,1,1,,103167027,5280343,Active,,,3.56,IC50,Anticancer activity against human HeLa cells by HTS assay,Confirmatory,25139569.0,
2530,1189228,1,1,,103167027,5280343,Active,,,16.0,Ki,Inhibition of methylglucose uptake in rat adipocytes,Confirmatory,25122135.0,
2531,1191756,1,2,,103167027,5280343,Unspecified,206729922.0,4350.0,,,"Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay",Other,25650313.0,
2532,1191757,1,2,,103167027,5280343,Inactive,206729922.0,4350.0,,IC50,"Inhibition of MPG in human A549 cell extracts at 50 to 300 uM using 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay",Confirmatory,25650313.0,
2533,1191758,1,2,,103167027,5280343,Inactive,206729922.0,4350.0,,IC50,"Inhibition of MPG in human HeLa cell extracts at 50 to 300 uM using 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay",Confirmatory,25650313.0,
2534,1194978,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human SGC7901 cells by MTT assay,Other,25862199.0,
2535,1194979,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human A549 cells by MTT assay,Other,25862199.0,
2536,1194980,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against human HeLa cells by MTT assay,Other,25862199.0,
2537,1194981,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader based assay,Other,25862199.0,
2538,1194982,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins,Other,25862199.0,
2539,1194983,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as FRAP values at 12.5 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method,Other,25862199.0,
2540,1194984,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as FRAP values at 25 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method,Other,25862199.0,
2541,1194985,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as FRAP values at 50 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method,Other,25862199.0,
2542,1194986,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as FRAP values at 100 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method,Other,25862199.0,
2543,1198740,1,1,,103167027,5280343,Active,,,6.6,IC50,Inhibition of Saccharomyces cerevisiae alpha-glucosidase using 4-NPGP substrate assessed as reduction in 4-nitrophenol release pre-incubated for 10 mins before substrate addition by microplate reader based assay,Confirmatory,25728025.0,
2544,1198741,1,1,,103167027,5280343,Active,,,5.3,IC50,Inhibition of Saccharomyces cerevisiae alpha-glucosidase,Confirmatory,25728025.0,
2545,1198742,1,2,,103167027,5280343,Active,,,6.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated for for 5 mins by microplate spectrophotometry,Confirmatory,25728025.0,
2546,1198743,1,2,,103167027,5280343,Active,,,9.1,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,25728025.0,
2547,1202774,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by hydrophilic-ORAC fluorescence assay,Other,25625705.0,
2548,1202775,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by lipophilic-ORAC fluorescence assay,Other,25625705.0,
2549,1202776,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by hydrophilic-TEAC fluorescence assay,Other,25625705.0,
2550,1202777,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by lipophilic-TEAC fluorescence assay,Other,25625705.0,
2551,1202778,1,1,,103167027,5280343,Active,,,6.1,EC50,Antioxidant activity assessed as H2O2 scavenging activity after 15 mins,Confirmatory,25625705.0,
2552,1202779,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity measured for 1 to 6 mins by lipophilic-TEAC fluorescence assay,Other,25625705.0,
2553,1202780,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured every 1.14 mins for 120 mins by lipophilic-ORAC fluorescence assay,Other,25625705.0,
2554,1204216,1,2,,103167027,5280343,Unspecified,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol at 100 uM preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control,Other,25935644.0,
2555,1204217,1,2,,103167027,5280343,Unspecified,6686288.0,100157809.0,70.0,IC50,Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol preincubated for 15 mins followed by substrate addition measured after 15 mins,Confirmatory,25935644.0,
2556,1204902,1,2,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity measured as decoloration of a MeOH solution after 10 mins by spectrophotometry,Other,25611215.0,
2557,1209972,1,2,,103167027,5280343,Active,60416369.0,1557.0,10.5,IC50,Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2558,1209973,1,2,,103167027,5280343,Active,84028191.0,1565.0,18.8,IC50,Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2559,1209974,1,2,,103167027,5280343,Active,116241312.0,1576.0,2.11,IC50,Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2560,1210013,1,2,,103167027,5280343,Unspecified,21264413.0,1573.0,,,Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control,Other,22328583.0,
2561,1210014,1,2,,103167027,5280343,Unspecified,21264413.0,1573.0,,,Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control,Other,22328583.0,
2562,1210015,1,2,,103167027,5280343,Active,117144.0,1544.0,1.55,IC50,Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2563,1210016,1,2,,103167027,5280343,Active,117225.0,1558.0,1.39,IC50,Inhibition of CYP2C8 in human liver microsomes using paclitaxel as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2564,1210017,1,2,,103167027,5280343,Active,6686268.0,1559.0,10.2,IC50,Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate after 8 mins by LC-MS/MS analysis,Confirmatory,22328583.0,
2565,1220236,1,1,,103167027,5280343,Unspecified,,,,,Oral clearance in human,Other,22685216.0,
2566,1220237,1,1,,103167027,5280343,Unspecified,,,,,Unbound fraction during UGT-mediated glucuronidation in human intestinal microsomes,Other,22685216.0,
2567,1220238,1,1,,103167027,5280343,Unspecified,,,,,Intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance,Other,22685216.0,
2568,1220239,1,1,,103167027,5280343,Unspecified,,,,,Unbound intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance,Other,22685216.0,
2569,1220240,1,1,,103167027,5280343,Inconclusive,,,,,Unbound fraction during CYP4500-mediated metabolism in human intestinal microsomes,Other,22685216.0,
2570,1220241,1,1,,103167027,5280343,Unspecified,,,,,Intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance,Other,22685216.0,
2571,1220242,1,1,,103167027,5280343,Unspecified,,,,,Unbound intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance,Other,22685216.0,
2572,1220243,1,2,,103167027,5280343,Unspecified,549152.0,54659.0,,,Activity of human UGT1A3 expressed in insect cells assessed as reduction in compound level after 30 mins,Other,22685216.0,
2573,1220244,1,2,,103167027,5280343,Unspecified,136729.0,54658.0,,,Activity of human UGT1A1 expressed in insect cells assessed as reduction in compound level after 30 mins,Other,22685216.0,
2574,1220252,1,1,,103167027,5280343,Unspecified,,,,,Drug absorption in po dosed human,Other,22685216.0,
2575,1220255,1,1,,103167027,5280343,Unspecified,,,,,Apparent permeability by PAMPA method,Other,22685216.0,
2576,1220256,1,1,,103167027,5280343,Unspecified,,,,,Total clearance in human,Other,22685216.0,
2577,1220257,1,2,,103167027,5280343,Unspecified,,,,,Ratio of drug level in blood to plasma in human,Other,22685216.0,
2578,1220258,1,1,,103167027,5280343,Unspecified,,,,,Renal clearance in human,Other,22685216.0,
2579,1220259,1,1,,103167027,5280343,Unspecified,,,,,Oral absorption in human,Other,22685216.0,
2580,1224748,1,2,,103167027,5280343,Unspecified,20178276.0,5563.0,,,Delta TM value showing the stabilisation of AMPKA2 produced by compound binding,Other,18077363.0,
2581,1224749,1,2,,103167027,5280343,Unspecified,56404610.0,57118.0,,,Delta TM value showing the stabilisation of CAMK1D produced by compound binding,Other,18077363.0,
2582,1224750,1,2,,103167027,5280343,Unspecified,73620970.0,57172.0,,,Delta TM value showing the stabilisation of CAMK1G produced by compound binding,Other,18077363.0,
2583,1224751,1,2,,103167027,5280343,Unspecified,296434552.0,815.0,,,Delta TM value showing the stabilisation of CAMK2A produced by compound binding,Other,18077363.0,
2584,1224752,1,2,,103167027,5280343,Unspecified,334302890.0,816.0,,,Delta TM value showing the stabilisation of CAMK2B produced by compound binding,Other,18077363.0,
2585,1224753,1,2,,103167027,5280343,Unspecified,116242602.0,817.0,,,Delta TM value showing the stabilisation of CAMK2D produced by compound binding,Other,18077363.0,
2586,1224754,1,2,,103167027,5280343,Unspecified,62512173.0,818.0,,,Delta TM value showing the stabilisation of CAMK2G produced by compound binding,Other,18077363.0,
2587,1224755,1,2,,103167027,5280343,Unspecified,2499586.0,814.0,,,Delta TM value showing the stabilisation of CAMK4 produced by compound binding,Other,18077363.0,
2588,1224756,1,2,,103167027,5280343,Unspecified,317373374.0,10645.0,,,Delta TM value showing the stabilisation of CAMKK2 produced by compound binding,Other,18077363.0,
2589,1224757,1,2,,103167027,5280343,Unspecified,116051.0,1017.0,,,Delta TM value showing the stabilisation of CDK2 produced by compound binding,Other,18077363.0,
2590,1224758,1,2,,103167027,5280343,Unspecified,266423.0,1021.0,,,Delta TM value showing the stabilisation of CDK6 produced by compound binding,Other,18077363.0,
2591,1224759,1,2,,103167027,5280343,Unspecified,229463050.0,8814.0,,,Delta TM value showing the stabilisation of CDKL1 produced by compound binding,Other,18077363.0,
2592,1224760,1,2,,103167027,5280343,Unspecified,6685284.0,11200.0,,,Delta TM value showing the stabilisation of CHEK2 produced by compound binding,Other,18077363.0,
2593,1224761,1,2,,103167027,5280343,Unspecified,206729857.0,1195.0,,,Delta TM value showing the stabilisation of CLK1 produced by compound binding,Other,18077363.0,
2594,1224762,1,2,,103167027,5280343,Unspecified,1705919.0,1196.0,,,Delta TM value showing the stabilisation of CLK2 produced by compound binding,Other,18077363.0,
2595,1224763,1,2,,103167027,5280343,Unspecified,148887358.0,1198.0,,,Delta TM value showing the stabilisation of CLK3 produced by compound binding,Other,18077363.0,
2596,1224764,1,2,,103167027,5280343,Unspecified,18202957.0,53944.0,,,Delta TM value showing the stabilisation of CK1G1 produced by compound binding,Other,18077363.0,
2597,1224765,1,2,,103167027,5280343,Unspecified,3024060.0,1455.0,,,Delta TM value showing the stabilisation of CK1G2 produced by compound binding,Other,18077363.0,
2598,1224766,1,2,,103167027,5280343,Unspecified,47117932.0,1456.0,,,Delta TM value showing the stabilisation of CK1G3 produced by compound binding,Other,18077363.0,
2599,1224767,1,2,,103167027,5280343,Unspecified,38604691.0,1613.0,,,Delta TM value showing the stabilisation of DAPK3 produced by compound binding,Other,18077363.0,
2600,1224768,1,2,,103167027,5280343,Unspecified,363548519.0,1760.0,,,Delta TM value showing the stabilisation of DMPK1 produced by compound binding,Other,18077363.0,
2601,1224769,1,2,,103167027,5280343,Unspecified,20455502.0,2932.0,,,Delta TM value showing the stabilisation of GSK3B produced by compound binding,Other,18077363.0,
2602,1224770,1,2,,103167027,5280343,Unspecified,215274013.0,3716.0,,,Delta TM value showing the stabilisation of JAK1~B produced by compound binding,Other,18077363.0,
2603,1224771,1,2,,103167027,5280343,Unspecified,547915.0,5605.0,,,Delta TM value showing the stabilisation of MEK2 produced by compound binding,Other,18077363.0,
2604,1224772,1,2,,103167027,5280343,Unspecified,1709088.0,5608.0,,,Delta TM value showing the stabilisation of MAP2K6 produced by compound binding,Other,18077363.0,
2605,1224773,1,2,,103167027,5280343,Unspecified,6685617.0,4217.0,,,Delta TM value showing the stabilisation of ASK1 produced by compound binding,Other,18077363.0,
2606,1224774,1,2,,103167027,5280343,Unspecified,134047835.0,5600.0,,,Delta TM value showing the stabilisation of p38beta produced by compound binding,Other,18077363.0,
2607,1224775,1,2,,103167027,5280343,Unspecified,232066.0,5595.0,,,Delta TM value showing the stabilisation of ERK1 produced by compound binding,Other,18077363.0,
2608,1224776,1,2,,103167027,5280343,Unspecified,2499596.0,5597.0,,,Delta TM value showing the stabilisation of ERK3 produced by compound binding,Other,18077363.0,
2609,1224777,1,2,,103167027,5280343,Unspecified,73621232.0,51765.0,,,Delta TM value showing the stabilisation of MST4(1) produced by compound binding,Other,18077363.0,
2610,1224778,1,2,,103167027,5280343,Unspecified,1709252.0,4751.0,,,Delta TM value showing the stabilisation of NEK2 produced by compound binding,Other,18077363.0,
2611,1224779,1,2,,103167027,5280343,Unspecified,37537993.0,10783.0,,,Delta TM value showing the stabilisation of NEK6 produced by compound binding,Other,18077363.0,
2612,1224780,1,2,,103167027,5280343,Unspecified,73621340.0,9943.0,,,Delta TM value showing the stabilisation of OSR1 produced by compound binding,Other,18077363.0,
2613,1224781,1,2,,103167027,5280343,Unspecified,12585288.0,10298.0,,,Delta TM value showing the stabilisation of PAK4 produced by compound binding,Other,18077363.0,
2614,1224782,1,2,,103167027,5280343,Unspecified,12585290.0,57144.0,,,Delta TM value showing the stabilisation of PAK5 produced by compound binding,Other,18077363.0,
2615,1224783,1,2,,103167027,5280343,Unspecified,23396789.0,56924.0,,,Delta TM value showing the stabilisation of PAK6 produced by compound binding,Other,18077363.0,
2616,1224784,1,2,,103167027,5280343,Unspecified,266425.0,5127.0,,,Delta TM value showing the stabilisation of PCTK1 produced by compound binding,Other,18077363.0,
2617,1224785,1,2,,103167027,5280343,Unspecified,17380162.0,5170.0,,,Delta TM value showing the stabilisation of PDK1 produced by compound binding,Other,18077363.0,
2618,1224786,1,2,,103167027,5280343,Unspecified,83305339.0,5292.0,,,Delta TM value showing the stabilisation of PIM1 produced by compound binding,Other,18077363.0,
2619,1224787,1,2,,103167027,5280343,Unspecified,20139243.0,11040.0,,,Delta TM value showing the stabilisation of PIM2 produced by compound binding,Other,18077363.0,
2620,1224788,1,2,,103167027,5280343,Unspecified,215274221.0,415116.0,,,Delta TM value showing the stabilisation of PIM3 produced by compound binding,Other,18077363.0,
2621,1224789,1,2,,103167027,5280343,Unspecified,1709658.0,5347.0,,,Delta TM value showing the stabilisation of PLK1 produced by compound binding,Other,18077363.0,
2622,1224790,1,2,,103167027,5280343,Unspecified,160113150.0,10733.0,,,Delta TM value showing the stabilisation of PLK4 produced by compound binding,Other,18077363.0,
2623,1224791,1,2,,103167027,5280343,Unspecified,125205.0,5566.0,,,Delta TM value showing the stabilisation of PRKACA produced by compound binding,Other,18077363.0,
2624,1224792,1,2,,103167027,5280343,Unspecified,143811448.0,55781.0,,,Delta TM value showing the stabilisation of RIOK2 produced by compound binding,Other,18077363.0,
2625,1224793,1,2,,103167027,5280343,Unspecified,1730070.0,6197.0,,,Delta TM value showing the stabilisation of RSK2a produced by compound binding,Other,18077363.0,
2626,1224794,1,2,,103167027,5280343,Unspecified,1730070.0,6197.0,,,Delta TM value showing the stabilisation of RSK2b produced by compound binding,Other,18077363.0,
2627,1224795,1,2,,103167027,5280343,Unspecified,74762732.0,9748.0,,,Delta TM value showing the stabilisation of SLK produced by compound binding,Other,18077363.0,
2628,1224796,1,2,,103167027,5280343,Unspecified,12643358.0,6793.0,,,Delta TM value showing the stabilisation of LOK produced by compound binding,Other,18077363.0,
2629,1224797,1,2,,103167027,5280343,Unspecified,46577677.0,8576.0,,,Delta TM value showing the stabilisation of MPSK1 produced by compound binding,Other,18077363.0,
2630,1224798,1,2,,103167027,5280343,Unspecified,317373279.0,9263.0,,,Delta TM value showing the stabilisation of DRAK1 produced by compound binding,Other,18077363.0,
2631,1224799,1,2,,103167027,5280343,Unspecified,56749457.0,11329.0,,,Delta TM value showing the stabilisation of NDR1 produced by compound binding,Other,18077363.0,
2632,1224800,1,2,,103167027,5280343,Unspecified,73621232.0,51765.0,,,Delta TM value showing the stabilisation of MST4 (2) produced by compound binding,Other,18077363.0,
2633,1224801,1,2,,103167027,5280343,Unspecified,13124559.0,6789.0,,,Delta TM value showing the stabilisation of MST1 produced by compound binding,Other,18077363.0,
2634,1224802,1,2,,103167027,5280343,Unspecified,29840818.0,23043.0,,,Delta TM value showing the stabilisation of TNIK produced by compound binding,Other,18077363.0,
2635,1224803,1,2,,103167027,5280343,Unspecified,83305809.0,55872.0,,,Delta TM value showing the stabilisation of PBK produced by compound binding,Other,18077363.0,
2636,1224804,1,2,,103167027,5280343,Unspecified,45593726.0,7443.0,,,Delta TM value showing the stabilisation of VRK1 produced by compound binding,Other,18077363.0,
2637,1224805,1,2,,103167027,5280343,Unspecified,90116515.0,7444.0,,,Delta TM value showing the stabilisation of VRK2 produced by compound binding,Other,18077363.0,
2638,1224806,1,2,,103167027,5280343,Unspecified,45593724.0,51231.0,,,Delta TM value showing the stabilisation of VRK3 produced by compound binding,Other,18077363.0,
2639,1224807,1,2,,103167027,5280343,Unspecified,12643529.0,10494.0,,,Delta TM value showing the stabilisation of YSK1 produced by compound binding,Other,18077363.0,
2640,1224818,1,1,,312345122,5280343,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
2641,1224819,1,1,,312345122,5280343,Inconclusive,325495545.0,2101.0,16.7855,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2642,1224820,1,1,,312345122,5280343,Inactive,325495545.0,2101.0,18.8336,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2643,1224821,1,1,,312345122,5280343,Inactive,325495545.0,2101.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2644,1224822,1,1,,312345122,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
2645,1224823,1,1,,312345122,5280343,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2646,1224824,1,1,,124881272,5280343,Inactive,,,0.3722,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
2647,1224825,1,1,,124881272,5280343,Inactive,,,16.6261,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
2648,1224834,3,1,,144209506,5280343,Active,,,43.6294,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2649,1224834,3,1,,144210605,5280343,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2650,1224835,1,1,,144209506,5280343,Active,160794.0,,35.8937,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2651,1224835,1,1,,144210605,5280343,Active,160794.0,,35.5742,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2652,1224836,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2653,1224836,1,1,,144210605,5280343,Inconclusive,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2654,1224837,1,1,,144209506,5280343,Inconclusive,,,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2655,1224837,1,1,,144210605,5280343,Inconclusive,,,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2656,1224838,1,1,,144209506,5280343,Inactive,66775687.0,9970.0,69.148,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2657,1224838,1,1,,144210605,5280343,Inactive,66775687.0,9970.0,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2658,1224839,1,1,,144209506,5280343,Inconclusive,66775687.0,9970.0,61.6282,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2659,1224839,1,1,,144210605,5280343,Inconclusive,66775687.0,9970.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2660,1224840,3,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2661,1224840,3,1,,144210605,5280343,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2662,1224841,3,1,,144209506,5280343,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2663,1224841,3,1,,144210605,5280343,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2664,1224842,3,1,,144209506,5280343,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2665,1224842,3,1,,144210605,5280343,Inconclusive,325495545.0,2101.0,6.1131,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2666,1224843,1,1,,144209506,5280343,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2667,1224843,1,1,,144210605,5280343,Inconclusive,119601739.0,7253.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2668,1224844,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2669,1224844,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2670,1224845,1,1,,144209506,5280343,Inconclusive,344243002.0,100757539.0,45.3719,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2671,1224845,1,1,,144210605,5280343,Inconclusive,344243002.0,100757539.0,44.9878,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2672,1224846,1,1,,144209506,5280343,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2673,1224846,1,1,,144210605,5280343,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2674,1224847,1,1,,144209506,5280343,Inconclusive,,,25.5145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2675,1224847,1,1,,144210605,5280343,Inconclusive,,,40.0954,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2676,1224848,3,1,,144209506,5280343,Active,325495545.0,2101.0,69.148,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2677,1224848,3,1,,144210605,5280343,Active,325495545.0,2101.0,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2678,1224849,3,1,,144209506,5280343,Inactive,325495545.0,2101.0,69.148,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2679,1224849,3,1,,144210605,5280343,Inactive,325495545.0,2101.0,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2680,1224857,2,1,,124881272,5280343,Inactive,,,3.7221,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2681,1224857,2,1,,312345122,5280343,Inconclusive,,,35.4813,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2682,1224859,2,1,,90341524,5280343,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2683,1224859,2,1,,124881272,5280343,Inactive,,,0.7427,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2684,1224867,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2685,1224867,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2686,1224868,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2687,1224868,1,1,,144210605,5280343,Inconclusive,,,34.6654,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2688,1224869,1,1,,144209506,5280343,Inconclusive,,,49.3919,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2689,1224869,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2690,1224870,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2691,1224870,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2692,1224871,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2693,1224871,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2694,1224872,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2695,1224872,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2696,1224873,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2697,1224873,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2698,1224874,1,1,,144209506,5280343,Inconclusive,,,49.3919,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2699,1224874,1,1,,144210605,5280343,Inconclusive,,,34.6654,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2700,1224875,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2701,1224875,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2702,1224876,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2703,1224876,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2704,1224877,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2705,1224877,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2706,1224878,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2707,1224878,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2708,1224879,1,1,,144209506,5280343,Inconclusive,,,8.7833,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2709,1224879,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2710,1224880,1,1,,144209506,5280343,Inconclusive,,,49.3919,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2711,1224880,1,1,,144210605,5280343,Inconclusive,,,34.6654,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2712,1224881,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2713,1224881,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2714,1224882,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2715,1224882,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2716,1224883,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2717,1224883,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2718,1224884,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2719,1224884,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2720,1224885,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2721,1224885,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2722,1224886,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2723,1224886,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2724,1224887,1,1,,144209506,5280343,Inconclusive,,,34.9668,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2725,1224887,1,1,,144210605,5280343,Inconclusive,,,54.941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2726,1224888,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2727,1224888,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2728,1224889,1,1,,144209506,5280343,Inconclusive,,,49.3919,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2729,1224889,1,1,,144210605,5280343,Inconclusive,,,38.8952,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2730,1224890,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2731,1224890,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2732,1224892,1,1,,144209506,5280343,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2733,1224892,1,1,,144210605,5280343,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2734,1224893,1,1,,144209506,5280343,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2735,1224893,1,1,,144210605,5280343,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2736,1224894,1,1,,144209506,5280343,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2737,1224894,1,1,,144210605,5280343,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2738,1224895,1,1,,144209506,5280343,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2739,1224895,1,1,,144210605,5280343,Inconclusive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2740,1224896,1,1,,144209506,5280343,Active,344243002.0,100757539.0,43.6637,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2741,1224896,1,1,,144210605,5280343,Inconclusive,344243002.0,100757539.0,48.5767,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2742,1224905,2,1,,121361903,5280343,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2743,1224905,2,1,,121361903,5280343,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2744,1226439,1,1,,103167027,5280343,Active,,,28.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 1 hr,Confirmatory,25906385.0,
2745,1226440,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1 mM after 1 hr,Other,25906385.0,
2746,1226442,1,1,,103167027,5280343,Active,,,25.13,IC50,Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2747,1226443,1,1,,103167027,5280343,Active,,,16.35,IC50,Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2748,1226444,1,1,,103167027,5280343,Active,,,24.12,IC50,Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2749,1226445,1,1,,103167027,5280343,Active,,,20.9,IC50,Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2750,1226446,1,1,,103167027,5280343,Active,,,22.15,IC50,Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2751,1226447,1,1,,103167027,5280343,Active,,,23.04,IC50,Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2752,1226448,1,1,,103167027,5280343,Active,,,34.37,IC50,Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2753,1226449,1,1,,103167027,5280343,Active,,,21.18,IC50,Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2754,1226450,1,1,,103167027,5280343,Active,,,37.62,IC50,Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2755,1226451,1,1,,103167027,5280343,Unspecified,,,,,"Resistance factor, ratio of IC50 for human MCF7/ADR cells to IC50 for human MCF7 cells",Other,25906385.0,
2756,1226452,1,1,,103167027,5280343,Unspecified,,,,,"Resistance factor, ratio of IC50 for cisplatin-resistant human A431 cells to IC50 for human A431 cells",Other,25906385.0,
2757,1226453,1,1,,103167027,5280343,Unspecified,,,,,"Resistance factor, ratio of IC50 for cisplatin-resistant human C13 cells to IC50 for human 2008 cells",Other,25906385.0,
2758,1226454,1,1,,103167027,5280343,Unspecified,,,54.65,IC50,Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay,Confirmatory,25906385.0,
2759,1226455,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human A375 cells",Other,25906385.0,
2760,1226456,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human HCT15 cells",Other,25906385.0,
2761,1226457,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human BxPC3 cells",Other,25906385.0,
2762,1226458,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human MCF7 cells",Other,25906385.0,
2763,1226459,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human MCF7/ADR cells",Other,25906385.0,
2764,1226460,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human A431 cells",Other,25906385.0,
2765,1226461,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for cisplatin-resistant human A431 cells",Other,25906385.0,
2766,1226462,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human 2008 cells",Other,25906385.0,
2767,1226463,1,1,,103167027,5280343,Unspecified,,,,,"Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human C13 cells",Other,25906385.0,
2768,1228058,1,1,,103167027,5280343,Unspecified,,,,,Induction of intracellular ROS generation in Leishmania amazonensis MHOM/BR/75/LTB0016 promastigotes at 96 uM incubated for 48 hrs by H2DCFDA dye based assay,Other,25768915.0,
2769,1230141,1,1,,103167027,5280343,Active,296434407.0,23621.0,6.5,IC50,Inhibition of human recombinant BACE1 by fluorescence resonance energy transfer (FRET) assay,Confirmatory,26003344.0,
2770,1233221,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs by microplate reader analysis relative to control,Other,25987378.0,
2771,1233222,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs by microplate reader analysis relative to control,Other,25987378.0,
2772,1233223,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs by microplate reader analysis relative to control,Other,25987378.0,
2773,1233224,1,1,,103167027,5280343,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs by microplate reader analysis relative to control,Other,25987378.0,
2774,1233226,1,1,,103167027,5280343,Active,,,15.0,IC50,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs by microplate reader analysis,Confirmatory,25987378.0,
2775,1233227,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 1 uM after 70 hrs by WST-8 assay relative to control,Other,25987378.0,
2776,1233228,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 3 uM after 70 hrs by WST-8 assay relative to control,Other,25987378.0,
2777,1233229,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 10 uM after 70 hrs by WST-8 assay relative to control,Other,25987378.0,
2778,1233230,1,1,,103167027,5280343,Unspecified,,,,,Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 30 uM after 70 hrs by WST-8 assay relative to control,Other,25987378.0,
2779,1233232,1,1,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 10 uM after 5 mins by microplate reader analysis relative to control,Other,25987378.0,
2780,1233233,1,1,,103167027,5280343,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 100 uM after 5 mins by microplate reader analysis relative to control,Other,25987378.0,
2781,1233235,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2782,1233236,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2783,1233237,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2784,1233238,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2785,1233239,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2786,1233240,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2787,1233241,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2788,1233242,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2789,1233243,1,1,,103167027,5280343,Unspecified,,,,,Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis,Other,25987378.0,
2790,1233244,1,1,,103167027,5280343,Unspecified,130316.0,5340.0,,,Inhibition of plasmin (unknown origin) at 100 uM after 18 hrs by arianor mahogany dye-based fibrin plate assay relative to control,Other,25987378.0,
2791,1234240,1,1,,103167027,5280343,Active,,,1.8,IC50,Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production incubated for 24 hrs by Griess reagent based assay,Confirmatory,26143931.0,
2792,1234555,1,1,,103167027,5280343,Active,,,0.2,IC50,Antioxidant activity in soybean large unilamellar vesicles assessed as inhibition of AAPH-induced lipid peroxidation compound added prior to AAPH induction measured after 90 mins by UV-visible absorption spectrometric analysis,Confirmatory,26068016.0,
2793,1235034,1,1,,103167027,5280343,Active,,,10.9,EC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,26116179.0,
2794,1238320,1,1,,103167027,5280343,Unspecified,2506326.0,7498.0,,,Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate at 33 to 100 umol/L after 10 mins by HPLC method relative to control,Other,26096677.0,
2795,1239520,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 by disk diffusion assay,Other,26267658.0,
2796,1239521,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 by disk diffusion assay,Other,26267658.0,
2797,1239522,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 by disk diffusion assay,Other,26267658.0,
2798,1239523,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 by disk diffusion assay,Other,26267658.0,
2799,1239524,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 by disk diffusion assay,Other,26267658.0,
2800,1239525,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 by disk diffusion assay,Other,26267658.0,
2801,1239526,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 by disk diffusion assay,Other,26267658.0,
2802,1239527,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 by disk diffusion assay,Other,26267658.0,
2803,1239528,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 by disk diffusion assay,Other,26267658.0,
2804,1239529,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 after 24 hrs by checkerboard assay,Other,26267658.0,
2805,1239530,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 24 hrs by checkerboard assay,Other,26267658.0,
2806,1239531,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 24 hrs by checkerboard assay,Other,26267658.0,
2807,1239532,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 after 24 hrs by checkerboard assay,Other,26267658.0,
2808,1239533,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 after 24 hrs by checkerboard assay,Other,26267658.0,
2809,1239534,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 after 24 hrs by checkerboard assay,Other,26267658.0,
2810,1239535,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 after 24 hrs by checkerboard assay,Other,26267658.0,
2811,1239536,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 after 24 hrs by checkerboard assay,Other,26267658.0,
2812,1239537,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 after 24 hrs by checkerboard assay,Other,26267658.0,
2813,1239538,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 after 24 hrs by checkerboard assay,Other,26267658.0,
2814,1239539,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 after 24 hrs by checkerboard assay,Other,26267658.0,
2815,1239540,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by checkerboard assay,Other,26267658.0,
2816,1239565,1,1,,103167027,5280343,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as log reduction of bacterial growth after 9 hrs,Other,26267658.0,
2817,1239568,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 1.69 mM after 5 hrs by time kill assay,Other,26267658.0,
2818,1239569,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 1.69 mM after 5 hrs by time kill assay,Other,26267658.0,
2819,1239574,1,1,,103167027,5280343,Active,,,,,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 1.69 mM after 4 hrs by time kill assay,Other,26267658.0,
2820,1239575,1,1,,103167027,5280343,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 1.69 mM after 4 hrs by time kill assay,Other,26267658.0,
2821,1239576,1,1,,103167027,5280343,Inactive,,,,,Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 at 1.69 mM after 4 hrs by time kill assay,Other,26267658.0,
2822,1239713,1,1,,103167027,5280343,Unspecified,,,,,Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition,Other,26096681.0,
2823,1242158,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,50.0,IC50,Inhibition of HSF1 (unknown origin),Confirmatory,26164188.0,
2824,1242164,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human ASB145 cells assessed as potentiation of 17-DMAG-induced reduction in cell proliferation at 20 uM relative to 17-DMAG alone,Other,26164188.0,
2825,1242165,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human ASB244 cells assessed as potentiation of 17-DMAG-induced reduction in cell proliferation at 20 uM relative to 17-DMAG alone,Other,26164188.0,
2826,1242166,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human HNE1 cells assessed as potentiation of 17-DMAG and heat-induced increase in apoptosis at 100 uM relative to 17-DMAG and heat alone,Other,26164188.0,
2827,1242167,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human HeLa cells assessed as potentiation of 17-DMAG-induced increase in cell death at 30 uM relative to 17-DMAG alone,Other,26164188.0,
2828,1242168,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human HeLa cells assessed as potentiation of 17-DMAG and heat-induced increase in cell death at 30 uM relative to 17-DMAG and heat alone,Other,26164188.0,
2829,1242169,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human ASB145 cells assessed as potentiation of geldanamycin-induced reduction in cell proliferation at 25 uM relative to geldanamycin alone,Other,26164188.0,
2830,1242170,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human ASB244 cells assessed as potentiation of geldanamycin-induced reduction in cell proliferation at 25 uM relative to geldanamycin alone,Other,26164188.0,
2831,1242171,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human ASB244 cells assessed as potentiation of geldanamycin-induced reduction in cell migration at 20 uM relative to geldanamycin alone,Other,26164188.0,
2832,1242172,1,1,,103167027,5280343,Unspecified,462333.0,3297.0,,,Inhibition of HSF1 in human HeLa cells assessed as potentiation of radicicol and heat-induced increase in cell death at 30 uM relative to radicicol and heat alone,Other,26164188.0,
2833,1243355,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Other,26248805.0,
2834,1243356,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins,Other,26248805.0,
2835,1246444,1,1,,103167027,5280343,Active,,,1.18,IC50,Antioxidant activity assessed as ABTS cation radical scavenging activity measured after 6 mins,Confirmatory,26244990.0,
2836,1246445,1,1,,103167027,5280343,Active,,,,,Antioxidant activity assessed as cupric reducing antioxidant capacity measured after 1 hr,Other,26244990.0,
2837,1247840,1,1,,103167027,5280343,Active,317373595.0,1612.0,8.9,IC50,Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay,Confirmatory,26322379.0,
2838,1247842,1,1,,103167027,5280343,Active,,,1.0,IC50,Inhibition of recombinant human CK2 expressed in Escherichia coli using RRRADDSDDDDD as substrate after 10 mins,Confirmatory,26322379.0,
2839,1248048,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 200 ug/ml after 3 hrs by TBA-MDA test,Other,26344590.0,
2840,1248049,1,1,,103167027,5280343,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation after 3 hrs by TBA-MDA test,Other,26344590.0,
2841,1248069,1,1,,103167027,5280343,Active,,,10.98,IC50,Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate after 30 mins by spectrophotometric analysis,Confirmatory,26351039.0,
2842,1250230,1,1,,103167027,5280343,Active,117293.0,1588.0,12.0,IC50,Inhibition of aromatase (unknown origin),Confirmatory,26301554.0,
2843,1250694,1,1,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay,Confirmatory,26341135.0,
2844,1250695,1,1,,103167027,5280343,Unspecified,,,100.0,IC50,Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay,Confirmatory,26341135.0,
2845,1250696,1,1,,103167027,5280343,Active,,,45.5,IC50,Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay,Confirmatory,26341135.0,
2846,1254801,1,1,,103167027,5280343,Active,,,17.4,IC50,Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated nitric oxide production after 24 hrs by Griess assay,Confirmatory,26327273.0,
2847,1259241,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2848,1259241,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2849,1259242,1,1,,144209506,5280343,Inconclusive,,,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2850,1259242,1,1,,144210605,5280343,Inconclusive,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2851,1259243,1,1,,144209506,5280343,Active,124375976.0,367.0,13.7968,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2852,1259243,1,1,,144210605,5280343,Active,124375976.0,367.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2853,1259244,1,1,,144209506,5280343,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2854,1259244,1,1,,144210605,5280343,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2855,1259247,1,1,,144209506,5280343,Active,124375976.0,367.0,18.0487,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2856,1259247,1,1,,144210605,5280343,Active,124375976.0,367.0,19.3312,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2857,1259248,1,1,,144209506,5280343,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2858,1259248,1,1,,144210605,5280343,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2859,1259252,1,1,,124881272,5280343,Active,169655958.0,,10.4904,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
2860,1259253,1,1,,124881272,5280343,Active,169655958.0,,18.6548,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
2861,1259255,1,1,,124881272,5280343,Active,169655958.0,,13.2066,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
2862,1259256,1,1,,124881272,5280343,Active,169655958.0,,20.930999999999997,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
2863,1259310,1,1,,321942813,5280343,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2864,1259310,1,1,,332950235,5280343,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2865,1259310,1,1,,332950457,5280343,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2866,1259310,1,1,,332950659,5280343,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2867,1259325,1,2,,336954424,5280343,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
2868,1259354,1,1,,348456807,5280343,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
2869,1259357,1,1,,124881274,5280343,Inconclusive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A2780, Spheroid)",Confirmatory,,
2870,1259358,1,1,,124881274,5280343,Inconclusive,,,29.5659,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Adherent)",Confirmatory,,
2871,1259359,1,1,,124881274,5280343,Inconclusive,,,0.5258,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Spheroid)",Confirmatory,,
2872,1259360,1,1,,124881274,5280343,Inconclusive,,,23.485,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Spheroid)",Confirmatory,,
2873,1259361,1,1,,124881274,5280343,Active,,,,Activity at 9.921 uM,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A278, Adherent)",Confirmatory,,
2874,1259362,1,1,,124881274,5280343,Inconclusive,,,14.818,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Adherent)",Confirmatory,,
2875,1259364,1,1,,144209506,5280343,Active,1013403374.0,9734.0,24.5346,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2876,1259364,1,1,,144210605,5280343,Active,1013403374.0,9734.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2877,1259365,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2878,1259365,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2879,1259366,1,1,,144209506,5280343,Active,,,30.8873,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2880,1259366,1,1,,144210605,5280343,Inconclusive,,,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2881,1259367,1,1,,144209506,5280343,Inconclusive,,,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2882,1259367,1,1,,144210605,5280343,Inconclusive,,,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2883,1259368,1,1,,144209506,5280343,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2884,1259368,1,1,,144210605,5280343,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2885,1259369,1,1,,144209506,5280343,Inconclusive,109731339.0,2737.0,30.8873,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2886,1259369,1,1,,144210605,5280343,Inconclusive,109731339.0,2737.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2887,1259370,2,2,,124637873,5280343,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2888,1259370,2,2,,124637873,5280343,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2889,1259370,2,2,,124637873,5280343,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2890,1259377,1,1,,144209506,5280343,Inconclusive,54288833.0,2100.0,27.5283,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2891,1259377,1,1,,144210605,5280343,Inconclusive,54288833.0,2100.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2892,1259378,1,1,,144209506,5280343,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2893,1259378,1,1,,144210605,5280343,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2894,1259379,1,1,,144209506,5280343,Inconclusive,,,54.9262,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2895,1259379,1,1,,144210605,5280343,Inconclusive,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2896,1259380,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2897,1259380,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2898,1259381,1,1,,144209506,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2899,1259381,1,1,,144210605,5280343,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2900,1259382,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2901,1259382,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2902,1259383,1,1,,144209506,5280343,Inconclusive,348019627.0,2099.0,19.4886,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2903,1259383,1,1,,144210605,5280343,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2904,1259384,1,1,,144209506,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2905,1259384,1,1,,144210605,5280343,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2906,1259385,1,1,,144209506,5280343,Inconclusive,119601739.0,7253.0,69.148,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2907,1259385,1,1,,144210605,5280343,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2908,1259386,1,1,,144209506,5280343,Inconclusive,,,48.953,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2909,1259386,1,1,,144210605,5280343,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2910,1259387,1,1,,144209506,5280343,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2911,1259387,1,1,,144210605,5280343,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2912,1259388,1,1,,144209506,5280343,Active,1013403374.0,9734.0,24.5346,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2913,1259388,1,1,,144210605,5280343,Active,1013403374.0,9734.0,21.6899,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2914,1259389,1,1,,124637873,5280343,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
2915,1259390,1,1,,144209506,5280343,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2916,1259390,1,1,,144210605,5280343,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2917,1259391,1,1,,144209506,5280343,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2918,1259391,1,1,,144210605,5280343,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2919,1259392,1,1,,144209506,5280343,Inconclusive,109731339.0,2737.0,13.7968,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2920,1259392,1,1,,144210605,5280343,Inconclusive,109731339.0,2737.0,2.43365,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2921,1259393,1,1,,144209506,5280343,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2922,1259393,1,1,,144210605,5280343,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2923,1259394,1,1,,144209506,5280343,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2924,1259394,1,1,,144210605,5280343,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2925,1259395,1,1,,144209506,5280343,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2926,1259395,1,1,,144210605,5280343,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2927,1259396,1,1,,144209506,5280343,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2928,1259396,1,1,,144210605,5280343,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2929,1259401,1,1,,144209506,5280343,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2930,1259401,1,1,,144210605,5280343,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2931,1259402,1,1,,144209506,5280343,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2932,1259402,1,1,,144210605,5280343,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2933,1259403,1,1,,144209506,5280343,Inconclusive,325495545.0,2101.0,58.1808,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2934,1259403,1,1,,144210605,5280343,Active,325495545.0,2101.0,24.3365,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2935,1259404,1,1,,144209506,5280343,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2936,1259404,1,1,,144210605,5280343,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2937,1259407,1,1,,363899589,5280343,Inactive,,,,,CCRIS mutagenicity studies,Other,,
2938,1259408,1,1,,363895347,5280343,Active,,,,,GENE-TOX mutagenicity studies,Other,,
2939,1259409,1,1,,363899589,5280343,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
2940,1259410,1,1,,363899589,5280343,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
2941,1259411,1,1,,363899589,5280343,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
2942,1259416,1,2,,340082260,5280343,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2943,1259416,1,2,,375177851,5280343,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2944,1259418,1,1,,340082260,5280343,Active,56786138.0,3458.0,17.6,AC50_uM,Toxoplasma gondii at dose in the presence of IFN-y,Confirmatory,,
2945,1259420,1,1,,340082260,5280343,Active,56786138.0,3458.0,15.78,AC50_uM,Toxoplasma gondii at dose in the absence of IFN-y,Confirmatory,,
2946,1259421,1,1,,340082260,5280343,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2947,1259421,1,1,,375177851,5280343,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2948,1259423,1,2,,354752394,5280343,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2949,1259423,1,2,,354767093,5280343,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2950,1259423,1,2,,354912015,5280343,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
